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 In the recent decade there has been a shift in drug development to favor planar, 
aromatic small molecules with easy synthetic access, despite centuries of research in bioactive 
natural products, which are often highly rigid, three-dimensional structures like spirocycles. 
These scaffolds remain underexplored in drug development efforts, predominantly due to the 
challenges associated with their synthesis, and lack of a general, convergent methodology.  
 To address these challenges, we have designed an O–H Insertion/Conia-ene reaction 
cascade between homopropargylic alcohols and acceptor/acceptor diazo compounds, which 
uses dual Rh/Au+ catalytic system. This cascade occurs instantly at room temperature, and has 
been applied towards the synthesis of substituted tetrahydrofurans when linear diazo 
compounds are used. Thus far, the cascade accommodates a variety of substituted diazo 
compounds with carboxylic acids/alcohols to provide functionalized tetrahydrofurans, and -
butyrolactones, with a high degree of regio- and stereo-selectivity.  
 Next, we were able to extend the utility of our O–H Insertion/Conia-ene reaction cascade 
towards the synthesis of spiroheterocycles by employing cyclic diazo substrates with propargylic 
alcohols. This convergent approach furnishes an array of spiroheterocycles by employing the 
same dual Rh/Au+ catalytic system in refluxing dichloromethane. This approach has proven 
general, and was used to synthesize a substrate scope of twenty-four substrates based on natural 
product scaffolds, including spirobarbituates, spiromeldrum’s acids, spirooxindoles, and the 





 Lastly, we have extended our X–H Insertion/Conia-ene strategy towards uncommon 
nucleophiles, for the synthesis of sulfur- and all-carbon spirocycles. When propargylic thiols are 
employed as substrates with linear diazos, we have found that the S-H insertion reaction 
proceeds in high yield, and Conia-ene cyclization can be promoted when the reaction is 
conducted in a stepwise fashion. However, when the reaction is conducted in a single pot, we 
isolated a new, thiofuranofuran compound, which we expect forms via undesired 5-endo-dig 
cyclization of the propargylic thiol, followed by cyclopropanation and subsequent ring opening. 
Additionally,  by changing our retrosynthetic approach to an intramolecular disconnection, we 
were able to synthesize an all-carbon spirocycle through a benzylic C-H Insertion/Conia-ene 
cascade, by using a catalytic mixture consisting of Rh2(HFB)4, ClAuPPh3, and CuOTf in refluxing 
dichloromethane.  
 In an orthogonal research effort, we have also developed a metal-free cascade for the 
synthesis of aromatic heterocycles. This cascade uses precursors synthesized from readily 
accessible 2’-hydroxy/aminochalcones, and commences with a DBU-mediated intramolecular 
aldol condensation, which occurs within 90 minutes at room temperature, to generate a 1,3,5-
triene. This triene is heated overnight (80 – 120 °C) to promote a 6-electrocyclization, and 
oxidative aromatization to generate a new aromatic ring. This cascade has proven general, and 
has been applied towards the synthesis of benzo[c]coumarins, phenanthradinones, 
dibenzofurans, and carbazoles, up to a 1-gram scale.  
 The cascade reactions developed throughout the course of this dissertation research 
provide new retrosynthetic strategies for the formation of natural product cores, which could be 
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1.1 Introduction   
 The rising cost of therapeutics has been a topic of great debate in the last decade, and 
this topic strikes at a core issue in America – public health. With the current outbreak of the novel 
COVID-19 virus, public health is at the forefront of public consideration, on a global scale. This 
attention has spurred an urgent need for the development of new bioactive entities for the 
treatment of diseases, novel or otherwise. The rising cost of therapeutics is caused by a number 
of factors, including but not limited to their development time, average success rate, and method 
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of their synthesis. Innovation in the field of synthetic methodologies can contribute to reducing 
these development costs.  
A recent study published in the Journal of Health Economics has reported the cost of 
developing a new prescription medication is $2.6 billion, which has raised from $802 million in 
2003.1 These rising costs have several contributing factors, including the increased timeline of 
drug development and approval process in the 2010’s, often lasting a decade or more. And it is 
best not forgotten that development costs are high for entities that do not receive FDA approval 
– placing a higher burden of cost on drugs that are approved. The majority of these compounds 
fail during phase II or III clinical trials, which are often 3.5-7 years into the development timeline, 
after submission of an Investigational New Drug Application (IND) with the FDA. To recoup 
development costs, many compounds that do not receive FDA approval for their initial treatment 
goals are screened for treating other diseases.  
Even for drug compounds that are approved for production, one key factor contributing 
to the cost of their development is the number of steps associated with their synthesis. Currently 
the desire to minimize the number of synthetic steps in drug development, and the effort to 
prioritize combinatorial chemistry, the practice of high-throughput synthesis of compounds, has 
resulted in a number of blockbuster drugs however these compounds are primarily achiral, 
saturated, aromatic molecules.2   
These features have severely limited the chemical space explored in current drug 
development efforts. Chemical space provides a representation of all possible carbon-based 
molecules than can be created.3 Just like the number of planets, solar systems, and galaxies is 
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vast on a universal macroscale, the number of small molecules in chemical space is equally vast 
on the atomic microscale. By focusing modern drug development efforts on planar, aromatic 
molecules like those prepared in combinatorial chemistry, an entire realm of chemical space is 
being ignored, which could hold the key to highly potent, selective drug entities. Structurally 
complex, biologically relevant spirocycles, meanwhile, recently have been classified and their role 
in chemical space comprehensively mapped.3b-e 
 One area of chemical space that has been explored in drug development is the field of 
natural products. Natural products are generated as either primary or secondary metabolites of 
all living plants, animals, and marine organisms, and boast a high degree of structural complexity 
underexplored in chemical space. The enzymes responsible for the biosynthesis of these 
compounds are the ultimate chiral environment, often installing functional groups with a degree 
of stereocontrol that is unprecedented in synthetic chemistry. Natural products and their 
analogues had been a boon for pharmaceuticals throughout the 20th century, until the expansion 
of synthetic medicinal chemistry in the 1990’s shifted attention away from structurally complex 
molecules towards smaller molecules with short, straightforward synthetic routes, which could 
be easily screened in a high-throughput fashion from a library of compounds.4  
Indeed, a survey on four databases consisting of over 10,000 drugs and 3,000 natural 
products and has served to quantify the structural complexity lacking in modern pharmaceuticals. 
Namely, natural products typically contain more atoms (avg. M.W. 414 g/mol vs 340 g/mol), 
chiral centers (6.2 vs. 2.3), and H-Bond donors/acceptors. Likewise, successful drugs have more 
in common with compounds synthesized via combinatorial chemistry – these compounds have 
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an average molecular weight of 393 g/mol, 0.4 chiral centers per compound, and fewer H-Bond 
donors/acceptors.  
The inherent disadvantage of pursuing natural products as drug candidates is that the 
methods to obtain large quantities needed for mass production rely on long total synthesis, often 
on the magnitude of 20 to 40 steps, or unsustainable depletion of their source material. 
Therefore, there is a great need to harness the structural complexity found in natural products, 
which breeds target binding specificity, while minimizing the number of steps required to install 
said complexity from readily available starting materials. To circumvent the lengthy synthesis 
required to prepare complex natural product structures, one can install a high degree of 
complexity using cascade reactions, in which two or more transformations occur in a single 
reaction vessel.  
1.2 CASCADE REACTIONS IN TOTAL SYNTHESIS 
 In traditional organic synthesis, a multi-step reaction scheme is conducted by isolating 
the product of each individual reaction – this approach can be marred by time, characterization, 
and purification costs, especially when chromatographic purification is required. Ideally, one 
would perform multiple reactions without isolating intermediate products, in a process known 
as a reaction cascade. An ideal reaction cascade has to assure that the individual components are 
only involved in the reaction when they are required to do so, else byproducts arising from 
undesired reactivity pathways can result in a reduced yield. The literature contains many terms, 
used somewhat interchangeably, for the process of performing multiple reactions in a one-pot 
fashion, including cascade, domino, and tandem. For the purpose of this section, we will consider 
 Ch. 1 – Cascade Reactions: The Key to Molecular Complexity in Drug Development  
5 
 
cascade reactions only where all catalysts and reagents are present from the start of the reaction, 
and no additional additives are added throughout the course of the reaction. 
 The application of a reaction cascade lies at the pinnacle of synthetic design – 
generally producing complex, rigid scaffolds from simple starting materials. Because of their 
ability to install molecular complexity, cascade reactions have been a valuable tool in natural 
product total synthesis for decades, with R. Robinson’s 1917 total synthesis of tropinone 
considered the seminal work in the field.5-6  
 Because the field of cascade reactions broadly encompasses all chemical 
transformations, classification of the cascades can be difficult; In a recent review of cascade 
reactions, K. C. Nicolaou and coworkers separated the field into five classes.5c Nicolaou et. al. 
classified a litany of cascade reactions used in total synthesis by their principal component 
reactivity – nucleophilic, electrophilic, radical-mediated, pericyclic, and transition-metal 
mediated processes. Notably, these classifications are restricted to the synthetic transformations 
of small molecules using organic reagents and transition-metal catalysts, and does not cover the 
wealth of advances made in enzymatic catalysis.  
 Nucleophilic cascade reactions generally employ the use of a base to generate the 
active nucleophile, or commence from pre-formed organometallic nucleophiles; this approach is 
exemplified in Sorenson’s 2004 synthesis of (+)-harziphilone (Scheme 1.1a).7a Likewise, their 
electrophilic cascade counterparts use acid to increase the electrophilicity of pre-existing 
functional groups, or utilize traditional electrophilic reagents (e.g. BF3·OEt2, organosilanes, 
organoselenates, etc.), as seen in Padwa et. al’s 2002 synthesis of racemic jamine (Scheme 
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1.1b).7b In both cases, thermodynamic or photochemical conditions may need be employed to 
promote desired reactivity.  
 
Scheme 1.1 a.) Representative example of nucleophilic cascade reactions b.) Representative example of 
electrophilic cascade reactions 
 Because organic radicals are, by definition, a highly reactive species, they represent 
the ideal candidate for cascade transformations. In many cases, an organic radical will break a 
pre-existing or create a new -bond, generating a new radical intermediate capable of continuing 
the cascade, until the radical is ultimately trapped or scavenged. Parker and Fokas’ synthesis of 
morphine utilizes a radical cyclization cascade to form of the compound’s core (Scheme 1.2).7c 
 
Scheme 1.2 Representative example of radical cascade reactions 
 Pericyclic reactions have also been used in cascades, and are perhaps the most 
common processes encountered in cascade reactions. Because pericyclic reactions typically only 
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require thermal or photochemical input to proceed, this reaction class boasts a high degree of 
functional group tolerance which is ideal in cascade methodology. This class broadly includes 
cycloadditions, sigmatropic rearrangements and electrocyclic reactions. Due to the concerted 
nature of their reaction mechanisms, pericyclic reactions often generate complex scaffolds with 
a high degree of stereocontrol. One key example of a pericyclic reaction cascade is Boger et. al’s 
2006 synthesis of vindorosine, in which a -lactone core is generated through a Diels-Alder 
reaction of an 1,3,4-oxadiazole, followed by intramolecular [3+2] cycloaddition (Scheme 1.3).7d 
 
Scheme 1.3 Representative example of pericyclic cascade reactions 
 Lastly, the advances in transition metal catalysis has resulted in a wealth of examples 
in the development of multi-step cascade reactions; In recent years, development of chiral 
ligands for metal catalysts provides potential for cascades with a high degree of 
enantioselectivity. Palladium catalysis has provided a wealth of transformations for the synthetic 
chemist’s toolbox in the past 50 years, and its catalytic cycle could be considered a reaction 
cascade in its own regard. Amongst the palladium-catalyzed C-C bond coupling reactions, the 
Heck reaction has found numerous applications in cascade development. This principle is 
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exemplified in Keay et. al’s total synthesis of (+)-xestoquinone, in which a palladium (0) catalyst 
paired with a chiral BINAP ligand, promotes multiple 1,2-additions of palladium (II) intermediates 
to olefins, and terminates through -hydride elimination (Scheme 1.4).7e 
 
Scheme 1.4 Representative example of transition-metal mediated cascade reactions 
 Cascade reactions have been shown to generate complex scaffolds with a high degree of 
selectivity in a single step. This strategy has been applied to the total synthesis of several natural products, 
and can be an asset in drug discovery to reduce the cost of generating bioactive scaffolds in multi-step 
schemes. Despite significant advances in the field of cascade reactions, further development is needed to 
access underexplored scaffolds like spirocycles.   
1.3   SPIROCYCLIC NATURAL PRODUCT SYNTHESIS 
 Spirocycles are valuable targets in drug discovery because their rigid scaffolds are 
capable of directing their substituents in a precise, 3D fashion. Although they are valuable 
targets, methodology remains limited for the convergent construction of spirocycles. This section 
will highlight some key spirocyclic natural products, and a recent example of their synthesis. 
Several of these syntheses utilize -diazocarbonyls to generate carbenoids, but their ambiphilic 
reactivity is not exploited to generate the full spirocenter, with several additional steps needed 
to form the second ring. Examples such as these however have inspired our approach – designing 
a new reaction cascade, utilizing substrates containing a nucleophile and electrophile, in 
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combination with diazo compounds such as those explored in this section to generate spirocycles 
in a single step with a high degree of selectivity.  
1.3.1  SYNTHESIS OF (±)-BERKELEYAMIDE D AND NATURAL (–)-BERKELEYAMIDE D 
 The spirocyclic -lactam natural product Berkeleyamide D was originally isolated by 
Stierle, et al. in 2008 from the acid lake fungus Penicillium rubrum from Berkeley Pit Lake in Butte, 
Montana. This potent natural product was found to inhibit MMP3 and caspase-1.11 
Berkeleyamide belongs to a family of related -spiro--lactam natural products including the 
Pseurotin family and Azaspirene (Fig. 1.1).  
 
Figure 1.1. Spiro--lactam natural products 
 While the absolute configuration of spiro--lactams Pseurotin A and Azaspirene were 
able to be determined by extensive NMR characterization and X-Ray crystallography, the 
absolute configuration of Berkeleyamide D at C5 and relationship between substituents at C8 and 
C9 remained unknown until the first racemic synthesis was reported in 2014 by Tsubaki et al. The 
prepared racemate with separated by chiral HPLC gave both (+)- and (–)-enantiomers of 
Berkeleyamide D, with specific rotation values of []17D = +84.6 and -85.7, respectively.; the 
specific rotation of natural Berkeleyamide D was reported to be []25D = -55.9, which confirms 
the natural source as the (–)-enantiomer.12  
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 The 2014 Tsubaki racemic synthesis of Berkeleyamide D was accomplished in four 
synthetic steps and relies on a Darzens reaction to form an ,-epoxy--lactam, a central 
structure of several natural products, followed by formation of the spirocenter through C-
acylation. (Scheme 1.5).   
 
Scheme 1.5. Tsubaki et. al’s first reported synthesis of (±)-Berkeleyamide D 
 Starting from an -bromoketoamide, the authors developed a Darzens reaction using 
isobutyl glyoxyal to prepare an ,-epoxy--lactam in modest yield. This was treated with 
camphorsulfonic acid and exposed to triisopropyl orthoformate to generate the isopropyl ether 
as a single diastereomer; it is proposed that the nucleophile trajectory was dictated by the stearic 
bulk of the neighboring epoxide functionality.  A lithium enolate of this ether was generated by 
exposure to LiHMDS which was quenched with phenylacetyl chloride to prepare the desired 
spirolactam A, along with the undesired homodimer B. Unfortunately, screening of alternative 
bases and additives were unable to improve the yield of A. Finally, hydrolysis of A using para-
toluenesulfonic acid afforded racemic Berkeleyamide D.  
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 The first asymmetric synthesis of Berkeleyamide D was recently completed in 2019, 
due to methodology developed by Shen, et al.13 They describe a new asymmetric Darzens 
reaction to produce optically pure ,-epoxy--lactams (Scheme 1.6).  
 
Scheme 1.6. Shen et. al’s asymmetric Darzens reaction to access (–)-Berkeleyamide D 
 Shen’s formal synthesis utilized a new method developed in their group for the 
asymmetric synthesis of -epoxy--lactams with a chiral Ytterbium (III) catalyst, generated in 
situ via the reaction between Yb(OTf)3 and the chiral N,N’-dioxide ligand L-PePr2. While both 
chiral organocatalysis and Lewis acid catalysis have been successfully employed for 
enantioselective Darzens reactions, the nucleophile had been limited to α-halo carbonyls, 
chloroacetonitrile, chloromethylsulfones, and 2-halo-1-indanones until this point. The authors 
describe challenges in the desired asymmetric Darzens cascade including the steric hindrance of 
the new α-bromo-β-ketoamide nucleophile hampering the SN2 cyclization processes. Also, the 
diastereoselectivity of the aldol addition is directly related to the subsequent formation of the 
epoxide and lactam due to stereochemistry requirements, and the potential of a retro-aldol 
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process could reduce the enantioselectivity of the reaction. Nevertheless, using the new Yb-
catalyzed conditions, the -epoxy--lactam was formed in good yields with excellent 
enantioselectivity, and the authors were then able to complete the synthesis of (–)-Berkleyamide 
D following the remaining steps as outlined by Tsubaki et al.  
1.3.2 SYNTHESIS OF INDOLE ALKALOID (–)-SPIROTRYPROSTATIN B 
  (–)-Spirotryprostain B is a natural product classified as an indole alkaloid which was 
isolated in 1996 by Osada et al. from the fermentation broth of Aspergillus fumigatus BM939.8 
The compound, which can only be isolated in trace amounts (11 mg/400 mL fermentation broth), 
is known to inhibit the cell cycle in the G2/M phase and shows cytotoxic activity against the 
growth of human leukemia cell lines. While the first total synthesis of (–)-Spirotryprostatin B was 
reported in 2000,8b a total synthesis of the compound was reported by Meyers and Carreira in 
2003 which utilizes cyclopropane formation from 3-diazooxindole (Scheme 1.7).8 While this 
approach to (–)-Spirotryprostatin B is elegant in its own regard, it relies on multiple steps to 
generate the spirocenter, which could be reduced to a single step via novel cascade 
methodology.  




Scheme 1.7 Meyers and Carreira’s Synthesis of (–)-Spirotryprostatin B 
 The first step in Carreira’s synthesis involved a rhodium-catalyzed cyclopropanation 
between 3-diazooxindole and piperylene, which was achieved in good yields but no 
diastereoselectivity. The spirocyclic piperidine ring was then formed by MgI2-mediated ring 
expansion of the resultant vinylcyclopropane in good yields, and with a 6:1 diastereomeric ratio 
favoring the desired stereoisomer. After cleavage of the N-allyic protecting group through 
palladium catalysis, the authors were then able to achieve asymmetry through coupling to the 
N-Boc-L-proline acid chloride, which generated a separable mixture of diastereomers and was 
incorporated in the final natural product structure.  
1.3.3 SYNTHESIS OF CLINICALLY ADVANCED SPIROLACTONE (+)-GRISEOFULVIN  
 One of the most clinically relevant spirocyclic natural products is griseofulvin, who’s 
development and chemistry dates back to the early 1940’s which was recently reviewed.9 The 
compound was first isolated from the mushroom Penicillium griseofulvum in 1939 by Oxford and 
coworkers. Efforts to elucidate the structure of griseofulvin were attempted by several groups 
over the next decade, until the absolute configuration was determined through single crystal X-
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ray in 1977.10 The compound has impressive biological activity – it was found in 2001 that it can 
potentiate the antitumorigenesis of nocodazole and induce apoptosis in cancer cell lines at 
concentrations as low as 1 M.10 Notably, the compound was launched in 1959 in the U.K. under 
the name “Grisovin” and in the U.S. as “Fulcin” for the treatment of ringworm in animals and 
humans. Several racemic total syntheses of griseofulvin have been reported as early as 1960, 
with only one asymmetric synthesis reported in 1991 by Pirrung et. al that utilizes a key 
intramolecular Rh-catalyzed O-R insertion/sigmatropic rearrangement sequence to form the vital 
spirocenter (Scheme 1.8).10  This sequence is carried out in multiple steps however, and a 
reaction cascade could be considered to generate the full spirocycle in a single step.  
 
Scheme 1.8 Pirrung et al.’s asymmetric synthesis of (+)-Griseofulvin 
 Pirrung’s synthesis began with a commercially available dimethoxyphenol, which was 
subjected to chlorination, acylation, and phenolic addition to (R)-pent-3-en-2-ol. This 
intermediate was condensed with Mander’s reagent to provide a ketoester intermediate, which 
was then subjected to diazo transfer to give an Acceptor/Acceptor diazo. Carbenoid generation 
was conducted using Rh2(piv)4 to form the crucial spiro-junction in good yields, with complete 
diastereoselectivity. The synthesis was completed by conversion of the methyl ester to the 
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corresponding methyl ketone, followed by Diekmann cyclization and subsequent ether formation 
to furnish (+)-Griseofulvin in 5% yield over 10 steps.  
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1.4 ELECTROCYCLIC REACTIONS AND APPLICATIONS IN CASCADE REACTIONS 
 Electrocyclic reactions are a valuable tool in synthetic chemistry due to the convenient 
accessibility of their polyene precursors, high degree of selectivity, and atom economy, and have 
been utilized as key reactions in numerous natural product total synthesis in recent years.14c Not 
only this, but they are ideal candidates for cascade reactions, as they require only thermal input, 
with no additional reagents, to proceed – this overcomes functional group, reagent, and catalyst 
compatibility issues that are often encountered when designing new cascade reactions. The 
electrocyclic reaction is a subset of pericyclic reactions, in which electrons from multiple pi bonds 
interact in order to generate a new sigma bond, and a rearranged pi system (Scheme 1.9).  
 
Scheme 1.9 Generalized electrocyclization reactions in a.) 2 systems b.) 4 systems c.) 6 systems d.) 
8 systems 
 This process generally results in a high degree of stereocontrol, because of the 
principle of the conservation of orbital symmetry applies, as dictated by the Woodward-
Hoffmann rules.14a These rules allow one to predict the stereochemical outcome of an 
electrocyclic reaction, by understanding whether the orbitals involved in bond formation are 
both rotating in the same direction (conrotatory), or opposite directions (disrotatory). 
Electrocyclization reactions are generally classified by the number of pi electrons interacting in a 
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given system – 2, 4, 6p, and 8 electrocyclizations have all been well documented. These 
reactions can be generated either under thermal or photochemical conditions, and the 
Woodward-Hoffman rules summarize the impact of number of participating pi bonds and 
reaction conditions on the resulting product stereochemistry (Table 1).  
Electrocyclization Classification Number of  -bonds Thermal Outcome Photochemical Outcome 
2 1 Conrotatory Disrotatory 
4 2 Disrotatory Conrotatory 
6 3 Conrotatory Disrotatory 
8 4 Disrotatory Conrotatory 
Table 1.1 Summary of Woodward-Hoffman Rules for Electrocyclizations 
It should be noted however that the 1,3,5,7-cyclooctatrienes, generated through 8 
electrocyclization, are rarely isolated, and can undergo a subsequent 6 electrocyclization to 
yield bicyclo[4.2.0]octadienes (Scheme 1.9d). 
 In addition, oxo- and aza- variants of electrocyclization reactions are known and have 
been used to generate new heterocycles.14b This is most often exemplified in 6 electrocyclic 
substrates, whereby aldehydes and ketones are used to generate -pyrans, and imines generate 
dihydropyridines, which are readily oxidized to their pyridine counterpart (Scheme 1.10). 
 
Scheme 1.10 Generalized reactivity of a.) oxo-electrocyclization b.) aza-electrocyclization 
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1.5 OBJECTIVE OF RESEARCH 
 The primary objective of this dissertation research is to develop new cascade 
reactions for the synthesis of bioactive scaffolds for drug discovery. Spirocyclic compounds, 
including those derived from natural products, represent a promising synthetic challenge 
because of their unique biological activities, arising from their 3-dimensional structure presenting 
functional groups in a well-defined manner to their protein targets. While many linear sequences 
have been successfully employed for the synthesis of spirocyclic compounds, our cascade 
approach provides a general, convergent method to generate these in a step-efficient fashion. 
 Cascade reactions have been utilized in numerous creative total synthesis in the last 
decade, exploiting cationic, anionic, electrocyclic, and radical reactivity. Because cascades 
employ multiple reactions in one pot without isolation of any intermediates, they have been 
valuable synthetic tools to address atom economy, reagent, and purification costs. In order to 
expand chemical space in the drug development process, we seek to develop a new 
retrosynthetic approach to spirocycles, bisecting the molecule at the quaternary spirocenter, 
which exploits the reactivity of diazo-derived metal carbenoids. In addition, we envision a new 
cascade approach to aromatic heterocycles, exploiting electrocyclic reactivity of triene 
intermediates to bisect the traditionally unreactive aromatic ring.  
 
Scheme 1.11 a.) cascade approach towards spirocycles b.) cascade approach towards aromatic 
heterocycles   
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2.1  INTRODUCTION   
 The synthesis of small molecules containing a spirocenter continues to be a major 
challenge in organic synthesis, primarily because it involves the formation of a quaternary center. 
Quaternary centers, which are defined as one atom connected to four other atoms that are not 
hydrogen, are often chiral centers, which are difficult to form with a high degree of selectivity. 
This selectivity challenge stems from the geometry of the spirocyclic precursor – which is often a 
 




functional group that sp2 hybridized, or in a trigonal planar geometry. When an oncoming 
nucleophile reacts with a trigonal planar functional group to generate a chiral center, there is 
rarely any outside interference dictating its facial trajectory, resulting in the formation of a 
racemic stereocenter.  
 
Figure 2.1. a.)  Common Strategies Towards Spirocycles b.) Natural Products Bearing a Spiroether Core 
 Synthetic strategies have been developed to form spirocenters with a modest degree 
of stereocontrol, including alkylation, rearrangement, ring closure, cycloaddition, and radical 
cyclization, but these methods are all met with their own limitations (Figure 2.1a).1a Spirocyles 
comprise the core of numerous bioactive natural products, including the pseurotin family, 
Berkeleyamide D, azaspirene, and griseofulvin – which is on the World Health Organization’s list 
of essential medicines (Figure 2.2b).1b-1f 
 With the abundance of bioactive natural products featuring a spirocyclic core, these 
scaffolds show promise as future drug leads. However, there does not appear to be a general 
route for spirocycle formation based on the intermolecular connection at the quaternary center 
 




with high stereocontrol. Developing a general method would allow for the convenient 
construction of a diverse library of spirocycles. To this end, we have developed a convergent 
approach to spirocycle formation harnessing the ambiphilic reactivity of diazo-derived metal 
carbenoids in multi-step cascade reactions (Figure 2.2a). 
 
Figure 2.2. a.) General convergent approach to spirocycles b.) Carbene O–H Insertion/Conia-ene 
Approach to Spiroethers  
 We have developed an intermolecular reaction cascade which uses a two-component 
approach to spirocycles through cascade reactivity (Figure 2.2b). Our innovative approach first 
exploits the electrophilic reactivity of carbenoid intermediates in a carbene O–H insertion 
reaction. Then, 1,2-proton transfer of the zwitterionic intermediate is bypassed in favor of a 
Conia-ene cyclization, generating a new carbon-carbon bond. This convergent approach benefits 
from readily accessible diazo and alkynol precursors (generally one-step), and does not rely on 
forming highly functionalized linear precursors.  
2.2 SYNTHESIS AND REACTIVITY OF THE DIAZO FUNCTIONAL GROUP 
 The diazo functional group is one that has been exploited for numerous creative 
transformations since their discovery in 1858.2 Diazo compounds bear diatomic nitrogen gas 
 




bonded to a single carbon atom, and have several resonance forms contributing to their reactivity 
(Figure 2.3a)3a. 
 
Figure 2.3. a.) Resonance forms of the diazo functional group b.) Classification of diazo compounds. c.) 
Inverse stability of diazo-derived carbenes 
 Diazo compounds can be sorted into three classifications, denoted by the presence of 
adjacent stabilizing or destabilizing functional groups (Figure 2.3b). The first and most stable 
diazo class is the Acceptor/Acceptor (A/A) diazo, which bears two electron withdrawing 
substituents stabilizing the carbanion resonance form. While azides and diazo compounds have 
a reputation for dangerous decomposition, many A/A diazos are benchtop stable, and can be 
stored in gram-quantities for months. A general guideline to assess azide and diazo reactivity has 
 




been established, and is commonly known as the “rule of six.” The rule of six states that six carbon 
(or other atoms of about the same size) per energetic functional group should provide enough 
dilution to render the compound safe to work with.3b Another method of generalizing diazo/azide 
reactivity is to assess their carbon-to-nitrogen ratio – if the sum of carbon and oxygen atoms in 
the molecule, divided by the number of nitrogen atoms exceeds 3, then the diazo is likely stable 
enough to isolate in large quantities.3c 
 The next diazo classification is the moderately stable acceptor-only diazo, which bears 
only one stabilizing electron-withdrawing substituent, with either a hydrogen or alkyl 
substituent. One of the most classical acceptor-only diazos, ethyl diazoacetate (EDA), is 
commercially available as a dilute solution in either toluene or dichloroethane. EDA has been 
widely studied in the field of diazo chemistry, in part due to its convenient availability, reactivity, 
and utility as a synthon in late-stage functionalization. The final diazo classification is the least 
stable Donor/Acceptor (D/A) diazo, which bears one stabilizing electron-withdrawing group and 
one destabilizing electron donating group; these electron-donating groups are most often 
alkynyl, alkenyl, or aryl substituents.  
 When a diazo compound is exposed to an appropriate metal catalyst, often using Rh, 
Cu, Ru, and recently Fe, N2 gas is expelled to generate a metal-stabilized carbene. These reactive 
intermediates follow an inverse stability trend to their diazo precursors – the highly stable A/A 
diazo compounds generate the most reactive, highly electrophilic, carbenoids (Figure 2.2c).  
 Several methods are known for synthesizing stabilized diazo compounds – two of the 
most common utilize a methylene or ketone precursor (Scheme 2.1).  
 





Scheme 2.1 Synthesis of diazo compounds by Regitz diazo transfer 
 By far, the most common method for synthesizing A/A diazo compounds is the diazo 
transfer reaction, also referred to as the Regitz diazo transfer. This named reaction, reported in 
1964, employs the enolization of an active methylene compound, which then interacts with a 
sulfonyl azide reagent to transfer dinitrogen from the azide component.4a The method uses 
common sulfonyl azides like methanesulfonyl-, p-tolylsulfonyl-, and more recently the solid p-
actamidobenzenesulfonyl azide (p-ABSA), which are generated via anion exchange between the 
corresponding sulfonyl chloride and sodium azide. Because the methylene precursors are 
typically quite acidic, mild organic bases like triethylamine and 1,8-diazabicyclo[5.4.0]undec-7-
ene (DBU) are sufficient for the formation of most A/A diazo compounds. These diazos are 
conveniently isolated after chromatographic purification, simplified further by filtration of the 
sulfonamide byproduct.  
 A modification of the Regitz diazo transfer reaction was reported by Regitz and Menz 
in 1968 which extends its utility to a new classification of diazo compounds (Scheme 2.2).  
 
Scheme 2.2 Deformylative/Deacylative/Debenzoylative Diazo Transfer Reaction 
 




 Regitz originally reported -formylketones can be exposed to diazo transfer 
conditions to generate acceptor–only diazo compounds, alongside the formation of an N-
acylsulfonamide byproduct instead of the sulfonamide from standard diazo transfer conditions.4b 
In the same year, Hendrickson and Wolf independently reported the deacylative diazo transfer 
reaction, whereby diazo compounds were synthesized through diacylation, as opposed to 
deformylation4c. These discoveries were groundbreaking in the study of diazo compounds, as it 
allowed for the formation of stabilized diazos from scaffolds other than malonates and 
ketoesters. In the subsequent decades, Taber et. al reported an improved variation of Regitz’ 
deformylative diazo transfer reaction utilizing a benzoyl leaving group.4d 
 Diazo transfer reactions can also be used to synthesize donor–acceptor diazo 
compounds, depending on the effect of surrounding substituents on the active methylene 
acidity; generally, a stronger organic base like DBU is required in these circumstances. In 
situations where diazo transfer is not suitable for diazo preparation, aryldiazos can also be 
generated in a two-step sequence from a ketones, -ketoamides, and -ketoesters, in a variation 
of the Bamford-Stevens reaction (Scheme 2.3)5.  
 
Scheme 2.3 Diazo formation through reduction of sulfonyl hydrazones.  
  
 




2.3 TRAPPING OF ZWITTERIONIC INTERMEDIATE – THE CONIA–ENE 
REACTION 
 Broadly, an ene reaction can be classified as the concerted reaction between an alkene 
bearing an allylic hydrogen with a double- or triple-bond. These components are known as the 
“ene” and the “enophile,” respectively. Such a rearrangement benefits from high atom economy 
– as all atoms present in the starting material are incorporated in the final product. Variants of 
the ene reaction are known; replacing the ‘ene’ portion of an ene reaction with an enol is known 
as a Conia-ene reaction. This reaction was first reported in 1966 by J. M. Conia, who performed 
numerous studies on the thermal cyclization of unsaturated ketones at temperatures often 
exceeding 300 °C (Scheme 2.4a).6a In the subsequent years since its report, numerous authors 
have reported the addition of particular Lewis acids can promote the reaction at milder reaction 
conditions, either by increasing the amount of the nucleophile in the enol form, or by polarizing 
the electrophilic pi-system.  
 
Scheme 2.4 a.) Conia’s Thermal Ene Cyclization b.) Toste et. al.’s Au+ Promoted Conia–Ene Cyclization 
 




 In 2004 Toste et. al. reported a method for inducing a Conia-ene cyclization under 
much more mild reaction conditions than previously reported (Scheme 2.4b).7 After a screening 
of common Lewis acids and combinations thereof, Toste et. al. discovered that terminal alkynes 
could be polarized by cationic gold, generated via in situ reaction with various silver salts, and 
subsequently trapped intramolecularly with a large number of -ketoesters. This report has 
guided our design for a new method of trapping zwitterionic intermediates, generated through 
carbene heteroatom–insertion chemistry.  
2.4   CARBENOID CASCADE FOR THE FORMATION OF SUBSTITUTED 
TETRAHYDROFURANS AND -BUTYROLACTONES 
 In 2016 Hunter and Sharma reported a remarkable new method for the insertion of 
the carboxylic acid O–H bond into acceptor–acceptor diazo compounds, under mild conditions 
with an unprecedented reaction rate (Scheme 2.5a).8a This new method utilizes the catalyst 
Bis[rhodium),,’,’-tetramethyl-1,3-benzenedipropionic acid)] (Rh2(esp)2) to generate a 
reactive electrophilic carbenoid which reacts with carboxylic acids with reaction times of less 
than 10 minutes.  
 





Scheme 2.5. a.) Sharma and Hunter’s Carboxylic acid O–H Insertion to A/A Diazos b.) Mechanism of 
Carboxylic Acid O–H Insertion 
 The method reported by Sharma and Hunter displayed excellent chemoselectivity, 
favoring the acid O–H insertion over other known carbenoid–mediated processes such as olefin 
cyclopropanation, alkyne cyclopropenation, alcohol O–H insertion, and aryl sp2 C–H activation. 
When exposed to the rhodium catalyst, diazo A extrudes nitrogen gas to generate the 
electrophilic carbenoid intermediate B. The carboxylic acid then attacks the carbenoid, 
generating zwitterionic intermediate C. Finally, a 1,2-proton transfer regenerates the rhodium 
catalyst, resulting in the formation of insertion product D (Scheme 2.5b). This method has proven 
to be general, with a substrate scope of over 20 insertion compounds having yields ranging from 
good to excellent. 
 




2.4.1  SYNTHESIS OF -LACTONES THROUGH CARBENE O–H INSERTION/CONIA–ENE 
CASCADE 
 Expanding off of our earlier 2016 work, we hypothesized that the zwitterionic 
intermediate, generated in the process of acid O–H insertion, could be intercepted by a strong 
electrophile before 1,2-proton transfer occurs, to generate a new ring containing a quaternary 
center. Inspired by Toste’s 2004 work in the cationic-gold catalyzed Conia-ene reaction, Hunter 
and Sharma envisioned that a properly activated alkynoic acid would be capable of undergoing 
an intermolecular carbene O–H insertion/Conia-ene cascade to furnish substituted lactones. By 
exposing insertion compound 3 to a variety of Lewis acid catalysts, they found that cationic gold, 
generated through in situ formation of AgCl using a silver salt bearing a weakly–coordinating 
anion, could indeed induce annulation to the corresponding -lactone 4 efficiently at room 
temperature, whereas heating and a longer reaction time was needed for the only other 
successful Lewis Acid, copper (I) triflate (Scheme 2.6a).  
 





Scheme 2.6. a.) Lewis acid screening to promote intramolecular Conia-ene reaction b.) Carbene O–H 
Insertion/Conia-ene Cascade for –Lactones 
 Moreso, they found that butynoic acids are indeed capable of undergoing the desired 
reaction cascade in a one-pot fashion using a mixture of rhodium, gold, and silver catalysts with 
no trace of insertion products detected. This one-pot cascade approach was applied towards the 
synthesis of six different -lactones, with yields ranging from good to excellent (Scheme 2.7b). 
2.4.2 SYNTHESIS OF TETRAHYDROFURANS VIA ALCOHOL O–H INSERTION/CONIA–ENE 
CASCADE 
 Inspired by the results of Hunter and Sharma, we turned our attention towards 
harnessing alternative nucleophiles for the O–H insertion portion of the reaction cascade. While 
there is literature precedent for the O–H insertion of alcohols to diazo–derived carbenoids,9 an 
alcohol O–H insertion/Conia-Ene cascade would be a novel route to substituted 
 




tetrahydrofurans. Indeed, when butynoic acid was replaced with commercially available 3-butyn-
1-ol, the O–H insertion/Conia-ene reaction cascade was successful with a range of diazo 
compounds (Scheme 2.7).8b  
 
Scheme 2.7. O–H Insertion/Conia-ene Cascade Approach to Tetrahydrofurans 
 The reaction was successful with three different -diazoketoesters, resulting in 
tetrahydrofurans 6a-6c, bearing methyl, tert-butyl, and ethyl esters. The reaction cascade was 
also successful using diazo compounds derived from malonates; the methylmalonate diazo 
cleanly afforded diazo 6d in good yields. Finally, we looked to the scope of the alcohol component 
– The cascade was successful with an unsubstituted primary alkynol but would the additional 
steric factors of a secondary dissuade O–H insertion? Fortunately, when racemic 1-phenyl-3-
butyn-1-ol was exposed to the Rh/Au+ reaction conditions, tetrahydrofuran 6e was formed and 
isolated in good yields. Since a new chiral center is formed throughout the course of this reaction 
cascade, we then prepared a number of chiral primary and secondary alkynols to probe the 
diastereoselectivity of the transformation (Scheme 2.8). 
 





Scheme 2.8. Insertion of Chiral Primary and Secondary Alcohols to Probe Diastereoselectivity 
 To our delight, all prepared chiral primary and secondary alcohols withstood the reaction 
conditions well resulting in good yields of the corresponding furans. In the case of substituted primary 
alcohols, the reaction condition produced furan 6f with excellent diastereoselectivity, as determined by 
1H NMR analysis. Next, a chiral secondary alcohol was employed to generate furan 6g, also with excellent 
diastereoselectivity. Finally, an enantiomeric pair of substituted primary alcohols were exposed to the 
optimized reaction conditions in two parallel trials, and again we saw complete diastereoselectivity for 
compounds 6h and 6i. These products also had equal and opposite optical rotation values, as expected 
for a pair of enantiomers. 
2.5 REACTION DESIGN – ACCESSING THE SPIRO--LACTAM CORE OF 
BERKELEYAMIDE D 
 With the development of this successful reaction cascade we turned our attention 
toward our initial goal – The convergent formation of spirocycles. We targeted the core of 
Berkeleyamide D, as this would provide a similar route to the family of related -spiro--lactams. 
 




We began our substrate design by analyzing a truncated form of Berkeleyamide D, and bisecting 
the molecule down the spiro junction (Figure 2.4).  
 
Figure 2.4. Retrosynthesis and Cascade Approach to the Berkeleyamide D Core 
 We envisioned that the truncated Berkeleyamide D core could be accessed via our O–
H Insertion/Conia-ene cascade using secondary butynol 7 and -lactam diazo 8. After forming the 
spirocore of Berkeleyamide D, we expect the remaining functionality could be installed through 
reduction and elimination of the ketone, dihydroxylation, oxidative cleavage of exo-olefin, and 
subsequent enolization/oxidation sequence to add unsaturation to the furan ring. With this 
strategy in hand, we pursued the synthesis of -lactam diazo 7.  
  
 




2.5.1 SYNTHESIS of –LACTAM DIAZOS 
 All -lactam diazos were synthesized using a modified procedure originally reported by 
Wood et. al (Scheme 2.9).10 
 
Scheme 2.9. Synthetic route to –Lactam diazo 7 
 We began our synthesis using benzyl-protected -lactam diazo 7 as a model substrate. 
First, amino acid methyl ester hydrochlorides 9 were exposed to reductive amination conditions 
with benzaldehyde to furnish N-benzyl protected amines 10. This secondary amine was coupled 
to ethyl hydrogen malonate using carbodiimide coupling conditions to furnish amides 11. Next, 
the amides were exposed to Dieckmann cyclization conditions using in situ generated sodium 
ethoxide, followed by a hydrolysis/decarboxylation sequence to furnish -lactams 12. Finally, 
lactams 12 were exposed to Regitz diazo transfer conditions to furnish desired diazos 7. This 
 




synthetic route provides a useful handle for substrate diversification – Altering amino acid 9 
would affect the - alkyl substituent, and using leucine provides the exact alkyl chain present in 
natural Berkeleyamide D.  
2.5.2  REACTION OPTIMIZATION 
 With a synthetic route to lactam diazos accomplished, we then turned our attention 
towards reaction condition optimization (Table 2.1).  
 
Entry R P.G. Catalyst A Catalyst B d.r. Isolated Yield 
1 Me Bn Rh2(esp)2 (2 mol %) – 2.5:1.0 14% 
2 Me Bn Rh2(esp)2 (2 mol %) PPh3AuCl (10 mol %) 
AgOTf (10 mol %) 
2.5:1.0 53% yield 
3 iBu Bn Rh2(esp)2 (2 mol %) PPh3AuCl (10 mol %) 
AgOTf (10 mol %) 
10:1.0 58% yield 
4 iBu DMB Rh2(esp)2 (2 mol %) PPh3AuCl (10 mol %) 
AgOTf (10 mol %) 
>20:1.0 54% yield 
5 iBu DMB Rh2(esp)2 (2 mol %) PPh3AuCl (10 mol %) 
AgSbF6 (10 mol %) 
>20:1.0 68% yield 
Table 2.1 Reaction optimization for spiro––lactam synthesis 
Alanine–derived diazo 7a was first exposed to Rh2(esp)2, which has proven successful for acid and 
alcohol O–H insertion to A/A carbenoids. We observed no reaction initially at room temperature, 
so the temperature was increased to DCM reflux. To our delight, rhodium alone produced desired 
spirocycle 13, with no trace of insertion byproduct, albeit with a low yield and almost no 
 




diastereoselectivity (entry 1). We hypothesized that the addition of cationic gold would increase 
the electrophilicity of the alkyne component, as was the case in our tetrahydrofuran synthesis. 
The addition of 10 mol % of PPh3AuCl and AgOTf improved the yield of desired spirocycle 13a to 
53%, albeit with no major improvement in diastereoselectivity (entry 2). We then hypothesized 
that increasing the bulk on the alkyl component of diazo 7 would direct the trajectory of the 
incoming nucleophile better than a methyl substituent. In the case of leucine-derived diazo 7b (R 
= iBu), the reaction conditions cleanly afforded spirocycle 13b in good yields, with a marked 
increase in diastereoselectivity (entry 3). We then turned our attention towards affecting the 
stearic bulk of the amide protecting group (PG). When the standard benzyl protecting group was 
changed to the bulkier 2,4-dimethoxybenzyl protecting group, the diastereoselectivity of the 
transformation improved to >20:1, the greatest that can be determined by NMR integration 
(entry 4). Finally, we turned our attention towards the role of the counter anion, paired with the 
gold catalyst. Since the active catalyst is cationic gold, effectively PPh3Au+, we hypothesized that 
a weakly coordinating anion would improve the yield of the overall Conia-ene reaction. We 
screened a variety of silver salts bearing weakly coordinating anions (OAc–, OTf–, BF4–, PF6–, SbF6–
), and found a slight increase in yield using a silver salt bearing a hexafluoroantimonate (SbF6–) 
counter ion (entry 5). With optimized reaction conditions, we turned our attention toward 
determining the absolute configuration of the spirocenter formed during this reaction cascade.  
  
 




2.5.3 DETERMINING THE ABSOLUTE CONFIGURATION OF SPIRO--LACTAMS 13 
 We had hypothesized that the stearic bulk of the lactam -alkyl group would dictate 
the trajectory of the oncoming nucleophile to attack from the opposite face of the ring, after 
formation of the trigonal planar carbenoid intermediate. If this were indeed the case, the 
resulting product would have an S- configuration at the C5 spirocenter, while its diastereomer 
would have an R- configuration at the spirocenter (Figure 2.5a). We then performed Nuclear 
Overhauser effect (nOe) NMR experiments, which analyze through-space interactions of nearby 
protons, to glean insight into the configuration of this compound.  
 
Figure 2.5. a.) Diastereomer options for spiro--lactam 32b. b.) nOe experiment hypothesis 
 We envisioned that irradiating the chiral proton at C8 would provide valuable 
information into the orientation of the neighboring tetrahydrofuran ring. If the spirocenter was 
of the R- configuration, it may weakly couple to the olefin protons on the furan ring. Meanwhile, 
if the spirocenter was of the S- configuration, the olefin would lie on the same face of the C8 alkyl 
component, no such coupling would be present (Figure 2.5b). When these NMR experiments 
were performed however, we did indeed observe coupling between olefin protons and the chiral 
proton set at C8 (Figure 2.6a). These results serve to refute our initial hypothesis, and lead us to 
conclude that the configuration of the spirocenter at C5 is not dictated by the trajectory of the 
 




incoming alcohol nucleophile, but rather the stearic bulk of the resulting olefin after Conia-ene 
cyclization.  
 
Figure 2.6. a.) nOe correlations between C8 H and olefin H. Signal suppression has been applied to 
irradiated protons for clarity. b.) Single crystal X-Ray results of 13c and its enantiomer 
 Finally, in order to support the new hypothesis, we pursued crystal growth for 
spirolactam 13c and its enantiomer; fortunately, we were able to accomplish crystal growth by 
slow evaporation of the pure material in acetonitrile. The single crystal X-ray structure of 13c and 
 




its enantiomer supported our conclusion from the NMR experiments – when the diazo alkyl 
component is of the S- configuration, the resulting spirocenter will be the R- configuration. 
(Figure 2.6b). With this knowledge in hand, we explored the scope of diazos for this 
transformation.  
2.5.4   SPIRO--LACTAM SUBSTRATE SCOPE 
 The reaction conditions proved general with a range of N-Benzyl and N-
dimethoxybenzyl protected diazo substrates (Scheme 2.10). 
 
Scheme 2.10 Scope of -lactam Diazos Employed 
 As discovered during optimization studies, N-benzyl protected substrates 13a and 13b 
could be prepared in modest yields, albeit with fair diastereoselectivity at best. Fortunately, 
when the protecting group was changed to N-dimethoxybenzyl, the analogous substrates could 
be prepared in similar yields with complete diastereosectivity (13f and 13c). The reaction was 
also conducted with the enantiomer of leucine-derived diazo 7, and we were able to isolate 13d 
in good yields, which had an equal and opposite optical rotation to 13c, which is expected for 
 




enantiomers. Lastly, incorporation of a bulky benzyl alkyl group did not greatly impact overall 
yields or diasteroselecttivies (13e). 
2.5.5  COMPUTATIONAL INSIGHTS ON SELECTIVITY OF SPIROCENTER FORMATION  
 Next, we turned to computational collaborators at the University of Pittsburgh (Prof. 
Peng Liu) for computational insights into the energetics of spirocycle formation for our reaction 




































G = 2.8 kcal/mol
 
Figure 2.7. Transition State Calculation for Simplified Reaction Cascade Substrates  
 Ground state energy level calculations were performed using the B3LYP density 
functional and a mixed basis set of 6-31G(d) and SDD was used for Rh, Au, and non-metal atoms. 
To reduce computational resource strain, a simplified version of catalysts and substrates were 
used – Rh2(esp)2 ligands were simplified to acetate ligands, PPh3AuCl truncated to PH3AuOTf, and 
the alanine-derived diazo was used. Geometry optimizations were employed to determine the 
ground state energy level for starting materials and products, and transition state calculations 
were used to determine the energy of the transition states leading to the major and minor 
 




diastereomers. Even in the case of this simplified model system, we observe a 2.8 kcal/mol 
difference in energy between the O–H nucleophile attacking from the same face as the diazo 
methyl groups versus the opposite face.  
2.6  ROLE OF CHIRAL ALCOHOLS ON SPIROCENTER FORMATION 
 With the reaction cascade proving to be robust with respect to the -lactam diazo 
substrate, we then performed a series of experiments to probe the effect of pre-existing chirality 
of the O–H nucleophile on the resulting spirocenter formation (Scheme 2.11). Our previous 
success using chiral alcohols with linear diazos 1 led us to hypothesize that chiral alcohols would 
not have a major impact on the success of the reaction cascade. -lactam diazos 7 however, also 



















































Scheme 2.11 Role of Alcohol Chirality on Reaction Cascade 
 In the case of secondary alkynol 5b bearing the S-absolute configuration, which matched the 
S-configuration of diazo 7c, the reaction proceeded cleanly and in good yields to provide a single 
diastereomer of spirocycle 13g. When the absolute configuration of the secondary alcohol was changed 
 




to R-, however, we observed a sluggish reaction overall and alcohol 5c was not fully consumed. Indeed, in 
the mismatched case the reaction was sluggish and low yielding, resulting in poor diastereoselectivity for 
formation of spirocycle 13h. Next, we hypothesized that adding a linker CH2 to the mismatched secondary 
alcohol would result in a less-crowded transition state, leading to a higher diastereomeric ratio. In 
addition, Berkeleyamide D is substituted with a benzyl group at the C2 position. Indeed, when benzyl-
substituted secondary alcohol 5d was employed as a substrate, we observed an increase in yield and a 
modest increase in diastereoselectivity compared to its fellow mismatched substrate 13h. Ultimately, if a 
full synthesis for Berkeleyamide D were to be pursued,  the S- enantiomer of secondary alcohol 8d should 
be employed, which would result in good diastereoselectivity in the formation of the C5 spirocenter; since 
Berkeleyamide D features unsaturation between the C2 and C3 position, the preceding configuration at 
C2 would be inconsequential.  
  
 




2.7  APPLICATION OF REACTION CASCADE TO N,N-DIMETHYLBARBITUATE 
AND MELDRUM’S ACID SYSTEMS 
 Lastly, we wanted to extend our application to other cyclic diazo substrates, to probe 
its utility in the synthesis of alternative spiroethers (Scheme 2.12). 
 
Scheme 2.12 Cascade Approach to Spirobarbituates and Spiromedrum’s Acids 
 To our delight, known Meldrum’s acid and N,N-dimethyl barbiturate diazos tolerated 
reaction conditions to afford the corresponding spiroethers in moderate to good yields. Lower 
yields were obtained broadly for spiromedrum’s acids 15a-15c, presumably due to their tendency 
to undergo fragmentation in the presence of Lewis Acids.11 
  
 




2.8 SUMMARY & FUTURE DIRECTIONS 
 Completion of this research program has afforded a convergent cascade approach to 
substituted tetrahydrofuran, -butyrolactone, spiro--lactam, and general spiroether scaffolds. 
This intermolecular reaction cascade employs the formation of an electrophilic carbenoid 
through the rhodium-catalyzed decomposition of stable A/A diazo compounds, followed by the 
O–H insertion reaction of alkynols and finally intramolecular trapping of the generated ylide with 
cationic gold-activated alkynes. The cascade has proven to be quite general in terms of reagent 
tolerance, with A/A diazos able to react with primary and secondary alkynols, resulting in a 
substrate scope of nine different tetrahydrofurans and over ten spirocycles prepared. Currently, 
the X-H Insertion/Conia-ene cascade has been successfully applied to O–H, N–H, and sp2 C–H 
insertion substrates to produce a diverse set of spiroheterocycles; further developments to this 
cascade include harnessing S–H, sp3 C–H, and Si–H reactivity to produce uncommon heterocyclic 
and spiroheterocyclic frameworks. While the reactivity of the X–H insertion reaction to carbenes 
is well developed, trapping their reactive intermediates with electrophiles in cascade reactions is 
still in its infancy – Our group has successfully utilized activated-alkynes and ketone electrophiles, 
however other electrophilic trapping agents can be explored, such as electron-deficient esters, 
cobalt acetylides, and silanes.  
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2.10  EXPERIMENTAL SECTION 
PUBLICATION AND CONTRIBUTION STATEMENT 
The research presented in this chapter were published in the Chemistry – A European Journal 
(DOI: 10.1002/chem.201603934) and the Journal of Organic Chemistry (DOI: 
10.1021/acs.joc.7b03196). Dr. Indrajeet Sharma and Arianne Hunter contributed with assistance 
in project design, manuscript writing, and editing.  The examples presented in Schemes 2.7, 2.10, 
2.11, and examples 15d – 15g were contributed by Steven Schlitzer, with starting material 
preparation assistance by co-author Bilal Almutwalli. Examples 15a – 15b were contributed by 
co-author Arianne Hunter. The examples presented in Scheme 2.8 were contributed equally by 
Steven Schlitzer and Arianne Hunter.  
MATERIALS AND METHODS  
Reagents  
Reagents and solvents were obtained from Sigma-Aldrich (www.sigma-aldrich.com), ChemImpex 
(www.chemimpex.com) or Acros Organics (www.fishersci.com) and used without further 
purification unless otherwise indicated. Dry solvents (acetonitrile) were obtained from Acros 
Organics (www.fishersci.com), and dichloromethane was distilled over CaH2 under N2 unless 
otherwise indicated. THF purchased from Sigma-Aldrich was distilled over Na metal with 
benzophenone indicator. Diazo compounds were stored as a dilute solution frozen in benzene 
for periods longer than 24 hours.  
Reactions  
 




All reactions were performed in flame-dried glassware under positive N2 pressure with magnetic 
stirring unless otherwise noted. Liquid reagents and solutions were transferred thru rubber septa 
via syringes flushed with N2 prior to use. Cold baths were generated as follows: 0 °C with wet 
ice/water and −78 °C with dry ice/acetone. Syringe pump addition reactions were conducted 
using a CMA/100 microinjection pump.  
Chromatography  
TLC was performed on 0.25 mm E. Merck silica gel 60 F254 plates and visualized under UV light 
(254 nm) or by staining with potassium permanganate (KMnO4), cerium ammonium molybdenate 
(CAM), phosphomolybdic acid (PMA), and ninhydrin. Silica flash chromatography was performed 
on Sorbtech 230–400 mesh silica gel 60.  
Analytical Instrumentation  
IR spectra were recorded on a Shimadzu IRAffinity-1 FTIR or a Nicolet 6700 FTIR spectrometer 
with peaks reported in cm–1. NMR spectra were recorded on a Varian VNMRS 400, 500 and 600 
MHz NMR spectrometer in CDCl3 unless otherwise indicated. Chemical shifts are expressed in 
ppm relative to solvent signals: CDCl3 ((1H, 7.26 ppm, 13C, 77.0 ppm); coupling constants are 
expressed in Hz. NMR spectra were processed using Mnova 
(www.mestrelab.com/software/mnova-nmr). Mass spectra were obtained at the OU Analytical 
Core Facility on an Agilent 6538 High-Mass-Resolution QTOF Mass Spectrometer and an Agilent 
1290 UPLC. X-ray crystallography analysis was carried out at the University of Oklahoma using a 
Bruker APEX ccd area detector and graphite-monochromated Mo Kα radiation (λ = 0.71073 Å) 
source and a D8 Quest diffractometer with a Bruker Photon II cmos area detector and an Incoatec 
 




Iµs microfocus Mo Kα source (λ = 0.71073 Å). Crystal structures were visualized using CCDC 
Mercury software (http://www.ccdc.cam.ac.uk/products/mercury/).  
Nomenclature  
N.B.: Atom numbers shown in chemical structures herein correspond to IUPAC nomenclature, 
which was used to name each compound. 
 
3-butyn-1-ol is commercially available from Chem. Impex. and was used without further 
purification.  
 
(S)-1-phenylbut-3-yn-1-ol 5b and (R)-1-phenylbut-3-yn-1-ol 5c were synthesized in a four-step 
procedure as reported by Sandgren et. al12a. 
 
(R)-1-phenylpent-4-yn-2-ol 5d was synthesized in a four-step procedure as reported by 
Montagnat et. al12b. 
 




2.10.1 GENERAL PROCEDURE FOR THE SYNTHESIS OF TETRAHYDROFURANS (GP1) 
Alkynol (1 equiv.), Rh2((esp))2 (1 mol%), AgOTf (10 mol%), PPh3AuCl (10 mol%), and activated 4Å 
molecular sieves (36 mg per mL of solvent) were added to a round bottom flask, dissolved in 
anhydrous dichloromethane (0.2 M), and allowed to pre–mix for 5 minutes. The diazo (1.2 equiv.) 
was dissolved in anhydrous dichloromethane (0.2 M making a total 0.1 M solution for the 
reaction) was then added dropwise via syringe over a span of 2 minutes. Once the release of N2 
gas ceased, reaction was observed to be complete by TLC. After completion, reaction mixture 
was filtered through a pad of celite and concentrated by rotary evaporation to provide the crude 
compound. Purification by flash chromatography (EtOAc/Hex) afforded pure tetrahydrofurans 
29. 
 
Methyl 2–benzoyl–3–methylenetetrahydrofuran–2–carboxylate (6a). Prepared from methyl 2– 
diazo–3–oxo–3–phenylpropanoate and 3–butyn–1–ol using general procedure GP1. Yellow liquid 
(52 mg, 86%). 1H NMR (400 MHz) δ 8.05–7.99 (m, 2H), 7.57–7.51 (m, 1H), 7.46–7.39 (m, 2H), 5.50 
(t, J = 2.1 Hz, 1H), 5.41 (t, J = 2.3 Hz, 1H), 4.21 (q, J = 7.8 Hz, 1H), 4.08 (dt, J = 8.3, 6.4 Hz, 1H), 3.74 
(s, 3H), 2.73 (ddt, J = 7.5, 4.4, 1.4 Hz, 2H). 13C NMR (101 MHz) δ 191.2, 170.0, 143.8, 134.3, 133.2, 
129.7 (2C), 128.4 (2C), 112.6, 90.2, 68.9, 53.0, 32.9. 
 
tert–Butyl 2–benzoyl–3–methylenetetrahydrofuran–2–carboxylate (6b). Prepared from 
tertbutyl 2–diazo–3–oxo–3–phenylpropanoate and 3–butyn–1–ol using general procedure GP1. 
 




Yellow oil (47 mg, 80%). TLC: Rf 0.5 (4:1 hexanes/EtOAc). IR (NaCl) max: 2958, 2924, 2854, 2127, 
1722, 1598, 1583 cm-1. 1H NMR (400 MHz) δ 8.07–8.03 (m, 2H), 7.57–7.50 (m, 1H), 7.47–7.39 (m, 
2H), 5.50 (t, J = 2.1 Hz, 1H), 5.41 (t, J = 2.2 Hz, 1H), 4.23 (q, J = 7.8 Hz, 1H), 4.07 (dt, J = 8.2, 6.3 Hz, 
1H), 2.73 (ddt, J = 8.3, 4.4, 1.7 Hz, 2H), 1.32 (s, 9H). 13C NMR (101 MHz) δ 191.3, 168.5, 144.3, 
134.8, 132.9, 129.6 (2C), 128.3 (2C), 111.9, 90.1, 83.1, 68.8, 33.2, 29.7, 27.6. ESI–MS m/z calcd 
for C17H20O4 ([M+Na]+) 311.1; found 311.1. 
 
Ethyl 2–acetyl–3–methylenetetrahydrofuran–2–carboxylate (6c). Prepared from ethyl 2–diazo–
3–oxobutanoate and 3–butyn–1–ol using general procedure GP1. Yellow oil (45 mg, 64%). TLC: 
Rf 0.60 (7:3 hexanes/EtOAc). IR (NaCl) max: 2963, 2925, 1745, 1662 cm-1. 1H NMR (400 MHz) δ 
5.32 (t, J = 2.4 Hz, 1H), 5.30 (t, J = 2.2 Hz, 1H), 4.17 (qd, J = 7.1, 2.9 Hz, 2H), 4.09–3.97 (m, 2H), 
2.70– 2.59 (m, 2H), 2.17 (s, 3H), 1.21 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz) δ 201.6, 168.1, 143.3, 
112.0, 90.2, 68.4, 61.9, 32.7, 30.8, 25.4, 13.9. HRMS (ESI) m/z calcd for C10H14O4 ([M+Na]+) 
221.0790; found 221.0784. 
 
1,1'–(3–Methylenetetrahydrofuran–2,2–diyl)bis(ethan–1–one) (6d). Prepared from 3–
diazopentane–2,4–dione and 3–butyn–1–ol using general procedure GP1. Orange oil (52 mg, 
78%). 1H NMR (400 MHz) δ 5.34 (t, J = 2.2 Hz, 1H), 5.30 (t, J = 2.4 Hz, 1H), 4.08 (t, J = 7.1 Hz, 2H), 
2.67 (ddd, J = 7.1, 4.9, 2.3 Hz, 2H), 2.23 (s, 6H). 13C NMR (101 MHz) δ 198.8, 178.9, 144.7, 112.9, 
95.5, 42.3, 25.9. 
 









1,1'–(3–Methylene–5–phenyltetrahydrofuran–2,2–diyl)bis(ethan–1–one) (6e). Prepared from 
3– diazopentane–2,4–dione and 1–phenylbut–3–yn–1–ol using general procedure GP1. Yellow 
oil (72mg, 72%). TLC: Rf 0.63 (7:3 hexanes/EtOAc). 1H NMR (400 MHz) δ 7.46–7.30 (m, 5H), 5.37 
(dd, J = 2.8, 1.6 Hz, 1H), 5.34 (dd, J = 3.0, 1.6 Hz, 1H), 5.07 (dd, J = 10.3, 6.1 Hz, 1H), 3.03 (ddt, J = 
15.7, 6.1, 1.6 Hz, 1H), 2.65 (ddt, J = 15.8, 10.3, 2.9 Hz, 1H), 2.31 (d, J = 5.4 Hz, 6H). 13C NMR (101 
MHz) δ 203.3, 202.6, 142.6, 139.9, 128.7 (2C), 128.3 (2C), 126.1, 111.9, 81.4, 41.2, 26.3, 26.0. 
HRMS (ESI) m/z calcd for C15H16O3 ([M+Na]+) 267.0997; found 267.0993. 
 
Methyl (2S,4S)–2–benzoyl–3–methylene–4–phenyltetrahydrofuran–2–carboxylate (6f). 
Prepared from methyl 2–diazo–3–oxo–3–phenylpropanoate and 2–phenylbut–3–yn–1–ol using 
general procedure GP1. Clear oil (47 mg, 77%). TLC: Rf 0.65 (4:1 hexanes/EtOAc). 1H NMR (400 
MHz) δ 8.14–8.02 (m, 2H), 7.63–7.53 (m, 1H), 7.52–7.37 (m, 2H), 7.40–7.15 (m, 5H), 5.55 (d, J = 
3.0 Hz, 1H), 5.13 (d, J = 2.7 Hz, 1H), 4.47 (t, J = 8.2 Hz, 1H), 4.27 (dd, J = 10.1, 8.3 Hz, 1H), 3.97 
(ddt, J = 10.7, 8.1, 2.8 Hz, 1H), 3.80 (s, 3H). 13C NMR (101 MHz) δ 190.6, 170.2, 148.7, 138.5, 134.2, 
133.4, 129.8 (2C), 128.9 (2C), 128.7 (2C), 128.5 (2C), 127.3, 114.4, 91.4, 76.1, 53.1, 50.6. 
 
Methyl (2S,5R)–2–benzoyl–3–methylene–5–phenyltetrahydrofuran–2–carboxylate (6g). 
Prepared from methyl 2–diazo–3–oxo–3–phenylpropanoate and 1–phenylbut–3–yn–1–ol using 
 




general procedure GP1. Clear oil (52 mg, 77%). TLC: Rf 0.64 (7:3 hexanes/EtOAc). 1H NMR (400 
MHz) δ 8.16–8.03 (m, 4H), 7.60–7.50 (m, 1H), 7.48–7.39 (m, 1H), 7.37–7.19 (m, 4H), 5.53 (dd, J = 
2.8, 1.3 Hz, 1H), 5.46 (dd, J = 3.1, 1.2 Hz, 1H), 5.42 (dd, J = 10.8, 5.6 Hz, 1H), 3.77 (s, 3H), 3.04 (ddt, 
J = 15.2, 5.7, 1.3 Hz, 1H), 2.67 (ddt, J = 15.1, 10.8, 2.9 Hz, 1H). 13C NMR (101 MHz) δ 190.8, 170.3, 
144.2, 140.0, 134.4, 133.2, 129.9 (2C), 128.4 (2C), 128.4 (2C), 128.3 (2C), 127.9, 125.9, 112.6, 
82.2, 52.9, 41.9. HRMS (ESI) m/z calcd for C20H18O4 ([M+Na]+) 345.1095; found 345.1102. 
 
Methyl (2R,5R)–2–benzoyl–5–((benzyloxy)methyl)–3–methylenetetrahydrofuran–2–
carboxylate (6h). Prepared from methyl 2–diazo–3–oxo–3–phenylpropanoate and (R)–1–
(benzyloxy)pent–4–yn– 2–ol using general procedure GP1. Clear oil (62 mg, 64%): [α]21D +22.8 (c 
= 1, CHCl3). TLC: Rf 0.52 (7:3 hexanes/EtOAc). 1H NMR (400 MHz) δ 8.13–8.00 (m, 2H), 7.40 (t, J 
= 7.8 Hz, 3H), 7.23 (dd, J = 5.2, 1.7 Hz, 3H), 7.16 (dd, J = 6.9, 2.8 Hz, 2H), 5.48 (dd, J = 2.7, 1.6 Hz, 
1H), 5.40 (dd, J = 2.9, 1.6 Hz, 1H), 4.43 (s, 2H), 3.75 (s, 3H), 3.66 (ddd, J = 14.6, 4.8, 2.4 Hz, 1H), 
3.53 (t, J = 4.3 Hz, 2H), 2.84 – 2.72 (m, 1H), 2.68 (ddt, J = 8.9, 5.9, 2.7 Hz, 1H). 13C NMR (101 MHz) 
δ 191.3, 170.2, 143.8, 138.0, 134.4, 133.1, 129.9, 129.3, 128.6, 128.3, 128.3, 128.2, 127.5, 127.4, 
112.8, 90.9, 79.9, 77.3, 73.2, 71.1, 53.0, 35.2. HRMS (ESI) m/z calcd for C22H22O5 ([M+Na]+) 
389.1357; found 389.1365. 
 
Methyl (2R,5S)–2–benzoyl–5–((benzyloxy)methyl)–3–methylenetetrahydrofuran–2–
carboxylate (6i). Prepared from methyl 2–diazo–3–oxo–3–phenylpropanoate and (S)–1–
 




(benzyloxy)pent–4–yn–2–ol using general procedure GP1. Clear oil (47 mg, 75%): [α]21D –22.8 (c 
= 1, CHCl3). TLC: Rf 0.52 (7:3 hexanes/EtOAc). 1H NMR (400 MHz) δ 8.13–8.00 (m, 2H), 7.40 (t, J 
= 7.8 Hz, 3H), 7.23 (dd, J = 5.2, 1.7 Hz, 3H), 7.16 (dd, J = 6.9, 2.8 Hz, 2H), 5.48 (dd, J = 2.7, 1.6 Hz, 
1H), 5.40 (dd, J = 2.9, 1.6 Hz, 1H), 4.43 (s, 2H), 3.75 (s, 3H), 3.66 (ddd, J = 14.6, 4.8, 2.4 Hz, 1H), 
3.53 (t, J = 4.3 Hz, 2H), 2.84 – 2.72 (m, 1H), 2.68 (ddt, J = 8.9, 5.9, 2.7 Hz, 1H). 13C NMR (101 MHz) 
δ 191.3, 170.2, 143.8, 138.0, 134.4, 133.1, 129.9, 129.3, 128.6 (2C), 128.3, 128.2, 127.5, 127.4, 
112.8, 90.9, 79.9, 77.3, 73.2, 71.1, 53.0, 35.2. HRMS (ESI) m/z calcd for C22H22O5 ([M+Na]+) 
389.1357; found 389.1365. 
2.10.3  GENERAL PROCEDURE FOR THE SYNTHESIS OF DIAZO COMPOUNDS (GP2) 
To a flame dried round bottom flask equipped with a magnetic stir bar was added A prepared solution of 
lactam precursor in acetonitrile (0.2M, 1.0 equiv) and p–acetamidobenzenesulfonyl azide (1.2 equiv).  The 
reaction mixture was cooled to 0 ºC and triethylamine (3.0 equiv) was added dropwise by hand. The 
reaction mixture was monitored via TLC until complete lactam consumption was observed. The reaction 
mixture was then diluted with ethyl acetate, and washed with a saturated solution of ammonium chloride. 
The aqueous layer was extracted with additional ethyl acetate, and combined organics were dried over 
sodium sulfate, filtered, and concentrated. The crude mixture was then purified via flash silica gel 












(S)–3–diazo–1–(2,4–dimethoxybenzyl)–5–isobutylpyrrolidine–2,4–dione (7c).  Prepared using (S)–1–
(2,4–dimethoxybenzyl)–5–isobutylpyrrolidine–2,4–dione and general procedure E.  Bright yellow oil (600 
mg, 77%).  [α]21D –85.5 (c = 0.023, CHCl3).  TLC: Rf 0.51 (40% Ethyl acetate in hexanes).  IR (NaCl) max: 
2999, 2957, 2872, 2839, 2360, 2335, 2123, 1762, 1689, 1612, 1508, 1402, 1363, 1209, 1157, 1122, 1037, 
835 cm-1.  1H NMR (500 MHz) δ 7.22 (d, J = 8.1 Hz, 1H), 6.48–6.42 (m, 2H), 4.99 (d, J = 14.8 Hz, 1H), 4.13 
(d, J = 14.8 Hz, 1H), 3.80 (d, J = 1.0 Hz, 6H), 3.76 (dd, J = 7.5, 3.9 Hz, 1H), 1.89 (m, J = 13.4, 6.6, 5.4, 1.7 Hz, 
1H), 1.78–1.65 (m, 2H), 0.92 (d, J = 6.7 Hz, 3H), 0.86 (d, J = 6.6 Hz, 3H). 13C NMR (126 MHz) δ 190.3, 161.6, 
160.9, 158.4, 131.6, 128.3, 116.3, 104.4, 98.5, 62.7, 55.41, 55.4, 38.9, 38.1, 23.9, 23.6, 22.5. LRMS (ESI) 





(R)–3–diazo–1–(2,4–dimethoxybenzyl)–5–isobutylpyrrolidine–2,4–dione (7d). Prepared using (R)–1–
(2,4–dimethoxybenzyl)–5–isobutylpyrrolidine–2,4–dione and general procedure E.  Bright yellow oil 
(255mg, 71%).  [α]21D +85.3 (c = 0.017, CHCl3).  TLC : Rf 0.51 (40% Ethyl acetate in hexanes). IR (NaCl) max: 
2957, 2870, 2396, 2388, 2123, 1683, 1614, 1589, 1506, 1404, 1361, 1209, 1157, 1122, 1035, 858 cm-1.   1H 
NMR (500 MHz) δ 7.23 (d, J = 8.1 Hz, 1H), 6.52–6.41 (m, 2H), 5.00 (d, J = 14.8 Hz, 1H), 4.14 (d, J = 14.8 Hz, 
 




1H), 3.81 (s, 6H), 3.77 (dd, J = 7.6, 3.9 Hz, 1H), 1.96 – 1.84 (m, 1H), 1.73 (m, 2H), 0.93 (d, J = 6.7 Hz, 3H), 
0.87 (d, J = 6.5 Hz, 3H).  13C NMR (101 MHz) δ 190.2, 161.6, 160. 8, 158.3, 131.5, 128.3, 116.1, 104.3, 98.3, 
62.6, 55.3, 55.3, 38.8, 38.0, 23.8, 23.6, 22.4.  LRMS (ESI) m/z calcd for C17H24N3O4Na ([M+Na]+) 354.4; 
found 353.9. 
 
(S)–5–benzyl–3–diazo–1–(2,4–dimethoxybenzyl)pyrrolidine–2,4–dione (7e).  Prepared using (S)–5–
benzyl–1–(2,4–dimethoxybenzyl)pyrrolidine–2,4–dione  and general procedure E.  Bright yellow oil (126 
mg, 47%).  [α]21D –40.2 (c = 0.024, CHCl3).  TLC : Rf 0.62 (50% Ethyl acetate in hexanes). IR (NaCl) max: 
3028, 3001, 2935, 2937, 2360, 2335, 1768, 1695, 1612, 1506, 1456, 1415, 1259, 1207, 1157, 1122, 1035, 
925, 833 cm-1. 1H NMR (400 MHz) δ 7.36 (s, 2H), 7.31–7.22 (m, 3H), 7.17 (d, J = 9.0 Hz, 1H), 7.12 (m, 2H), 
6.49 – 6.42 (m, 2H), 5.03 (d, J = 14.6 Hz, 1H), 4.24 (d, J = 14.6 Hz, 1H), 4.02 (t, J = 4.4 Hz, 1H), 3.81 (d, J = 
5.7 Hz, 6H), 3.19 (t,  J = 4.8 Hz, 2H). 13C NMR (126 MHz) δ 189.3, 161.8, 161.0, 158.5, 134.5, 131.8, 129.7 
(2C), 128.5(2C), 128.3 (2C), 127.2, 116.1, 104.5, 98.5, 64.6, 55.4, 39.4, 34.8. LRMS (ESI) m/z calcd for 
C20H19N3O4Na ([M+Na]+) 388.4; found 387.9. 
 
 




(S)–3–diazo–1–(2,4–dimethoxybenzyl)–5–methylpyrrolidine–2,4–dione (7f).  Prepared using (S)–1–
(2,4–dimethoxybenzyl)–5–methylpyrrolidine–2,4–dione and general procedure E.  Faint yellow oil (499 
mg, 93%).  [α]21D –162.2 (c = 0.024, CHCl3).  TLC : Rf 0.63 (50% Ethyl acetate in hexanes).  IR (NaCl) max: 
2939, 2837, 2360, 2335, 2214, 1664, 1612, 1508, 1462, 1265, 1213, 1157, 1122, 1037, 974, 935, 835 cm-
1.   1H NMR (400 MHz) δ 7.22–7.15 (m, 1H), 6.42 (d, J = 6.8 Hz, 2H), 4.92 (d, J=14.8 Hz, 1H), 4.15 (d, J = 14.8 
Hz, 1H), 3.77 (d, J = 7.4 Hz, 6H), 3.73 (q, 1H), 1.36 (d, J = 6.9 Hz, 3H).  13C NMR (101 MHz) δ 190.2, 161.0, 
160.9, 158.4, 131.4, 116.3, 104.5, 98.4, 60.1, 55.4, 55.4, 43.5, 38.6, 15.3.  LRMS (ESI) m/z calcd for 
C14H15N3O4Na ([M+Na]+) 312.3; found 311.9. 
2.10.3 GENERAL PROCEDURE FOR THE SYNTHESIS OF SPIRO––LACTAMS (GP3) 
To a 4.0 mL vial equipped with a magnetic stir bar was added powdered 4Å molecular sieves (70 
mg/ mL solvent).  The molecular sieves were activated via heat and allowed to cool to room 
temperature under vacuum.  Rh2((esp))2 (1 mol %), AuClPPh3 (10 mol %), and AgSbF6 (10 mol %) 
were then measured directly into the reaction vessel.  A solution of alkynol (1.2 equiv.) and diazo 
(1.0 equiv.)  in dichloromethane (0.3M) was added, and the mixture was sonicated for 30 
seconds.   The reaction vessel was sealed, and heated to reflux.   The reaction was monitored by 
TLC until complete consumption of diazo was observed (between 30 minutes – 5 h).  The crude 
reaction mixture was then cooled to room temperature, filtered through a pad of celite, 
concentrated, and analyzed via 1H NMR. The crude mixture was then purified via flash 
chromatography to furnish spirocyclic compounds.  
 
 





6,9–dione (13c). Prepared from (S)–3–diazo–1–(2,4–dimethoxybenzyl)–5–isobutylpyrrolidine–
2,4–dione and but–3–yn–1–ol using general procedure GP3 (Conversion of Diazo observed in 1 
hour).  Yellow–orange crystalline solid (38 mg, 68%).  m.p. 128–136 ºC.  [α]21D –22.5 (c = 0.006, 
CHCl3).  TLC :  Rf 0.30 (40% Ethyl acetate in hexanes).  IR (NaCl) max: 2956, 2929, 2973, 2360, 
2335, 1772, 1702, 1612, 1589, 1508, 1463, 1438, 1413, 1365, 1294, 1267, 1209, 1159, 1126, 1035, 
914, 833, 786 cm-1.  1H NMR (500 MHz) δ 7.29 (m, 1H), 6.47 (m, 2H), 5.19 (d, J = 14.3 Hz, 1H), 5.10 
(s, 1H), 4.59 (s, 1H), 4.33 (t, J = 7.1 Hz, 2H), 4.11 (d, J = 14.4 Hz, 1H), 3.88 (t, J = 5.3 Hz, 1H), 3.81 
(d, J = 3.3 Hz, 6H), 2.78 (m, 2H), 1.90 – 1.72 (m, 3H), 0.95 (d, J = 6.3 Hz, 3H), 0.80 (d, J = 6.2 Hz, 
3H).  13C NMR (126 MHz) δ 208.0, 170.1, 161.0, 158.5, 148.0, 132.2, 116.0, 107.9, 104.4, 98.5, 
83.2, 70.1, 61.1, 55.4, 55.3, 38.7, 37.1, 33.2, 24.3, 23.6, 22.5.  HRMS (ESI) m/z calcd for 
C21H27NO5Na ([M+Na]+) 396.1787; found 396.1783.   
 
(5S,8R)–7–(2,4–dimethoxybenzyl)–8–isobutyl–4–methylene–1–oxa–7–azaspiro[4.4]nonane–
6,9–dione (13d). Prepared from (R)–3–diazo–1–(2,4–dimethoxybenzyl)–5–isobutylpyrrolidine–
2,4–dione and but–3–yn–1–ol using general procedure GP3 (Conversion of Diazo observed in 1 
hour).  Yellow crystalline solid (37 mg, 66%). m.p. 127–139 ºC.  [α]21D +22.9 (c = 0.011, CHCl3).  TLC 
: Rf 0.30 (40% Ethyl acetate in hexanes).  IR (NaCl) max: 2956, 2875, 2841, 2360, 2335, 1772, 1703, 
1612, 1587, 1508, 1462, 1413, 1294, 1267, 1209, 1159, 1128, 1089, 1033, 910, 833 cm-1.  1H NMR 
 




(500 MHz) δ 7.29 (m, 1H), 6.49 – 6.45 (m, 2H), 5.19 (d, J = 14.4 Hz, 1H), 5.10 (s, 1H), 4.58 (s, 1H), 
4.33 (t, J = 7.8, 2H), 4.11 (d, J = 14.4 Hz, 1H), 3.88 (t, J = 5.3 Hz, 1H), 3.81 (d, J = 3.2 Hz, 6H), 2.86 – 
2.73 (m, 2H), 1.89 – 1.72 (m, 3H), 0.95 (d, J = 6.3 Hz, 3H), 0.79 (d, J = 6.2 Hz, 3H).  13C NMR (126 
MHz) δ 208.0, 170.1, 161.0, 158.5, 148.0, 132.2, 116.0, 107.9, 104.4, 98.4, 83.2, 70.1, 61.3, 55.4, 
55.3, 38.7, 37.1, 33.2, 24.3, 23.6, 22.5.  HRMS (ESI) m/z calcd for C21H27NO5Na ([M+Na]+) 
396.1787; found 396.1787.   
 
(5R,8S)–8–benzyl–7–(2,4–dimethoxybenzyl)–4–methylene–1–oxa–7–azaspiro[4.4]nonane–
6,9–dione (13e).  Prepared from (S)–5–benzyl–3–diazo–1–(2,4–dimethoxybenzyl)pyrrolidine–
2,4–dione and but–3–yn–1–ol using general procedure GP3 (Conversion of Diazo observed in 30 
minutes).  Vibrant yellow oil (23 mg, 64%).  [α]21D –37.8 (c = 0.017, CHCl3).  TLC : Rf 0.33 (50% Ethyl 
acetate in hexanes).  IR (NaCl) max: 3294, 3076, 2958, 2872, 2841, 2360, 2335, 1772, 1703, 1612, 
1589, 1508, 1462, 1413, 1294, 1267, 1209, 1126, 1035, 916, 833, 732 cm-1.  1H NMR (400 MHz) δ 
7.32 – 7.18 (m, 4H), 7.13 – 7.09 (m, 2H), 6.51 – 6.43 (m, 2H), 5.14 (d, J = 14.4 Hz, 1H), 5.06 (s, 1H), 
4.54 (s, 1H), 4.28 – 4.23 (m, 2H), 4.21 – 4.15 (m, 2H), 3.81 (d, J = 2.1 Hz, 6H), 3.30 (dd, J = 14.7, 
3.4 Hz, 1H), 3.17 (dd, J = 14.7, 6.4 Hz, 1H), 2.72 (m, 2H).  13C NMR (101 MHz) δ 207.2, 170.0, 161.0, 
158.5, 147.9, 135.1, 132.3, 129.57 (2C), 128.6 (2C), 127.1, 115.9, 108.0, 104.5, 98.5, 83.2, 70.0, 
63.2, 55.4, 55.4, 39.1, 34.5, 33.1.  HRMS (ESI) m/z calcd for C24H25NO5Na ([M+Na]+) 430.1630; 
found 430.1635. 
 








6,9–dione (13f).  Prepared from (S)–3–diazo–1–(2,4–dimethoxybenzyl)–5–methylpyrrolidine–
2,4–dione and but–3–yn–1–ol using general procedure GP3 (Conversion of Diazo observed in 1 
hour).  Faint yellow oil (32 mg, 63%).  [α]21D –68.0 (c = 0.011, CHCl3).  TLC :  Rf 0.28 (50% Ethyl 
acetate in hexanes).  IR (NaCl) max: 2956, 2873, 2841, 2360, 2335, 2125, 2096, 1772, 1701, 1612, 
1508, 1462, 1413, 1367, 1294, 1207, 1161, 1126, 1089, 1035, 833 cm-1. 1H NMR (500 MHz) δ 7.33 
– 7.25 (m, 1H), 6.47 (m, 2H), 5.20 (d, J = 14.5 Hz, 1H), 5.12 (s, 1H), 4.63 (s, 1H), 4.34 (t, J = 7.0 Hz, 
2H), 4.11 (d, J = 14.5 Hz, 1H), 3.90 (q, J = 6.8 Hz, 1H), 3.82 (s, 6H), 2.84 – 2.73 (m, 2H), 1.41 (d, J = 
6.7 Hz, 3H). 13C NMR (126 MHz) δ 207.2, 169.4, 161.0, 158.5, 147.5, 132.1, 116.0, 108.0, 104.5, 
98.5, 83.6, 70.0, 58.1, 55.4, 55.4, 38.3, 33.0, 14.3. HRMS (ESI) m/z calcd for C18H21NO5Na 
([M+Na]+) 354.1317; found 354.1299. 
 
(2S,5R,8S)–7–(2,4–dimethoxybenzyl)–8–isobutyl–4–methylene–2–phenyl–1–oxa–7–
azaspiro[4.4]nonane–6,9–dione (13g).  Prepared from (S)–3–diazo–1–(2,4–dimethoxybenzyl)–
 




5–isobutylpyrrolidine–2,4–dione and (S)–1–phenylbut–3–yn–1–ol using general procedure GP3 
(Conversion of Diazo observed in 45 minutes).  Vibrant yellow oil (16 mg, 65%).  [α]21D –72.4 (c = 
0.006, CHCl3).  TLC : Rf 0.61 (40% Ethyl acetate in hexanes).  IR (NaCl) max: 3001, 2958, 2933, 
2870, 2358, 2341, 2123, 1770, 1699, 1614, 1587, 1506, 1456, 1409, 1294, 1265, 1209, 1157, 1128, 
1089, 1033, 918, 835, 754, 736, 700 cm-1.  1H NMR (500 MHz) δ 7.54 – 7.51 (m, 2H), 7.39 – 7.28 
(m, 4H), 6.50 – 6.45 (m, 2H), 5.45 (dd, J = 10.6, 5.6 Hz, 1H), 5.19 (d, J = 14.4 Hz, 1H), 5.09 (s, 1H), 
4.62 (s, 1H), 4.14 (d, J = 14.4 Hz, 1H), 3.96 (t, J = 7.2 Hz, 1H), 3.82 (d, J = 3.1 Hz, 6H), 3.01 (m, 1H), 
2.75 (m, 1H), 1.94 – 1.83 (m, 1H), 1.82 – 1.77 (m, 2H), 0.95 (d, J = 6.6 Hz, 3H), 0.81 (d, J = 6.5 Hz, 
3H).  13C NMR (126 MHz) δ 206.9, 170.5, 161.0, 158.4, 147.7, 140.5, 132.4, 128.4 (2C), 128.1, 
126.6, 116.1, 108.1, 104.5, 98.5, 84.0, 82.9, 61.0, 55.4, 55.3, 42.1, 38.7, 37.3, 24.3, 23.7, 22.4, 
20.8.  HRMS (ESI) m/z calcd for C27H31NO5Na ([M+Na]+) 472.2100; found 472.2099.  
        
In this mismatch diazo/alcohol case, the reaction became sluggish after 5 hours and full 
consumption of alcohol compound was not observed. The overall yields based on recovered 
alcohol starting material 28c was 68%.  
(2R,5R,8S)–7–(2,4–dimethoxybenzyl)–8–isobutyl–4–methylene–2–phenyl–1–oxa–7–
azaspiro[4.4]nonane–6,9–dione (13h major).  Prepared from (S)–3–diazo–1–(2,4–
dimethoxybenzyl)–5–isobutylpyrrolidine–2,4–dione and (R)–1–phenylbut–3–yn–1–ol using 
general procedure GP3 (Partial conversion of diazo observed in 5 hours).  Vibrant yellow oil (14 
 




mg, 23%) [α]21D –38.1 (c = 0.008, CHCl3).  TLC : Rf 0.61 (40% Ethyl acetate in hexanes).  IR (NaCl) 
max: 3001, 2956, 2931, 2872, 2841, 2123, 1772, 1703, 1612, 1587, 1506, 1460, 1411, 1294, 1265, 
1209, 1159, 1128, 1087, 1033, 1004, 918, 833, 754, 700 cm-1.  1H NMR (500 MHz) δ 7.60 – 7.56 
(m, 2H), 7.40 – 7.33 (m, 2H), 7.32 – 7.28 (m, 2H), 6.48 (m, 2H), 5.47 (dd, J = 9.1, 6.6 Hz, 1H), 5.23 
(d, J = 14.3 Hz, 1H), 5.11 (s, 1H), 4.62 (sm, 1H), 4.14 (d, J = 14.4 Hz, 1H), 3.90 – 3.86 (m, 1H), 3.82 
(d, J = 2.8 Hz, 6H), 3.11 (m, 1H), 2.86 (m, 1H), 1.92 – 1.80 (m, 1H), 1.81 – 1.73 (m, 2H), 0.94 (d, J = 
6.6 Hz, 3H), 0.81 (d, J = 6.4 Hz, 3H).  13C NMR (101 MHz) δ 209.2, 169.4, 160.95, 158.5, 148.0, 
140.8, 132.1, 128.4 (2C), 128.1 (2C), 126.5, 115.8, 108.0, 104.4, 98.4, 82.7, 61.3, 55.4, 55.3, 42.1, 
38.8, 37.4, 29.7, 24.3, 23.7, 22.4.  HRMS (ESI) m/z calcd for C27H31NO5Na ([M+Na]+) 472.2100; 
found 472.2107. 
(2R,5S,8S)–7–(3,4–dimethylbenzyl)–8–isobutyl–4–methylene–2–phenyl–1–oxa–7–
azaspiro[4.4]nonane–6,9–dione (13h minor). Prepared from (S)–3–diazo–1–(2,4–
dimethoxybenzyl)–5–isobutylpyrrolidine–2,4–dione and (R)–1–phenylbut–3–yn–1–ol using 
general procedure GP3 (Partial conversion of diazo observed in 5 hours). Yellow oil (7 mg, 11%)  
1H NMR (400 MHz, Chloroform–d) δ 7.54 – 7.48 (m, 2H), 7.40 – 7.28 (m, 5H), 6.47 (d, J = 2.2 Hz, 
1H), 5.45 (dd, J = 10.6, 5.6 Hz, 1H), 5.19 (d, J = 14.4 Hz, 1H), 5.09 (d, J = 2.6 Hz, 1H), 4.61 (d, J = 2.9 
Hz, 1H), 4.13 (d, J = 14.4 Hz, 1H), 3.96 (t, J = 5.5 Hz, 1H), 3.82 (d, J = 2.5 Hz, 6H), 3.01 (dd, J = 15.1, 
5.4 Hz, 1H), 2.82 – 2.67 (m, 1H), 1.92 – 1.74 (m, 3H), 0.94 (d, J = 6.5 Hz, 2H), 0.81 (d, J = 6.4 Hz, 
2H).  13C NMR (101 MHz, cdcl3) δ 206.9, 170.5, 161.0, 158.4, 147.7, 140.5, 132.3, 128.4 (2C), 128.1, 
126.6, 125.6, 116.1, 108.0, 104.4, 98.5, 84.0, 82. 9, 61.0, 55.3, 42.1, 38.7, 37.3, 29.7, 24.3, 23.6, 
22.4.  HRMS (ESI) m/z calcd for C27H32NO5N ([M+H]+) ; 450.2280; found 450.2281. 
 













azaspiro[4.4]nonane–6,9–dione (13i major).  Prepared from (S)–3–diazo–1–(2,4–
dimethoxybenzyl)–5–isobutylpyrrolidine–2,4–dione and using general procedure GP3 
(Conversion of Diazo observed in 4 hours).  Vibrant yellow oil (41 mg, 49%).  [α]21D –63.5 (c = 
0.012, CHCl3).  TLC : Rf 0.69 (50% Ethyl acetate in hexanes).  IR (NaCl) max: 3032, 3001, 2956, 
2926, 2870, 2362, 2335, 2121, 1772, 1699, 1612, 1587, 1506, 1462, 1411, 1363, 1294, 1265, 1207, 
1159, 1126, 1089, 1037, 918, 833, 756, 700 cm-1.  1H NMR (500 MHz) δ 7.28 m, 2H), 7.26 – 7.18 
(m, 4H), 6.45 (m, 2H), 5.16 (d, J = 14.4 Hz, 1H), 5.01 (s, 1H), 4.78 – 4.68 (m, 1H), 4.53 (s, 1H), 4.10 
(d, J = 14.4 Hz, 1H), 3.89 – 3.86 (m, 1H), 3.80 (d, J = 3.2 Hz, 6H), 3.23 (dd, J = 13.6, 6.0 Hz, 1H), 2.84 
(dd, J = 13.6, 7.7 Hz, 1H), 2.69 (m, 1H), 2.52 – 2.44 (m, 1H), 1.84 (m, 1H), 1.77 (m, 2H), 0.95 (d, J 
= 6.5 Hz, 3H), 0.80 (d, J = 6.4 Hz, 3H).  13C NMR (101 MHz) δ 207.2, 170.4, 160.9, 158.4, 147. 9, 
137.7, 132.2, 129.3, 128.4 (2C), 126.4, 116.0, 108.1, 104.4, 98.4, 84.1, 82.2, 61.0, 55.4, 55.3, 41.8, 
38.6, 37.2, 29.7, 24.3, 23.7, 22.4, 14.1.  HRMS (ESI) m/z calcd for C28H33NO5Na ([M+Na]+]) 
486.2256; found 486.2264. 
(2S,5S,8S)–2–benzyl–7–(3,4–dimethylbenzyl)–8–isobutyl–4–methylene–1–oxa–7–
azaspiro[4.4]nonane–6,9–dione (13i minor).  Prepared from (S)–3–diazo–1–(2,4–
dimethoxybenzyl)–5–isobutylpyrrolidine–2,4–dione and using general procedure GP3 
(Conversion of Diazo observed in 4 hours).  Yellow oil (11 mg, 12%).  1H NMR (500 MHz, 
 




Chloroform–d) δ 7.36 – 7.28 (m, 4H), 7.25 – 7.14 (m, 3H), 6.48 (d, J = 7.9 Hz, 2H), 5.21 (d, J = 14.4 
Hz, 1H), 5.05 (d, J = 2.2 Hz, 1H), 4.72 (p, J = 6.8 Hz, 1H), 4.58 (d, J = 2.5 Hz, 1H), 4.14 (d, J = 14.4 
Hz, 1H), 3.87 (t, J = 5.5 Hz, 1H), 3.82 (d, J = 4.1 Hz, 6H), 3.26 (dd, J = 13.6, 6.4 Hz, 1H), 2.86 (dd, J 
= 13.6, 7.7 Hz, 1H), 2.78 – 2.70 (m, 1H), 2.61 – 2.54 (m, 1H), 1.89 – 1.81 (m, 1H), 1.77 (dd, J = 7.5, 
5.3 Hz, 2H), 0.95 (d, J = 6.6 Hz, 3H), 0.80 (d, J = 6.4 Hz, 3H).  13C NMR (126 MHz, cdcl3) δ 206.9, 
171.1, 158.5, 147.7, 132.3, 129.4 (2C), 128.4 (2C), 126.3, 116.0, 108.22, 104.4, 98.4, 82.1, 60.9, 
55.4, 41.9, 38.8, 38.2, 37.3, 30.9, 29.7, 24.3, 23.7, 22.4. HRMS (ESI) m/z calcd for C28H33NO5 


















Spectra Relevant to Chapter 2 
 





































































































































Compound : 13c  (A colourless, block-shaped crystal of dimensions 0.20 x 0.28 x 0.32 mm) 
Sample : SCS-2017-429 
User : Steven Schlitzer 





The displacement ellipsoids were drawn at the 50% probability level. 
 







Table S1. Crystal data and structure refinement for SCS-2017-429. 
Empirical formula   C21H27 N O5 
Formula weight   373.43 
Crystal system   orthorhombic 
Space group   P212121  
Unit cell dimensions    a=10.098(4) Å  α= 90° 
   b=13.103(5) Å = 90° 
          c=14.443(5) Å = 90° 
Volume  1911.0(12) Å3 
Z, Z'  4, 1  
Density (calculated)  1.298 Mg/m3  
Wavelength   0.71073 Å  
Temperature   100(2) K  
F(000)  800  
Absorption coefficient  0.092 mm-1  
Absorption correction  semi-empirical from equivalents  
Theta range for data collection  2.099 to 25.993°  
Reflections collected  29580  
Independent reflections  3739 [R(int)=0.1052]  
Data / restraints / parameters  3739 / 0 / 244  
wR(F2 all data)  wR2=0.1478  
R(F obsd data)  R1=0.0514  
Goodness-of-fit on F2  1.027  
Observed data [I > 2(I)]  2537  
Absolute structure parameter 
Largest and mean shift / s.u.  
-0.6(10) 
0.000 and 0.000  
Largest diff. peak and hole  0.223 and -0.214 e/Å3   
  
 










Compound : 13d (A colourless, rod-shaped crystal of dimensions 0.05 x 0.15 x 0.41 mm) 
Sample : SCS-2017-439 
User : Steven Schlitzer 













Table S2. Crystal data and structure refinement for SCS-2016-439. 
Empirical formula   C21H27 N O5 
Formula weight   373.43 
Crystal system   orthorhombic 
Space group   P212121  
Unit cell dimensions    a=10.1147(7) Å  α= 90° 
   b=13.1272(9) Å = 90° 
        c=14.4524(10) Å = 90° 
Volume  1919.0(2) Å3 
Z, Z'  4, 1  
Density (calculated)  1.293 Mg/m3  
Wavelength   0.71073 Å  
Temperature   100(2) K  
F(000)  800  
Absorption coefficient  0.092 mm-1  
Absorption correction  semi-empirical from equivalents  
Max. and min. transmission  0.995 and 0.963  
Theta range for data collection  2.096 to 27.498°  
Reflections collected  37767  
Independent reflections  4407 [R(int)=0.0354]  
Data / restraints / parameters  4407 / 0 / 244  
wR(F2 all data)  wR2=0.0794  
R(F obsd data)  R1=0.0302  
Goodness-of-fit on F2  0.990  
Observed data [I > 2(I)]  4105  
Absolute structure parameter 
Largest and mean shift / s.u.  
0.1(3) 
0.000 and 0.000  
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Method Development for the Synthesis of Spirothiophenes 
 and All-Carbon Spirocycles 
 
 
3.1  INTRODUCTION  
 Our research team has had considerable success with combining carbene-insertion 
chemistry with Conia-ene electrophilic trapping chemistry to prepare a diverse library of 
heterocyclic scaffolds; so far, our methodology has successfully utilized carboxylic acid O–H, 
alcohol O–H, amine N–H, and sp2 C–H insertion approaches to the corresponding heterocycle, 
and in all cases the cascade could be used to access spirocyclic scaffolds. We continue to explore 
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carbene-insertion chemistry of lesser-studied nucleophiles, namely the S-H insertion of thiols, 





































Scheme 3.1 a.) Rationale for carbene S–H insertion/Conia-ene cascade b.) Modified retrosynthetic 
disconnection for sp3 C–H insertion/Conia-ene cascade 
 In order to address the challenge of forming all-carbon spirocycles, we needed to 
adjust our strategic rationale from an intermolecular approach, to an intramolecular one 
(Scheme 3.1b). Site-selective reactivity remains a major challenge in the field of C-H insertion, 
and intramolecular variants have been the most successful substrates due to the reduced 
entropic factor, arising from the close proximity between nucleophile and carbenoid. 
Additionally, we expect that constraining our desired site of C-H insertion through ring constraint 
would improve the entropic driving force for the reaction.  
 Sulfur heterocycles have received attention in the field of medicinal chemistry, and 
are often used in bioiosteric replacement of the corresponding nitrogen- and oxygen- 
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heterocycles. While the field also includes scaffolds bearing nitrogen in addition to sulfur, like 
thiazoles, isothiazoles, and thiazolidines – 5-membered thiophenes and 6-membered thiopyrans 
all well represented in biologically active scaffolds.1a Additionally, all-carbon spirocycles are 
found in a number of synthetic and naturally-occurring compounds with unique biological 
activity.1b-1d Our innovative carbene cascade methodology seeks to provide new step- and atom- 
economic methods to provide such heterocycles.  
3.1.1 S–H INSERTION TO DIAZO-DERIVED CARBENES 
 While the carbene O–H insertion reaction has been well studied for nearly a half-
century, the reactivity of the isoelectronic sulfur S–H insertion reaction has only received 
moderate attention. These studies employed the use of reactive Donor/Acceptor diazo 
compounds, and predominantly benzylic/aromatic thiol substrates.2 Only a handful of somewhat 
dated reports exist, however, into the S-H insertion of Acceptor/Acceptor carbenoids.3 
 There are many similarities between the reactivity of O–H and S–H nucleophiles with 
carbenes, but one key difference leads to an entirely different reactive pathway for thiols 
(Scheme 3.2). 
 
Scheme 3.2. a.) General mechanism for carbene O–H insertion b.) Analogous reaction mechanism for S–
H insertion 
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 In both cases, a suitable metal catalyst decomposes the diazo compound to generate 
the reactive carbenoid, which bonds to either the oxygen- or sulfur-lone pair electrons. In the 
case of O–H insertion, the zwitterionic intermediate then undergoes 1,2-proton transfer to give 
the corresponding insertion compound, but in the case of S–H insertion the metal is capable of 
dissociation to generate a stabilized ylide. 1,2-proton transfer of this intermediate then provides 
the S–H insertion product. In addition, this ylide intermediate is capable of undergoing a number 
of sigmatropic rearrangements if thioethers are employed as substrates in place of thiols.  
3.1.2 S–R INSERTION TO CARBENES & REARRANGEMENT REACTIONS 
 Because they proceed through a somewhat stable ylide intermediate, thioethers are 
able to undergo a number of rearrangements, dependent on the identity of their substituent 
(Scheme 3.3).4 
 
Scheme 3.3. a.) 1,2-Stevens rearrangement of sulfur ylide intermediates b.) Doyle-Kirmse rearrangement 
of sulfur ylide intermediates 
 Generally, sulfur-ylide intermediates are capable of undergoing a 1,2-Stevens 
rearrangement, in which an alkyl migration occurs to provide a thioether product (Scheme 3.2a). 
These ylide intermediates have shown to be suitably stable for isolation, then photochemically 
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converted to the rearranged product.4d In the case of strongly electron deficient benzylic 
migrating groups, the related Sommelet-Hauser rearrangement is possible, in which the bond 
migration occurs to the ortho- ring position.  
 A similar rearrangement reaction, the Doyle-Kirmse rearrangement, occurs in the case 
of allylic thioethers under carbene-insertion conditions. (Scheme 3.3b). This concerted [2,3]-
sigmatropic rearrangement is known to occur under thermodynamic or photochemical 
conditions, and in the case of propargylic thioethers, has produced isolable allene products. 
Notably, there have been developments in both earth abundant catalysis and asymmetric 
induction for the Doyle-Kirmse reaction.4g,4h Unlike the related S–H insertion reaction, S–R 
insertion has been well studied for Acceptor/Acceptor diazo substrates, and has even been used 
as a key step in several total synthesis.4a,4d  
3.1.3 C–H INSERTION TO DIAZO-DERIVED CARBENES: REACTIVITY & MECHANISM 
 The C–H bond is ubiquitous in organic compounds, and selective utilization of this 
fundamentally inert functionality, remains a major challenge in organic synthesis. The field of C–
H functionalization, which has received considerable attention in the last decade, has established 
several unique strategies to promote C–H reactivity. Such strategies have been comprehensively 
collected in a number of reviews.5 
 The process of C-H functionalization, broadly describing the cleavage of a C–H bond 
which then binds to a new functionality, includes two distinct strategies – C–H activation, and C–
H insertion. C-H activation is classified by stepwise cleavage of a C–H bond by oxidative addition 
of an appropriate metal catalyst, followed by further functionalization using an organic substrate. 
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A representative example of this includes the common catalytic cycle of Rhodium(III) 
cylopentadenyl dimers (Scheme 3.4a).5a  
 
Scheme 3.4. a.) Doyle’s proposed mechanism for C–H insertion to rhodium carbenoids. b.) general 
mechanism for sp2 C–H activation by metal(III) catalysts.  
 In this C–H activation approach, the rhodium (III) catalyst undergoes oxidative addition 
to the sp2 C–H bond of electron-rich arenes to generate a rhodium (II) intermediate, capable of 
decomposing diazo substrates. Migratory insertion of the carbenoid ultimately generates the C–
H functionalized product.  
 C–H Insertion, meanwhile, can occur using carbenes generated with dirhodium(II) 
carboxylate dimers. C-H Insertion occurs through concerted homolysis the C-H bond, with 
simultaneous bond formation to the carbenoid (Scheme 3.4b).5f,5h  
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 A major challenge in C–H functionalization is site-selectivity. Because the C–H bond is 
so prevalent, trying to promote reactivity commonly results in a complex mixture of products, 
especially in the case of intermolecular reactions. In fact, an early quote by diazo pioneer Mike 
Doyle states that “Intermolecular C–H insertion reactions… are not synthetically useful.” This 
challenge has been addressed, and predominantly overcome, in the subsequent decades through 
efforts by research teams of Davies, Teyssie, and Moody, among others. Early reports by the 
Teyssie group showcase the intramolecular C–H insertion reactivity of ethyl diazoacetate to 
unactivated alkanes, which was moderately tunable by altering the electronics of the 
accompanying dirhodium(II) carboxylate dimer (Scheme 3.5).5i,j 
 
Catalyst a b c  d e f g  h i Comments 
Rh2(OAc)4 33 63 4 5 8 90 1 5 95 Low yielding 
Rh2(TFA)4 31 64 5 5 25 66 4 12 88 Higher Yields 
Rh2(9-trp)4 9 61 30 18 18 27 37 33 67 Highest Yields 
Scheme 3.5. Teyssie’s survey on selectivity in intermolecular C–H insertion to ethyl diazoacetate.  
  As preliminarily shown by Teyssie’s bulky Rh2(9-trp)4 catalyst results, further 
developments of dirhodium(II) carboxylate catalysts can help overcome the selectivity issues 
rampant in the field of C-H insertion. The group of Huw Davies disclosed a new bulky, chiral 
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dirhodium(II) catalyst in 1996 – tetrakis[(S)-(-)-N-(p-
dodecylphenylsulfonyl)prolinato]dirhodium(II) (Rh2(S-DOSP)4). In the years to follow, Davies and 
coworkers would go on to showcase Rh2(S-DOSP)4’s excellent reactivity in the intermolecular C-
H Insertion of donor-acceptor diazos into an array of C-H substrates (Scheme 3.6).5f  
 
Scheme 3.6. a.) Davies’ study towards the reaction rates of C-H substrates towards insertion. b.) Survey 
of reactivity for allylic and benzylic substrates towards with aryldiazo acetates. 
 In a series of competition studies, Davies’ was able to observe a high reaction rate for 
substrates capable of stabilizing a positive charge (Scheme 3.6a). Namely, the allylic system and 
adjacent to a heteroatom. Interestingly, in the case of 1,3-cyclohexadiene, the rate of C–H 
insertion overcame the rate of cyclopropanation of styrene. Later, the group would determine a 
relative reactivity spectrum of allylic and benzylic systems (Scheme 3.6b). It was shown that allylic 
systems bearing conjugation to silyl ethers displayed remarkable reactivity. Electron-neutral and 
electron-rich benzylic substrates meanwhile produced moderate reaction rates, while not 
overcoming the rate of secondary allylic substrates. With insight towards harnessing C–H 
insertion reactivity, we designed a substrate which would employ benzylic C–H insertion in a 
cascade manner.  
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3.2  DIVERGENT S-H INSERTION/CONIA-ENE CASCADE APPROACH TO 
SPIROTHIOPHENES 
 In order to access a new realm of heterocycles and spiroheterocycles based on sulfur, 
we pursued the synthesis of mercaptyne substrates, capable of undergoing a S–H 
insertion/Conia-ene cascade. 
3.2.1 SYNTHESIS OF SECONDARY MERCAPTYNE PRECURSORS 
 Thiols were prepared in a four-step sequence from commercially available styrene 
oxide (Scheme 3.7). 
 
Scheme 3.7. Synthesis of secondary mercaptyne 2 
 First, styrene oxide was exposed to ring-opening conditions with lithium actylide to 
produce racemic 2-phenylbutyn-1-ol. The alcohol was then converted to the corresponding 
tosylate, which was exposed to substitution conditions with in situ generated potassium 
thioacetate. The material could be stored as the thioacetate for long periods of time, and is 
converted to corresponding thiol 2 through hydride reduction conditions. While the route could 
be used to synthesize primary 3-butyn-1-thiol, we had difficulties during thiol isolation, 
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predominantly due to the volatility of the compound under vacuum. For this reason, we 
proceeded using secondary thiol 2.  
3.2.2 STEPWISE APPROACH TO SPIROTHIOPHENES 
 With a route established to the desired mercaptyne substrates, we turned our 
attention towards reaction optimization (Scheme 3.8). We began our optimization studied by 
using Rh2(esp)2, our previously established catalyst for O–H insertion. We had previously 
observed success in the stepwise Conia-ene cyclization of Acceptor/Acceptor O–H insertion 
products, so we envisioned being able to optimize the insertion and Conia-Ene steps individually, 
then proceed to a one-pot trial. 
 
Scheme 3.8 Stepwise S-H insertion/Conia-ene sequence to hydrothioufuran 4 
 First, ketoester diazo 1 and secondary mercaptyne 2 were exposed to Rh2(esp)2, and 
we were able to isolate insertion compound 3 with a moderate yield in dichloromethane at room 
temperature. Characterization of 3 by 1H NMR was complication by the compound’s tendency to 
undergo keto-enol tautomerization, and the diastereotopic peaks arising from a racemic 
nucleophile. We next exposed insertion product 3 to cationic gold catalytic conditions. We did 
not observe any conversion at room temperature, but quickly achieved conversion of 3 after 
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elevating temperatures to reflux. To our delight, we were able to isolate desired hydrothiofuran 
4, characterized by its diagnostic exo-olefin protons in 1H NMR.  
3.2.3 ONE-POT APPROACH TO THIOFURANOFURANS 
  Encouraged by this stepwise trial, we next turned our attention to one-pot 
conditions (Scheme 3.9). 
 
Scheme 3.9 One-pot S-H insertion/Conia-Ene trial 
 When diazo 1 and mercaptyne 2 were exposed to one-pot catalytic conditions, 
however, we did not observe any evidence of hydrothiophenes 4. Instead, we characterized a 
product distinctly lacking a ketone peak, and with 2 new olefin peaks observable on 13C NMR. 
We rationalize the formation of thiofuranofuran 5 due to interaction between mercaptyne 2 
and the cationic gold catalytic conditions (Scheme 3.10). 
  
Scheme 3.10 Proposed mechanism for thiofuranofuran formation 
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 We propose that, in the presence of cationic gold, mercaptyne 2 underwent a 5-
endo-dig cyclization to produce thiophene A before diazo 1 was able to undergo S–H insertion. 
Instead, with the formation of a new olein, thiophene 1 underwent carbenoid cyclopropanation 
to produce polarized cyclopropane B. C, a resonance form of B showcases the electrophilicity of 
the thiophene C2 once a polarized cyclopropane is generated. Lastly, the enolate resulting from 
ring opening underwent O-alkylation to quench the sulfonium ion, resulting in formation of 
thiofuranofuran 5. 
 While these preliminary results are not entirely encouraging, we have determined a 
novel new reactive pathway for secondary mercaptynes to generate a fused, heterocyclic 
scaffold. While these results may not bode well for a one-pot S–H insertion/Conia-ene approach 
to hydrothiophenes, reaction condition optimization may be able to circumvent the undesired 5-
endo-dig cyclization of mercaptyne 2.  
 For example, we could utilize slow addition of the diazo and gold mixture to a mixture 
of mercaptyne 2 and rhodium, which may circumvent the undesired 5-endo-dig cyclization; 
generation of carbenoids from diazos through gold catalysis is a known process however and 
should be anticipated from this approach. In addition, screening other additives besides silver 
salt for the generation of cationic gold could mitigate the undesired annulation reactivity. Copper 
and zinc salts are also well-known to generate cationic gold from AuRCl pre-catalysts. Lastly, the 
coordination ability of the paired silver counterion could be tuned; typically, weakly coordinating 
anions like AgSbF6- and OTf- produce highly cationic gold species, which were successful in cases 
where there were no chemoselectivity issues. It is possible that stronger anion coordination could 
affect the catalytic activity of the gold cation.  
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3.3  sp3 C-H INSERTION APPROACH TO ALL-CARBON SPIROCYCLES 
 Without being able to take advantage of the fundamental reactivity of functional 
groups, C–H insertion cascades represent a challenge in organic synthesis. The analogous all-
carbon spirocenters required a new retrosynthetic disconnection from our previous X–H 
insertion/Conia-ene strategies, now reliant on intramolecular C–H insertion to minimize entropic 
driving force for the process. 
3.3.1 HUNTER AND SHARMA’S sp2 C-H INSERTION/CONIA–ENE CASCADE FOR THE 
SYNTHESIS OF CARBOCYCLIC OXINDOLES 
 In 2018, Hunter et. al. disclosed a new reaction cascade using an interrupted C–H 
insertion strategy for the synthesis of carbocyclic oxindoles (Scheme 3.11).6 
 
Scheme 3.11. Hunter et. al’s sp2 C–H Insertion/Conia-ene cascade to synthesize spirocarbocycles 
 In their report, the group discloses a successful intramolecular C–H insertion/Conia-
ene reaction cascade using rhodium(II) carboxylate dimers, and gold-activated alkynes. The 
reaction conditions proved general for the formation of 5-, 6-, and 7- membered carbocycles, and 
was even suitable for the decomposition of acceptor-only diazos, with minor modifications of the 
optimized reaction conditions. This development led our hypothesis for the formation of a new 
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spirocyclic scaffolds – If a substrate could undergo ortho- sp2 C–H insertion and subsequent Cona-
ene cyclization, could a substrate be designed to harness the  analogous sp3 C–H insertion 
strategy? Guided by Davies’ survey of intermolecular sp3 C–H insertion, we suspected that a 
benzylic C–H bond would be the ideal site for our approach.  
3.3.2 SYNTHESIS OF C-H INSERTION LINEAR PRECURSOR 
 
Scheme 3.12. Synthetic approach to C–H insertion precursor 6 
 To access diazo 6, first 1,3-cyclohexandione was exposed to soft enolization 
conditions, and trapped with TMSOTf to generate the corresponding vinyl triflate. Next, the 
enolate of 2’-methylacetophenone was generated using LiHMDS, and quenched with the vinyl 
triflate, which undergoes ring opening to produce the desired methylene precursor.7a Lastly, 
diazo transfer conditions to the active methylene using p-ABSA cleanly afforded parent diazo 6.  
 To access 5-membered and 7-membered precursors, an alternative synthesis was 
sought due to 1,3-cylopenanedione’s incompatibility in vinylogous triflate ring opening, and the 
high cost of 1,3-cycloheptanedione (Scheme 3.13).  




Scheme 3.13. Synthesis of diazos 7 and 8 through acyl substitution of benzotriazoleamides 
 In both cases the correspond alkynoic acid, readily accessible via Jones oxidation of 
the commercially available alkynol, was converted to the triazole amide via carbodiimide 
coupling conditions. Next, inspired by a recent report,7b 2’-methylacetophenone was exposed to 
soft enolization conditions in the presence of a Lewis acid to afford the resulting methylene 
precursors. Lastly, diazo transfer conditions using p-ABSA afforded desired diazos 7 and 8. 
3.3.3  OPTIMIZATION STUDIES – BENZYLIC C–H INSERTION/CONIA-ENE CASCADE  
 Having established a convenient route to diazos 6-8, we turned our attention 
towards promoting the desired benzylic C–H reactivity. As was the case will acceptor/acceptor 
diazo substrates, we envisioned that we could optimize the insertion and Conia-ene processes 
sequentially, then combine these insights for a one pot approach (Scheme 3.14).  




Scheme 3.14 Proof-of-concept study: stepwise Benzylic sp3 C-H Insertion/Conia-ene of 6 
 Using basic carboxylate dimer Rh2OAc4, diazo 6 cleanly underwent the desired sp3 C–
H insertion to provide enol 9. The insertion compound then successfully underwent Conia-ene 
cyclization to produce carbocycle 10. The previously established Ag salt, used for in situ 
generation of Au+, needed to be switched to a Cu salt as was in the case in Hunter’s study, due 
to the propensity for these terminal alkynes to undergo hydrolysis to the resulting ketone. 
Inspired by these stepwise results, we next attempted the cascade reactions in a one-pot fashion 
(Scheme 3.15).  
 
Scheme 3.15 a.) One-pot cascade trial using Rh2(esp)4 b.) One-pot cascade trial using Rh2(HFB)4 
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 When 6 was exposed to Rh/Au/Ag in a one pot fashion however, we observed only a 
small amount of 10, and the presence of byproduct X, we expect formed due to a competing 
cyclopropanation pathway due to activation of the alkyne. We hypothesized that altering the 
electrophilicity of the rhodium catalyst could affect the nucleophilicity of the generated Rhoda-
enolate, favoring the desired insertion/Conia-ene pathway over the undesired cyclopropanation. 
Indeed, when Rh2(esp)2 was replaced with the highly electron deficient dirhodium(II) 
heptafluorobutyrate (Rh2(HFB)4), we observed no trace of diagnostic cyclopropane peaks on the 
crude 1H NMR, and instead clean formation of 10, which was isolated in 70% yield.  
 Inspired by Hunter and Sharma’s success generating 5- and 7- membered rings 
through their sp2 C–H Insertion/Conia-ene cascades, we next evaluated diazos 7 and 8 towards 
stepwise C–H insertion and resulting Conia-ene (Scheme 3.16). 
 
Scheme 3.16 a.) Stepwise-approach to five-membered carbocycles b.) Stepwise-approach to seven-
membered carbocycles 
 When diazo 7 was exposed to Rh2HFB4, we observed evidence of C–H insertion, but 
appears the substrate underwent further o-alkylation to produce exo-glycal 11. Hunter and 
Sharma also encountered this form of reactivity in their sp2 C–H Insertion/Conia-ene approach, 
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and cited the disfavored 5-enolendo-exo-dig cyclization encouraging undesired ketone alkylation. 
The authors were able to address this limitation by utilizing a donor/acceptor diazo without the 
reactive ketone, to circumvent its reactivity. When diazo 8 was exposed to Rh2HFB4 the reaction 
resulted in complete conversion to the C-H insertion compound 11. Then, when insertion product 
12 was exposed to the Au+ conditions, we did not observe any diagnostic exo-olefin protons 
indicative of successful Conia-ene cyclization, and recovered a complex mixture of products.  
3.4   SUMMARY & FUTURE DIRECTIONS 
 In this chapter, we have described an extension of our insertion/Conia-ene cascade 
methodology to underutilized S–H and benzylic C–H bonds. Success in these cascade reactions 
generate hydrothiophenes and all-carbon spirocycles, which are valuable bioisosteres and are 
found in bioactive natural products. By applying secondary mercaptynes to Rh/Au+ catalytic 
conditions, we were able to accomplish stepwise S–H insertion and Conia-ene cyclization to 
produce the desired hydrothiophenes. In a one-pot approach using the secondary mercaptyne 
and diazo substrates however, we obtained a thiofuranofuran product, which we expect formed 
by way of intramolecular 5-endo-dig cyclization of the mercaptyne in the presence of Au+, before 
diazo addition. Employing our knowledge of sp3 C–H insertion reactivity, we also applied our 
Rh/Au+ methodology for an intramolecular approach to 3-spiroindenones. While this approach 
has not proven as general as Hunter and Sharma’s previously disclosed method for generating 3-
spriooxindoles, we were able to apply our method to form 6-membered spiroindenes through a 
Conia-ene reaction. Efforts in these pursuits are ongoing and warrant future study.  
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3.6  EXPERIMENTAL SECTION 
PUBLICATION AND CONTRIBUTION STATEMENT 
The material presented in this chapter is unpublished and the sole contributor is Steven 
Schlitzer. Dr. Indrajeet Sharma contributed with assistance in project design and NMR analysis. 
MATERIALS AND METHODS  
Reagents  
Reagents and solvents were obtained from Sigma-Aldrich (www.sigma-aldrich.com), ChemImpex 
(www.chemimpex.com) or Acros Organics (www.fishersci.com) and used without further 
purification unless otherwise indicated. Dry solvents (acetonitrile) were obtained from Acros 
Organics (www.fishersci.com), and dichloromethane was distilled over CaH2 under N2 unless 
otherwise indicated. THF purchased from Sigma-Aldrich was distilled over Na metal with 
benzophenone indicator. Diazo compounds were stored as a dilute solution frozen in benzene 
for periods longer than 24 hours.  
Reactions  
All reactions were performed in flame-dried glassware under positive N2 pressure with magnetic 
stirring unless otherwise noted. Liquid reagents and solutions were transferred thru rubber septa 
via syringes flushed with N2 prior to use. Cold baths were generated as follows: 0 °C with wet 
ice/water and −78 °C with dry ice/acetone. Syringe pump addi on reac ons were conducted 
using a CMA/100 microinjection pump.  
Chromatography  
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TLC was performed on 0.25 mm E. Merck silica gel 60 F254 plates and visualized under UV light 
(254 nm) or by staining with potassium permanganate (KMnO4), cerium ammonium molybdenate 
(CAM), phosphomolybdic acid (PMA), and ninhydrin. Silica flash chromatography was performed 
on Sorbtech 230–400 mesh silica gel 60.  
Analytical Instrumentation  
IR spectra were recorded on a Shimadzu IRAffinity-1 FTIR or a Nicolet 6700 FTIR spectrometer 
with peaks reported in cm–1. NMR spectra were recorded on a Varian VNMRS 400, 500 and 600 
MHz NMR spectrometer in CDCl3 unless otherwise indicated. Chemical shifts are expressed in 
ppm relative to solvent signals: CDCl3 ((1H, 7.26 ppm, 13C, 77.0 ppm); coupling constants are 
expressed in Hz. NMR spectra were processed using Mnova 
(www.mestrelab.com/software/mnova-nmr). Mass spectra were obtained at the OU Analytical 
Core Facility on an Agilent 6538 High-Mass-Resolution QTOF Mass Spectrometer and an Agilent 
1290 UPLC. X-ray crystallography analysis was carried out at the University of Oklahoma using a 
Bruker APEX ccd area detector and graphite-monochromated Mo Kα radiation (λ = 0.71073 Å) 
source and a D8 Quest diffractometer with a Bruker Photon II cmos area detector and an Incoatec 
Iµs microfocus Mo Kα source (λ = 0.71073 Å). Crystal structures were visualized using CCDC 
Mercury software (http://www.ccdc.cam.ac.uk/products/mercury/).  
Nomenclature  
N.B.: Atom numbers shown in chemical structures herein correspond to IUPAC nomenclature, 
which was used to name each compound. 
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3.6.1 SYNTHESIS OF SECONDARY MERCAPTYNE 2 
 
1-Phenylbut-3-yne-1-thiol (2). To a suspension of LiAlH4 (1.25 eq.) in anhydrous diethyl ether (0.4 
M) was added a solution of 1-phenylbut-3-yn-1-yl ethanethioate in minimal diethyl ether under 
N2. The mixture was heated to reflux with stirring for 3 hours, then cooled to 0 oC, whereby 
residual LiAlH4 was destroyed by careful addition of acetone. The precipitate was dissolved by 
adding 1N HCl. The organic layer was separated, and aqueous layer extracted into Et2O (3x). 
Combined organics were washed with 1N HCl (2x), water (2x), and brine, then concentrated by 
rotatory evaporating, using a water bath set no higher than 35 oC. The resulting thiol was used 
without further purification. Foul-smelling yellow liquid (368 mg, 99%). 1H NMR (600 MHz, 
Chloroform-d) δ 7.39 – 7.24 (m, 5H), 4.23 (dt, J = 7.6, 5.5 Hz, 1H), 2.84 (m, J = 60 Hz, 2H), 2.40 (d, 
J = 5.2 Hz, 1H), 2.09 (s, 1H). 13C NMR (151 MHz, Chloroform-d) δ 142.2, 128.7 (2C), 127.8, 126.9 
(2C), 81.4, 71.0, 42.8, 30.2. 
3.6.2 REACTIVITY OF MERCAPTYNE 2 TOWARDS INSERTION AND CONIA-ENE CHEMISTRY 
 
Methyl 3-oxo-3-phenyl-2-((1-phenylbut-3-yn-1-yl)thio)propanoate  (3). To a solution of 1-
phenylbut-3-yne-1-thiol (1.0 eq) in dichloromethane (0.2 M) was added Rh2(esp)2 (2 mol %). The 
system was degassed with N2, followed by slow dropwise addition of a solution of 2-diazo-3-oxo-
3-phenylpropanoate (1.2 eq.) in dichloromethane (0.2 M). The reaction mixture was stirred at 
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room temperature while monitoring by TLC. After complete conversion of thiol was observed, 
the reaction was passed through a short celite pad, eluting with excess dichloromethane. The 
organics were concentrated and purified by column chromatography to provide insertion 
product 3 as a diastereomeric mixture of keto and enol tautomers. 1H NMR (600 MHz, 
Chloroform-d) δ 13.8z1 (s, 1H), 7.84 – 7.79 (m, 2H), 7.70 – 7.65 (m, 2H), 7.58 – 7.52 (m, 2H), 7.48 
– 7.45 (m, 2H), 7.44 – 7.27 (m, 24H), 7.22 – 7.17 (m, 4H), 6.97 (dd, J = 6.7, 3.0 Hz, 3H), 4.91 (s, 
1H), 4.73 (s, 1H), 4.29 (s, 1H), 4.20 (s, 1H), 3.90 (s, 1H), 3.82 (s, 5H), 3.72 (s, 4H), 3.63 (s, 3H), 2.87 
– 2.78 (m, 4H), 2.67 – 2.54 (m, 3H), 1.98 (dt, J = 3.7, 2.6 Hz, 2H), 1.88 (t, J = 2.6 Hz, 1H). 13C NMR 
(151 MHz, Chloroform-d) δ 190.5, 180.6, 174.2, 168.2, 168.0, 139.7, 133.8, 133.7, 130.1, 129.4, 
128.9, 128.7, 128. 7, 128.6, 128.6, 128.2, 128.2, 128.1, 128.1, 128.0, 127.7, 127.4, 127.4, 81.3, 
80.5, 80.3, 71.1, 70.1, 54.3, 53.4, 53.2, 52.8, 51.9, 48. 6, 48.4, 26.6, 26.1, 24.8. 
 
Methyl 2-benzoyl-3-methylene-5-phenyltetrahydrothiophene-2-carboxylate (4). To a stirred 
solution of AuClPPh3 (10 mol%) and AgSbF6 (10 mol %) in minimal dichloromethane was added a 
solution of insertion product 3 in dichloromethane (0.2 M) dropwise by syringe. The reaction was 
stirred at room temperature while monitoring by TLC, and after full conversion of 3 was observed, 
the reaction was diluted with excess dichloromethane. Organics were washed with sat. NaHCO3 
(2x), water (2x), and brine (1x), then dried over Na2SO4. Removal of solvent followed by 
purification by column chromatography furnished the title compound as a 5.2:1.0 mixture of 
diastereomers. Yellow oil (20 mg, 40%).  




Methyl 2,5-diphenyl-3a,4,5,6a-tetrahydrothieno[2,3-b]furan-3-carboxylate (5). A solution of 1-
phenylbut-3-yne-1-thiol (1.0 eq.), Rh2(esp)2, AuClPPh3, and AgSbF6 in dichloromethane (0.2 M) 
was prepared and degassed with N2. The mixture was stirred at room temperature, while a 
solution of methyl 2-diazo-3-oxo-3-phenylpropanoate (1.2 eq.) was added dropwise by syringe. 
The reaction was stirred at room temperature while monitoring by TLC, and after full conversion 
of thiol was observed, the reaction was diluted with excess dichloromethane. Organics were 
washed with sat. NaHCO3 (2x), water (2x), and brine (1x), then dried over Na2SO4. Removal of 
solvent followed by purification by column chromatography furnished the title compound. 1H 
NMR (600 MHz, Chloroform-d) δ 7.38 – 7.26 (m, 26H), 4.34 (s, 1H), 4.29 (s, 1H), 4.12 (dd, J = 8.1, 
6.3 Hz, 1H), 3.78 – 3.72 (m, 2H), 3.71 (s, 3H), 3.58 (s, 4H), 2.79 – 2.68 (m, 6H), 1.99 (t, J = 2.6 Hz, 
1H), 1.96 (t, J = 2.7 Hz, 1H). 13C NMR (151 MHz, Chloroform-d) δ 171.1, 170.6, 140.0, 136.0, 128. 
7, 128.6, 128.6, 128. 6, 128.5, 128.4, 128.3, 128.2, 128.0, 127.9, 80.6, 70.8, 52.7, 52.4, 51.6, 48.8, 
48.1, 26.5, 26.3. Yellow oil (23 mg, 68%). 
3.6.3 SYNTHESIS OF C-H ACTIVATION DIAZO SUBSTRATES 6-8 
General Procedure A for Diazo Transfer : Diketone (1.0 eq.) and p-ABSA (1.2 eq.) were dissolved 
in anhydrous MeCN (0.2 M) and cooled to 0 oC. Et3N (1.5 eq.) was added dropwise by syringe, 
and after 15 minutes the reaction was allowed to warm to room temperature. The reaction was 
stirred at this temperature while monitoring by TLC. After full conversion of diketone was 
observed (Typically within 2 hours), the reaction mixture was diluted with excess diethyl ether. 
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The organic layer was washed with sat. NH4Cl (2x), water (2x), and brine (1x), then dried over 
Na2SO4. Concentration of the organic layer followed by purification of the residue by column 
chromatography (EtOAc/Hex) furnished diazos 6-8.  
 
2-Diazo-1-(o-tolyl)oct-7-yne-1,3-dione (6). Prepared from (Z)-1-hydroxy-1-(o-tolyl)oct-1-en-7-
yn-3-one using General Procedure A. Yellow oil (476 mg, 50%). 1H NMR (300 MHz, Chloroform-
d) δ 7.43 – 7.27 (m, 4H), 3.05 (s, 2H), 2.40 (s, 3H), 2.31 (s, 2H), 1.98 (t, J = 2.6 Hz, 1H), 1.92 (t, J = 
7.1 Hz, 2H). 13C NMR (126 MHz, Chloroform-d) δ 192.2, 186.7, 137. 6, 135.4, 131.4, 131.0, 126.1, 
126.0, 86.12, 83.5, 69.2, 40.0, 22.9, 19.03, 17.8. 
 
2-Diazo-1-(o-tolyl)hept-6-yne-1,3-dione (7). Prepared from (Z)-1-hydroxy-1-(o-tolyl)hept-1-en-
6-yn-3-one using general procedure A. Yellow oil (322 mg, 59%). 1H NMR (300 MHz, Chloroform-
d) δ 7.43 – 7.27 (m, 4H), 3.20 (t, J = 7.1 Hz, 2H), 2.59 (td, J = 7.1, 2.7 Hz, 2H), 2.40 (d, J = 0.6 Hz, 
3H), 1.99 (t, J = 2.7 Hz, 1H). 13C NMR (101 MHz, Chloroform-d) δ 190.6, 186.4, 137.2, 135.4, 131.4, 
131.0, 125.9, 125.9, 85.9, 82.7, 68.8, 40.0, 18.9, 13.1. 
 
 




2-Diazo-1-(o-tolyl)non-8-yne-1,3-dione (8). Prepared from (Z)-1-hydroxy-1-(o-tolyl)non-1-en-8-
yn-3-one using general procedure A. Yellow oil (138 mg, 62%). 1H NMR (300 MHz, Chloroform-d) 
δ 7.41 – 7.27 (m, 3H), 7.25 (m, 1H), 2.93 (dd, J = 7.8, 6.9 Hz, 2H), 2.38 (s, 3H), 2.22 (td, J = 7.0, 2.7 
Hz, 2H), 1.94 (t, J = 2.6 Hz, 1H), 1.85 – 1.71 (m, 2H), 1.65 – 1.51 (m, 2H). 13C NMR (75 MHz, 
Chloroform-d) δ 192.6, 186.7, 137.6, 135.4, 131.4, 131.0, 126.0 (2C), 86.1, 84.0, 68.6, 40.7, 27.9, 
23.3, 19.0, 18.3.  
3.6.4 REACTIVITY OF DIAZOS 6-8 TOWARDS INSERTION AND CONIA-ENE CHEMISTRY 
General Procedure B for C-H insertion: A solution of Rh2HFB4 (2 mol%) in minimal 
dichloromethane was prepared and degassed using N2. The system was heated to reflux, and a 
solution of diazo 6-8 (1.0 eq.) in dichloromethane (0.2 M) was added dropwise by syringe. The 
reaction progress was monitored by TLC, and after full conversion of starting material was 
observed, the reaction was filtered through a celite plug, eluting with excess dichloromethane. 
Concentration of the organic layer followed by purification of the residue by column 
chromatography furnished insertion compounds 9, 11 and 12. 
 
1-(3-Hydroxy-1H-inden-2-yl)hex-5-yn-1-one (9). Prepared from 2-Diazo-1-(o-tolyl)oct-7-yne-1,3-
dione 6 using General Procedure B. Yellow oil (32 mg, 95%). 1H NMR (500 MHz, Chloroform-d) δ 
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7.83 (d, J = 7.7 Hz, 1H), 7.56 (td, J = 7.4, 1.2 Hz, 1H), 7.51 (d, J = 7.5 Hz, 1H), 7.42 (t, J = 7.4 Hz, 1H), 
3.65 (s, 3H), 2.61 (t, J = 7.3 Hz, 2H), 2.32 (td, J = 6.8, 2.6 Hz, 2H), 2.03 (t, J = 2.6 Hz, 1H), 2.00 – 1.93 
(m, 2H). 13C NMR (126 MHz, Chloroform-d) δ 179.9, 147.5, 138.2, 135.4, 132. 8, 127.7, 127.3, 
125.7, 123.2, 83.5, 69.3, 33.2, 30.1, 24.3, 17.9. 
 
1-(3-Hydroxy-1H-inden-2-yl)hept-6-yn-1-one (12). Prepared from 2-Diazo-1-(o-tolyl)non-8-yne-
1,3-dione 7 using General Procedure B. Yellow oil (10 mg, 35%). 1H NMR (300 MHz, Chloroform-
d) δ 7.83 (dt, J = 7.7, 1.0 Hz, 1H), 7.57 – 7.47 (m, 2H), 7.46 – 7.38 (m, 1H), 3.61 (s, 3H), 2.47 (t, J = 
7.5 Hz, 2H), 2.31 – 2.21 (m, 2H), 2.02 (t, J = 2.6 Hz, 1H), 1.92 – 1.80 (m, 2H), 1.72 – 1.55 (m, 2H). 
13C NMR (75 MHz, Chloroform-d) δ 191.5, 147. 5, 138.2, 132. 8, 127.4, 125.7, 123.2, 110.2, 68.7, 
61.2, 34.2, 30.2, 29.7, 28.0, 24.8, 18.2. 
General Procedure C for Conia-ene Cyclization: A solution of AuClPPh3 (10 mol%) and 
(Cu(OTf))2(C6H6) (10 mol %) in minimal dichloromethane was prepared and degassed using N2. 
The system was heated to reflux, and a solution of insertion product 9 (1.0 eq.) in 
dichloromethane (0.2 M) was added dropwise by syringe. The reaction progress was monitored 
by TLC, and after full conversion of starting material was observed, the reaction was filtered 
through a celite plug, eluting with excess dichloromethane. The organic solution was washed with 
sat. NaHCO3 (2x), water (2x), and brine, then dried over Na2SO4. Concentration of the organic 
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layer followed by purification of the residue by column chromatography furnished insertion 
compounds 9, 11 and 12. 
 
2-Methylenespiro[cyclohexane-1,2'-indene]-1',6(3'H)-dione (10).  Prepared from 1-(3-Hydroxy-
1H-inden-2-yl)hex-5-yn-1-one 9 using General Procedure C.  Yellow oil (22 mg, 75%). 1H NMR 
(600 MHz, Chloroform-d) δ 7.66 (d, J = 7.7 Hz, 1H), 7.60 (t, J = 7.4 Hz, 1H), 7.50 (d, J = 7.7 Hz, 
1H), 7.35 (t, J = 7.4 Hz, 1H), 4.90 (s, 1H), 4.77 (s, 1H), 4.17 (d, J = 17.5 Hz, 1H), 3.26 (d, J = 17.5 
Hz, 1H), 3.14 – 3.06 (m, 2H), 2.65 (d, 1H, J = 14.4 Hz, 1H), 2.50 (d, J = 14.4 Hz, 1H), 2.14 (m, 1H), 
1.76 (m, J = 13.1 Hz, 1H). 13C NMR (151 MHz, Chloroform-d) δ 204.9, 199.1, 153.3, 145. 8, 135.3, 
132.2, 127.7, 126.0, 125.3, 109.7, 73.8, 39.8, 32.9, 31.8, 23.9, 14.1. 
 
  









Spectra Relevant to Chapter 3 
  

































































4.1  INTRODUCTION   
 The efficient formation of medium-sized rings, broadly classified as rings containing 
between 8-12 atoms, remains a challenge in organic synthesis. Medium-sized rings are 
represented in numerous bioactive scaffolds, and challenges in their formation result from high 
angular and torsional strain, associated with the preferred bond angle of sp3 hybridized carbons. 
A study towards the rate of intramolecular lactonization (k(intra)) showcases this unique trend 
(Figure 1);1 This report shows the relative stability of small rings, between 5-7 atoms, met with a 
marked decrease in reaction rate to generate medium sized rings. As the ring size extends past 
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12 atoms, the increased size allows for conformational flexibility of the atoms, and resulting 
stabilization. 
 
Figure 4.1 Impact of ring size on rate of intramolecular lactonization 
 Recently, our group has developed a new method to access medium-sized rings, 
which utilizes carbene an X—H insertion/aldol/oxy-cope cascade.2 In continuing our interest in 
the formation of complex macrocyclic scaffolds, we initially designed a substrate that would lead 
to a metal-free approach to benzannulated oxacycles. We hypothesized that coupling readily 
accessible 2’-hydroxychalcones with crotonic acid would provide a substrate capable of 
enolization, intramolecular aldol addition, followed by an anionic oxy-cope rearrangement to 
access 10-membered Oxacycles (Figure 4.1a).  




Scheme 4.1 a.) Cascade approach to 10-membered oxacycles b.) Observed formation of 
Benzo[c]coumarins 
 When crotonate 1 was exposed to base however, we observed the clean formation of 
a product that, after NMR analysis, completely lacked any aliphatic protons, as would be 
expected in the desired macrolactone product. Upon full characterization, we discovered that 
the product was instead aromatic benzo[c]coumarin 3, which had formed through a base-
mediated aldol-elimination to generate 1,3,5-triene 2. This triene intermediate presumably 
underwent a thermal 6-electrocyclization3 and subsequent aerial oxidation to form a new 
aromatic ring (Scheme 4.1b). After surveying the literature, this tricyclic aromatic scaffold and 
related scaffolds are the core structures of several notable natural products (Figure 4.1).  




Figure 4.2 Fused Aromatic Heterocycles in Natural Products 
 Alternariol and autumnariol both feature a benzo[c]coumarin core directly, and the 
natural product cannabinol was recently synthesized from a benzo[c]coumarin intermediate in 
three steps.4a-e Likewise, the lactam counterparts, Phenanthradin-6(5H)-ones, comprise the core 
scaffold of oxynitidine and N-methylcrinasiadine.4g-h Lastly, similar bis-benzannulated scaffolds, 
dibenzofurans and carbazoles, are well represented in natural product cores, including 
karnatakafuran B and murrayacine.4i-j Although there are examples in literature of 6-
electrocyclization employed in the synthesis of biologically relevant natural products,5 this 
serendipitous cascade represents a unique retrosynthetic disconnection for the construction of 
benzannulated heterocycles that does not rely on modification of a pre-formed heterocyclic 
scaffold.6 
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4.2 CASCADE APPROACH TO BENZO[C]COUMARINS 
4.2.1 SUBSTRATE SYNTHESIS 
 The desired crotonate ester starting materials can be accessed via a high-yielding 
two-step route from commercially available acetophenones and aryl aldehydes (Scheme 4.2). 
All reactions could be conveniently performed on a multi-gram scale.  
 
Scheme 4.2 Synthesis of Croconate esters 1 
 Condensation between 2’-hydroxycetophenone and benzaldehydes under Claisen-
Schmidt conditions afford 2’-hydroxychalcones 4 in excellent yields; These products are easily 
purified by crystallization in ethanol. Next, carbodiimide coupling of 4 to crotonic acid produces 
desired ester 1 after acid/base purification. With desired crotonate ester in hand, we began 
searching for conditions that could encourage the desired intramolecular aldol addition/oxy-cope 
cascade.  
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4.2.2 REACTION OPTIMIZATION  
 With our preliminary observation, we then directed our attention towards 











1 2 3  
Entry Base (eq.) Solvent Temperature 2:3 
1 K2CO3 (3.0) Acetone Reflux 1:2 (23)c 
2 Et3N (3.0) DCM Reflux N.R. 
3 DBU (3.0) DCM rt 95:5 
4 DBU (3.0) DMSO rt 90:10 
5 DBU (3.0) DMSO rt → 80 oC 0:100 (82)c 
6 DBU (2.0) DMSO rt → 80 oC 0:100 (64)c 
7 DBU (1.0) DMSO rt → 80 oC 0:100 (45)c 
8 DBU (0.1) DMSO rt → 80 oC trace 
Table 4.1 Reaction optimization for aldol elimination/electrocyclization sequence. All optimization reactions were 
performed by adding base at room temperature to a solution of 1 in DMSO (0.15 M). The reaction vessel was sealed 
and heated at the indicated temperature for 16 hours.  bThe percent ratio of 2 and 3 was determined by crude 1H 
NMR integration. cIsolated yield of 3 obtained after column chromatography. 
 When we exposed crotonate 1 to potassium carbonate in refluxing acetone, we 
observed full conversion to triene 2, with a 66% conversion to 3; these reaction conditions 
however were low yielding, so we explored using common organic bases. We observed no 
reaction between crotonate 1 in dichloromethane, even when the reaction temperature was 
elevated to reflux over 24 hours. When DBU was used as the base, we observed full conversion 
of 1 to triene 2, with partial conversion to 3; this suggested that the desired thermal 
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electrocyclization could proceed at room temperature, however elevated temperatures may be 
needed to encourage this reactivity. Inspired by recent reports into the 6-electrocyclization of 
1,3,5-triene systems,6 DMSO was then used as the reaction solvent and we observed a slight 
increase in the formation of 3 at room temperature.  Finally, we elevated reaction temperatures 
to 80 °C, and full conversion of 2 to 3 was observed after heating for 16 hours, with an excellent 
isolated yield.  
 Lastly, we performed experiments to observe the effect on reducing base equivalency.  
Although reducing the amount of DBU still resulted in complete conversion of 1 to triene 2, and 
2 to 3, we observed a marked decrease in isolated yield when compared to using 3.0 equivalents. 
When a catalytic amount of DBU was employed, we observed only trace conversion of 1 to 2.  
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4.2.3 BENZO[C]COUMARIN SUBSTRATE SCOPE 
 With optimized reaction conditions established, we then explored the effects of 
substituents on crotonate ester 1 (Scheme 4.3).  
 
Scheme 4.3 Cascade approach to benzo[c]coumarins – Substrate scope 
 Parent crotonate ester 1 cleanly underwent optimized reaction conditions to give 3a in good 
yields. This reaction was also scaled-up to the 1-gram scale, with only a slight decrease in yield (76%). 
Aromatic bromination of acetophenone and subsequent coupling furnished ester 1b, which 
underwent cascade conditions cleanly, producing 2-bromobenzocoumarin 3b in excellent yield. 
1b bears an aryl bromide functionality, which was converted to an additional phenyl substituent 
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through palladium catalyzed coupling conditions. This substrate produced the corresponding 
benzocoumarin 3c in a good yield. Next, we examined the effects of altering the electronics of 
the chalcone functionality, conveniently accessed by using 4-substituted benzaldehyde starting 
materials. Overall, the reaction proceeded smoothly with electron-neutral and electron-donating 
substituents (3d – 3f), however strongly electron-withdrawing substituents resulted in 
diminished yield (3g). We also probed the effect of alternative heterocyclic scaffolds on the 
reactivity of crotonate 1; by condensing 2’-hydroxyacetophenone with 2-furaldehyde, 1g was 
cleanly prepared and withstood reaction conditions to furnish furan-substituted benzylcoumarin 
3g in good yield. Lastly, we observed the effects on alkylation of the crotonate ester in the -
position. Compound 1i was prepared by coupling 2’-hydroxychalcone with 3-methyl-2-butenoic 
acid, and did successfully undergo the desired aldol/electrocyclication cascade, however we 
noticed the reaction became sluggish, and evidence of incomplete electrocyclization was 
observed.  
4.3  SYNTHESIS OF PHENANTHRADIN-6(5H)-ONES 
 With a substrate scope of 9 substituted benzo[c]coumarins prepared, we then 
explored the possibility of utilizing the amide analogue of 1 in the reaction cascade, for the 
synthesis of phenanthradin-6(5H)-ones.  
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4.3.1 SUBSTRATE SYNTHESIS 
 Amide substrate 6 could be prepared in a three-step sequence beginning with 2’-
aminoacetophenone (Scheme 4.4). 
 
Scheme 4.4 Synthesis of N-methylcrotonamides 6 
 First, 2’-aminoacetophenone was mono-methylated using iodomethane in the 
presence of potassium carbonate in DMF. Mono-alkylation proved to be a challenge for this 
substrate, as the electron-deficient nature of the amine made reductive amination conditions 
unsuitable. Fortunately, the mono-methyl amine 4 could be separated from its bis-methyl 
counterpart and unreacted starting material by crystallization. Then, condensation with various 
aryl aldehydes provided 2’-methylaminochalcones 5 in good, reliable yields. Lastly, acyl 
substitution with crotonyl chloride produced desired N-methylcrotonylamide 6. Notably, 5 was 
unresponsive towards carbodiimide coupling conditions with crotonic acid, so the acyl chloride 
counterpart was used in its stead. With amide 5 in hand, we determined its efficacy in the 
reaction cascade. 
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4.3.2 PHENANTHRADIN-6(5H)-ONE SUBSTRATE SCOPE 
 To our delight, N-methyl-N-crotonylamide 6 withstood optimized conditions smoothly 
to cleanly afford the desired phenanthradin-6(5H)-one product. We then explored the substrate 
scope of this transformation with respect to crotonylamides 6 (Scheme 4.5). 
 
Scheme 4.5 Scope of Phenanthradin-6(5H)-one substrates prepared 
 Parent N-Methyl-N-crotonylamide 6a cleanly underwent the desired 
aldol/electrocyclization cascade to give 7a in excellent yields. This reaction was amenable to a 
scale up to 1-gram, with negligible loss in yield (89%). The reaction conditions also withstood the 
N-Benzyl protecting group to give 7b in good yields. As in the case of benzo[c]coumarins, bromo-
functionalized precursor also underwent the desired cascade to give 7c in good yields. We then 
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observed the effect of altering the electronics of the 1,3,5-triene intermediate, and isolated 
electron-neutral and electron-rich products 7d and 7e in good yields, with a slight decrease in 
yield for electron-poor 7f. Lastly, we explored linear substrates 6 bearing labile amide protecting 
groups. Unfortunately, the reaction conditions did not withstand the common electron-
withdrawing protecting groups tert-butyl carbamate (boc) and 4-toluenesulfonate (Ts). In the 
case of boc-protected 6g, the reaction produced a complex mixture of products, resulting from 
cleavage of the boc- protecting group. There are several examples of boc- protected amines 
undergoing deprotection in the presence of DBU.7 In the case of tosyl-protected 6h, exposure to 
DBU resulted in cleavage of the crotonylamide resulting in clean recovery of N-Tosyl-2’-
aminochalcone.  
4.4  ARYL-ELECTROCYCLIZATION 
 We next explored the possibility of exchanging one olefin component of 1,3,5-trine 
intermediate 2 to an aromatic ring. 6p electrocyclizations including an aromatic ring have been 
documented.8 Generation of the requisite aryl-diene intermediate would rely on direct -
enolization and attack of an active methylene precursor, as opposed to our established indirect 
-enolization and -enolate attack. If this approach proves successful, it will provide an expedient 
route to several new tetracyclic frameworks.  
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4.4.1 SUBSTRATE SYNTHESIS 
 We envisioned a route to linear precursors 8 involving coupling of prepared 2’-
heterochalcones to commercially available arylacetic acids (Scheme 4.6). Fortunately, the pre-
established coupling conditions between chalcones and crotonic acid, used to prepare precursors 
1 and 6, were well suited to coupling with the arylacetic acids, resulting in precursors 8 being 
formed in excellent yields in most cases.   
 
Scheme 4.6 a.) Synthesis of Hetroarylbenzo[c]coumarin Precursors b.) Synthesis of 
Hetroarylphenanthradin-6(5H)-one Precursors 
 Some of the linear substrates 8 however were prone to enolization and intramolecular 
aldol condensation during coupling conditions, likely due to the reduced pKa of the -methylene 
relative to the -crotonyl protons – In these cases the resulting aryl-diene was exposed to the 
reaction cascade conditions directly.  
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4.4.2 SUBSTRATE SCOPE AND LIMITATIONS 
 Phenyl-substituted precursor 8a was prepared and we proceeded to test our aryl-
electrocyclization hypothesis. The precursor underwent the desired aldol condensation in good 
yields at room temperature, but this intermediate did not undergo 6-electrocyclization at 80 oC, 
even after 24 hours. Unfortunately, this substrate did not undergo electrocyclization, even after 
48 hours at 180 oC. We hypothesized that exchanging the phenyl ring with electron-rich 
heterocycles would provide a driving force for the desired electrocyclization to occur. After 
exchanging the phenyl ring for an electron-rich furan ring, we were delighted to observe the 
formation of 9b, although a slight increase in temperature (120 oC) was required to induce 
electrocyclization. We next pursued the scope of aryl-donors that could undergo 
electrocyclization (Scheme 4.7).  
 
Scheme 4.7 Substrate Scope for Aryl-Electrocyclization Cascade 
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 Furan-substituted 9b was prepared in an excellent 90% yield, and the reaction was 
also well-suited to a thiofuran donor, resulting in an 83% yield of 9c. Notably, this thiofuran 
precursor was prone to intramolecular aldol condensation during coupling conditions, so the 
reaction was performed using the resulting aryl-diene. Next, we explored the possibility of using 
bicyclic aromatic heterocycle donors – To our delight, the reaction conditions also tolerated 
dibenzofuran and N-methylindole donors 8e and 8f well, resulting in good yields of 9e and 9f. 
The lactam analogs were also successful candidates, and phenanthradin-6(5H)-ones 9g and 9h 
were prepared in comparable yields to their lactone counterparts. Lastly, we attempted the 
reaction conditions with pyridine-donor 8i, however this compound did not undergo aryl-
electrocyclization even after 24 hours at 180 oC.  
4.5 SYNTHESIS OF DIBENZOFURANS AND CARBAZOLES 
 We next explored the possibility of synthesizing other heterocyclic scaffolds using 
our Aldol condensation/electrocyclization cascade. We were happy to find that this cascade 
could be applied to the synthesis of dibenzofurans and carbazoles (Scheme 4.8).  
 
Scheme 4.8 Cascade approach to dibenzofurans and carbazoles 
 2’-functionalized chalcones underwent substitution with ethyl 4-bromocrotonate in 
the presence of base to cleanly give electrocyclization precursors 8 and 9. These compounds 
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underwent the desired -deprotonation and -enolate attack to give the desired triene 
intermediate at room temperature. When the reaction was heated to 80 oC, no desired 
electrocyclization occurred, but when heated to 120 oC 8 and 9 were converted to dibenzofuran 
10 and carbazole 11 were isolated in good yields.  
4.6 ATTEMPTED FORMAL SYNTHESIS OF CANNABINOL 
 The natural product cannabinol (CBN), an agonist of the CB1 and CB2 receptors, was 
synthesized recently from a benzo[c]coumarin precursor.4d In their report, Wang et al. reported 
the synthesis of Benzo[c]coumarin B through intramolecular palladium-catalyzed lactonization of 
a biphenyl ortho-benzoic acid. Then a functionalization route employed by Teske et. al. was 
employed, involving addition of methyllithium followed by acid-catalyzed ring closure of the 
resulting diol, and subsequent ester cleavage.4e We envisioned that we could accomplish a formal 
synthesis of cannabinol by synthesizing B through an aldol/electrocyclization cascade of 
precursor A (Scheme 4.9).  
 
Scheme 4.9 Planned formal synthesis of Cannabinol, using methods from Teske et. al. 
 We proceeded forward towards the synthesis of A. We designed a three-step route 
that would afford desired electrocyclization precursor B (Scheme 4.10).  




Scheme 4.10 Synthesis of precursor A and exposure to cascade conditions 
  Methylresorcinol, which differs from methylolivitol, the actual precursor to CBN, was 
used as a model substrate to test our electrocyclization hypothesis. First, methylresorcinol 
underwent palladium-catalyzed arylation to give crotonophenone 14, which was exposed to a 
stoichiometric amount of boron trichloride. We envisioned that these conditions would result in 
mono-deprotection of a methyl ether, which occurred, but also resulted in Michael addition of 
chloride to the ,-unsaturated ketone. We expected this alkyl chloride to undergo elimination 
in the presence of a base to restore the ,-unsaturation, so we proceeded forward. Acyl 
substitution of crotonyl chloride then cleanly afforded desired precursor A.  
 Unfortunately, when A was exposed to the optimized reaction conditions, we were 
unable to isolate any quantity of desired CBN precursor, but rather observed a complex mixture 
of products. We then exposed A to DBU at room temperature, and quenched the reaction after 
90 minutes, to determine whether there was an issue with the aldol condensation step, or the 
subsequent electrocyclization. In this case, we obtained a mixture of products featuring distinct 
1H NMR peaks around 12.0 ppm – characteristic of 2’-hydroxychalcones. This leads us to suspect 
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that this compound, now bearing acidic protons at the ketone -position, underwent undesired 
enolization and subsequent attack on the ester component. Collapse of the resulting tetrahedral 
intermediate would lead to ester cleavage and fragmentation of the resulting phenol. These 
findings lead us to infer that a major limitation in substrate scope includes compounds that lack 
conjugation of the ,-unsaturated ketone to another functional group.  
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4.7 SUMMARY & FUTURE DIRECTIONS 
 In summary, while pursuing a new pathway to generate 10-membered oxacycles, we 
have discovered a reaction cascade whereby benzo[c]coumarins are formed through an aldol 
condensation/6-electrocyclization cascade; The cascade conditions proved general and resulted 
in a substrate scope of nine benzo[c]coumarins. Conditions were also well-suited to synthesize 
the lactam analogs, and eight N-alkylphenanthridin-6(5H)-ones were prepared. The parent 
benzo[c]coumarin and phenanthridine-6(5H)-one compounds were amenable to scale-up, and 
could be prepared at gram-scale. The 6-electrocyclization could also include an aromatic 
heterocycle, and by heating at 120 oC six different tetracycles were prepared. By changing the 
cascade precursor slightly, we were also able to extend this approach to dibenzofuran and 
carbazole scaffolds. Lastly, insights gained during an attempted formal synthesis of the natural 
product cannabinol revealed that the reaction cascade undergoes an undesired decomposition 
pathway in the case of substrates containing enolizable protons on the ketone component, by 
way of ester cleavage and resulting phenolic fragmentation. The developed cascade 
methodology has shown an impressive substrate scope, but a limitation requires the ,-
unsaturated ketone be in conjugation with an aromatic ring or ester. Identification of a labile 
conjugating group, which could be cleaved after electrocyclization, would greatly improve the 
merit of this methodology. In addition, electrocyclization methodology could be employed in 
diazo-derived carbene chemistry – carbene-carbene coupling is a well-known process to generate 
alkenes. Utilizing vinyl, styryl, or aryl diazo compounds could provide a triene intermediate 
suitable for electrocyclization, as a new approach to substituted heterocycles. 
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4.9  EXPERIMENTAL SECTION 
PUBLICATION AND CONTRIBUTION STATEMENT 
The material in this chapter was published as a cover article in Organic Chemistry Frontiers (DOI: 
10.1039/c9qo01336a). Dr. Indrajeet Sharma contributed with assistance in project design, 
manuscript writing, and editing. The compound examples produced in this chapter are 
contributed by Steven Schlitzer, with starting material preparation assistance contributed by co-
author Katelyn Stevens and purification assistance by co-author Dr. Dhanarajan ‘Arun’ 
Arunprasath.  
MATERIALS AND METHODS  
Reagents  
Reagents and solvents were obtained from Sigma-Aldrich (www.sigma-aldrich.com), ChemImpex 
(www.chemimpex.com) or Acros Organics (www.fishersci.com) and used without further 
purification unless otherwise indicated. Dry solvents (acetonitrile) were obtained from Acros 
Organics (www.fishersci.com), and dichloromethane was distilled over CaH2 under N2 unless 
otherwise indicated. THF purchased from Sigma-Aldrich was distilled over Na metal with 
benzophenone indicator.  
Reactions  
All reactions were performed in flame-dried glassware under positive N2 pressure with magnetic 
stirring unless otherwise noted. Liquid reagents and solutions were transferred thru rubber septa 
via syringes flushed with N2 prior to use. Cold baths were generated as follows: 0 °C with wet 
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ice/water and −78 °C with dry ice/acetone. Syringe pump addi on reac ons were conducted 
using a CMA/100 microinjection pump.  
Chromatography  
TLC was performed on 0.25 mm E. Merck silica gel 60 F254 plates and visualized under UV light 
(254 nm) or by staining with potassium permanganate (KMnO4), cerium ammonium molybdenate 
(CAM), phosphomolybdic acid (PMA), and ninhydrin. Silica flash chromatography was performed 
on Sorbtech 230–400 mesh silica gel 60.  
Analytical Instrumentation  
IR spectra were recorded on a Shimadzu IRAffinity-1 FTIR or a Nicolet 6700 FTIR spectrometer 
with peaks reported in cm–1. NMR spectra were recorded on a Varian VNMRS 400, 500 and 600 
MHz NMR spectrometer in CDCl3 unless otherwise indicated. Chemical shifts are expressed in 
ppm relative to solvent signals: CDCl3 ((1H, 7.26 ppm, 13C, 77.0 ppm); coupling constants are 
expressed in Hz. NMR spectra were processed using Mnova 
(www.mestrelab.com/software/mnova-nmr). Mass spectra were obtained at the OU Analytical 
Core Facility on an Agilent 6538 High-Mass-Resolution QTOF Mass Spectrometer and an Agilent 
1290 UPLC. X-ray crystallography analysis was carried out at the University of Oklahoma using a 
Bruker APEX ccd area detector and graphite-monochromated Mo Kα radiation (λ = 0.71073 Å) 
source and a D8 Quest diffractometer with a Bruker Photon II cmos area detector and an Incoatec 
Iµs microfocus Mo Kα source (λ = 0.71073 Å). Crystal structures were visualized using CCDC 
Mercury software (http://www.ccdc.cam.ac.uk/products/mercury/).  
Nomenclature  
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N.B.: Atom numbers shown in chemical structures herein correspond to IUPAC nomenclature, 
which was used to name each compound. 
4.9.1  GENERAL PROCEDURE 1 FOR THE SYNTHESIS OF CROTONYLHYDROXYCHALCONES (1)  
To a round bottom flask was measured 2’-hydroxyacetophenones (1) (1.0 equiv.), which was then 
dissolved in dichloromethane (0.2 M). This solution was cooled in an ice/water bath then crotonic 
acid (1.2 equiv.) and DMAP (0.1 equiv.) were added, followed by the addition of 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDCI, 1.5 equiv.). The reaction vessel was 
allowed to warm naturally to room temperature with stirring over 16 hours. The reaction mixture 
was then diluted with excess dichloromethane and washed sequentially with 1N HCl (2x) and sat. 
NaHCO3 (2x). Organics were dried over anhydrous Na2SO4, concentrated in vacuo, then purified 
by flash chromatography eluting with 1:20 ethyl acetate:hexanes gradient to 2:5 ethyl 
acetate:hexanes to furnish crotonylhydroxychalcones 1a-1h.  
 
2-cinnamoylphenyl (E)-but-2-enoate (1a). Synthesized using general procedure 1. Yellow oil (272 
mg, 79% yield). TLC: Rf 0.23 (ethyl acetate/hexanes = 1: 4). IR (neat) max: 3032, 1733, 1604, 1448, 
1331, 1194, 1146, 1098, 964, 748 cm-1. 1H NMR (600 MHz) δ 7.70 (dd, J = 7.6, 1.7 Hz, 1H), 7.60–
7.51 (m, 4H), 7.41–7.31 (m, 4H), 7.20 (dd, J = 8.2, 1.1 Hz, 1H), 7.17–7.08 (m, 2H), 5.97 (dd, J = 
15.5, 1.8 Hz, 1H), 1.82 (dd, J = 6.9, 1.7 Hz, 3H). 13C NMR (151 MHz) δ 191.6, 164.4, 148.7, 147.7, 
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145.1, 134.6, 132.6, 132.3, 130.5, 129.8, 128.9 (2C), 128.4 (2C), 125.9, 125.7, 123.4, 121.6, 18.1. 
HRMS (ESI) m/z calcd for C19H16O3Na ([M + Na]+) 315.0997; found 315.0995. 
 
4-bromo-2-cinnamoylphenyl (E)-but-2-enoate (1b). Synthesized using general procedure 1. 
Yellow oil (103 mg, 74% yield). TLC: Rf  0.29 (ethyl acetate/hexanes = 3: 7). IR (neat) max: 3060, 
3026, 2973, 1736, 1651, 1598, 1448, 1189, 1144, 966, 863, 741, 691 cm-1. 1H NMR (600 MHz) δ 
7.79 (d, J = 2.4 Hz, 1H), 7.63 (dd, J = 8.6, 2.4 Hz, 1H), 7.59–7.50 (m, 3H), 7.39 (m, 3H), 7.16–7.06 
(m, 4H), 5.94 (dd, J = 15.6, 1.7 Hz, 1H), 1.82 (dd, J = 7.0, 1.7 Hz, 3H). 13C NMR (151 MHz) δ 190.1, 
164.1, 148.4, 147.6, 145.9, 135.07, 134.3, 134.2, 132.4, 130.8, 128.9 (2C), 128.5 (2C), 125.2, 
125.0, 121.2, 119.1, 18.2. HRMS (ESI) m/z calcd for C19H15BrO3Na ([M + Na]+) 393.0102; found 
393.0102. 
 
3-cinnamoyl-[1,1'-biphenyl]-4-yl (E)-but-2-enoate (1c). Synthesized using general procedure 1. 
Yellow oil (154 mg, 35% yield). TLC: Rf 0.27 (ethyl acetate/hexanes = 3: 7). IR (neat) max: 3029, 
1734, 1652, 1596, 1477, 1330, 1189, 1097, 964, 789 cm-1. 1H NMR (600 MHz) δ 7.89 (d, J = 2.3 
Hz, 1H), 7.75 (dd, J = 8.4, 2.3 Hz, 1H), 7.65–7.59 (m, 3H), 7.59–7.53 (m, 2H), 7.46 (t, J = 7.7 Hz, 
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2H), 7.42–7.35 (m, 4H), 7.28 (d, J = 8.4 Hz, 1H), 7.18 (m, 2H), 5.99 (dd, J = 15.5, 1.8 Hz, 1H), 1.84 
(dd, J = 6.9, 1.7 Hz, 3H). 13C NMR (75 MHz) δ 191.7, 164.6, 148.0, 145.4, 139.5, 139.2, 134.6, 
132.8, 130.9, 130.7, 129.0, 128.9 (2C), 128.5 (2C), 128.4 (2C), 127.8, 127.2, 125.6, 123.8, 121.5, 
18.3. HRMS (ESI) m/z calcd for C25H20O3Na ([M + Na]+) 391.1310; found 391.1316. 
 
2-((E)-3-(p-tolyl)acryloyl)phenyl (E)-but-2-enoate (1d). Synthesized using general procedure 1. 
Yellow oil (328 mg, 12% yield). TLC: Rf 0.39 (ethyl acetate/hexanes = 1: 4). IR (neat) max:  2916, 
1713, 1605, 1443, 1395, 1271, 1076, 887, 811, 781 cm-1. 1H NMR (600 MHz) δ 7.68 (dd, J = 7.7, 
1.7 Hz, 1H), 7.55 (d, J = 16.0 Hz, 1H), 7.51 (ddd, J = 8.2, 7.4, 1.7 Hz, 1H), 7.43 (d, J = 7.9 Hz, 2H), 
7.32 (td, J = 7.5, 1.2 Hz, 1H), 7.19 (dd, J = 8.2, 1.1 Hz, 1H), 7.17 (d, J = 7.8 Hz, 2H), 7.15–7.07 (m, 
2H), 5.96 (dd, J = 15.5, 1.7 Hz, 1H), 2.35 (s, 3H), 1.82 (dd, J = 6.9, 1.7 Hz, 3H). 13C NMR (151 MHz) 
δ 191.7, 164.4, 148.7, 147.7, 145.4, 141.1, 132.7, 132.3, 131.8, 129.8, 129.7 (2C), 128.5 (2C), 









2-((E)-3-(4-chlorophenyl)acryloyl)phenyl (E)-but-2-enoate (1e). Synthesized using general 
procedure 1. Yellow oil (525 mg, 52% yield). TLC: Rf  0.25 (ethyl acetate/hexanes = 3: 7). IR (neat) 
max: 2915, 1732, 1603, 1489, 1293, 1192, 1092, 964, 820, 730 cm-1. 1H NMR (600 MHz) δ 7.68 
(dd, J = 7.6, 1.9 Hz, 1H), 7.53 (m, 1H), 7.52–7.47 (d, J = 18 Hz, 1H), 7.45 (m, 2H), 7.33 (m, 3H), 7.19 
(dd, J = 8.3, 1.9 Hz, 1H), 7.15–7.07 (m, 2H), 5.96 (d, J = 15.6 Hz, 1H), 1.85–1.81 (d, J = 6 Hz, 3H). 
13C NMR (151 MHz) δ 191.4, 164.4, 148.7, 147.9, 143.6, 136.4, 133.1 (2C), 132.5 (2C), 129.8 (2C), 
129.5 (2C), 129.2, 126.0, 123.5, 121.5, 18.2. HRMS (ESI) m/z calcd for C19H15ClO3Na ([M + Na]+) 
349.0607; found 349.0612. 
 
2-((E)-3-(4-methoxyphenyl)acryloyl)phenyl (E)-but-2-enoate (1f). Synthesized using general 
procedure 1. Yellow oil (146 mg, 45% yield). TLC: Rf  0.13 (ethyl acetate/hexanes = 3: 7). IR (neat) 
max: 2936, 1733, 1589, 1509, 1194, 1171, 1098, 1021, 966, 826, 730 cm-1. 1H NMR (600 MHz) δ 
7.67 (dd, J = 7.6, 1.7 Hz, 1H), 7.55–7.47 (m, 4H), 7.33 (td, J = 7.6, 1.1 Hz, 1H), 7.19 (dd, J = 8.1, 1.1 
Hz, 1H), 7.11 (dq, J = 15.5, 6.9 Hz, 1H), 7.01 (d, J = 15.8 Hz, 1H), 6.89 (d, J = 8.8 Hz, 2H), 5.97 (dd, 
J = 15.5, 1.8 Hz, 1H), 3.83 (s, 3H), 1.84 (dd, J = 7.0, 1.7 Hz, 3H). 13C NMR (151 MHz) δ 191.8, 164.5, 
 Ch. 4 – Development of a Metal-Free Cascade Approach to Aromatic Heterocycles 
200 
 
161.7, 148.6, 147.7, 145.2, 132.8, 132.1, 130.2, 129.7 (2C), 127.3 (2C), 125.8, 123.4, 121.6, 114.4, 
113.5, 55.4, 18.2. HRMS (ESI) m/z calcd for C20H18O4Na ([M + Na]+) 345.1103; found 345.1109. 
 
2-((E)-3-(4-(trifluoromethyl)phenyl)acryloyl)phenyl (E)-but-2-enoate (1g). Synthesized using 
general procedure 1. Yellow solid (565 mg, 68% yield, m.p. 55–56 ºC). TLC: Rf  0.47 (ethyl 
acetate/hexanes = 1:4). IR (neat) max: 3014, 1734, 1655, 1597, 1442, 1321, 1289, 1211, 1145, 
1066, 963, 836, 771 cm-1. 1H NMR (400 MHz) δ 7.70 (dd, J = 7.7, 1.7 Hz, 1H), 7.58 (d, J = 14.9 Hz, 
4H), 7.54–7.43 (m, 2H), 7.31 (td, J = 7.6, 1.2 Hz, 1H), 7.24–7.17 (m, 2H), 7.09 (m, J = 15.6, 1H), 
5.95 (dd, J = 15.5, 1.7 Hz, 1H), 1.79 (dd, J = 7.0, 1.8 Hz, 3H). 13C NMR (151 MHz) δ 191.0, 164.4, 
148.8, 148.0, 142.7, 138.0, 132.8, 131.7, 132.1, 129.9, 128.5, 127.6, 126.0, 125.7 (q, JC-F = 3.4 Hz), 
123.5, 121.44, 18.1 [Note : While peaks corresponding to the CF3 were observed, some portion 
of the peaks were lost in signal noise]. HRMS (ESI) m/z calcd for C20H15F3O3Na ([M + Na]+) 
383.0871; found 383.0869. 
 
2-((E)-3-(furan-2-yl)acryloyl)phenyl (E)-but-2-enoate (1h). Synthesized using general procedure 
1. Yellow oil (190 mg, 42% yield). TLC: Rf  0.30 (ethyl acetate/hexanes = 3: 7). IR (neat) max: 3057, 
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1732, 1655, 1598, 1550, 1477, 1037, 1217, 1194, 1098, 1012, 934, 750 cm-1. 1H NMR (300 MHz) 
δ 7.71–7.65 (m, 1H), 7.53–7.48 (m, 1H), 7.47 (td, J = 1.4, 0.8 Hz, 1H), 7.37–7.25 (m, 2H), 7.20–
7.01 (m, 3H), 6.63 (dd, J = 3.4, 0.6 Hz, 1H), 6.45 (dd, J = 3.4, 1.8 Hz, 1H), 5.98 (dd, J = 15.5, 1.8 Hz, 
1H), 1.85 (dd, J = 6.9, 1.7 Hz, 3H). 13C NMR (75 MHz) δ 190.8, 164.4, 151.3, 148.8, 147.6, 145.1, 
132.4, 131.0, 129.8, 125.9, 123.5, 122.9 (2C), 121.6, 116.4, 112.7, 18.2. HRMS (ESI) m/z calcd for 
C17H14O4Na ([M + Na]+) 305.0790; found 305.0790. 
 
 
2-cinnamoylphenyl 3-methylbut-2-enoate (1i). Synthesized using general procedure 1. Yellow 
oil (350 mg, 88% yield). TLC: Rf 0.48 (ethyl acetate/hexanes = 1: 4). IR (neat) max: 3061, 2917, 
2359, 1738, 1605, 1448, 1332, 1200, 1119, 1063, 749 cm-1. 1H NMR (600 MHz) δ 7.70 (dd, J = 7.6, 
1.7 Hz, 1H), 7.59–7.51 (m, 4H), 7.37 (m, 3H), 7.35–7.31 (t, 2H), 7.19–7.13 (m, 2H), 5.85 (d, J = 1.4 
Hz, 1H), 2.11 (s, 3H), 1.83 (s, 3H). 13C NMR (151 MHz) δ 191.8, 164.5, 161.0, 148.8, 144.9, 134.7, 
132.6, 132.4, 130.5, 129.8, 128.8 (2C), 128.4 (2C), 125.8, 125.7, 123.6, 114.7, 27.6, 20.5. HRMS 
(ESI) m/z calcd for C20H18O3Na ([M + Na]+) 329.1154; found 329.1153. 
 
4.9.2  SYNTHESIS OF (E)-4-STYRYL-3-VNIYL-2H-CHROMEN-2-ONE  (2)  




(E)-4-styryl-3-vinyl-2H-chromen-2-one (2). To a 4.0 mL vial was measured 
crotonylhydroxychalcone (1) (1.0 equiv.). DMSO (0.15M) was then added, followed by the 
addition of DBU (3.0 equiv.). The reaction vessel was equipped with a magnetic stir bar, sealed, 
and stirred at room temperature for 90 minutes. The reaction mixture was then diluted into ethyl 
acetate. Organics were washed sequentially with sat. NH4Cl (2x) and water (2x) then dried over 
anhydrous Na2SO4. Organics were concentrated in vacuo and purified by flash chromatography 
to furnish (E)-4-styryl-3-vinyl-2H-chromen-2-one (2). Yellow oil (375 mg, 60% yield). TLC: Rf  0.53 
(ethyl acetate/hexanes = 1:1). IR (neat): 3025, 1709, 1603, 1449, 1320, 1100, 984, 712. 1H NMR 
(400 MHz) δ 7.72 (d, J = 8.0 Hz, 1H), 7.57 (d, J = 7.5 Hz, 2H), 7.42 (tq, J = 14.3, 7.5 Hz, 4H), 7.30–
7.20 (m, 2H), 7.15–7.06 (m, 1H), 6.91–6.76 (m, 2H), 6.41 (dd, J = 17.6, 1.9 Hz, 1H), 5.60 (dd, J = 
11.9, 1.9 Hz, 1H). 13C NMR (101 MHz) δ 159.8, 152.4, 146.5, 139.6, 135.6, 131.3, 129.6, 129.3, 
129.0 (2C), 128.6 (2C), 127.0, 126.3, 124.1, 122.9, 120.8, 119.4, 116.7. HRMS (ESI) m/z calcd for 
C19H15O2 ([M + H]+) 275.1072; found 275.1081.  
 
4.9.3  GENERAL PROCEDURE 2 FOR THE SYNTHESIS OF BENZO[C]COUMARINS (3)  
To a 15 mL round bottom flask was measured crotonylhydroxychalcone (1) (1.0 equiv.). DMSO 
(0.15M) was then added, followed by the addition of DBU (3.0 equiv.). The reaction vessel was 
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equipped with a magnetic stir bar and stirred open to air at room temperature for 90 minutes. 
The reaction mixture was then heated to 80 oC  and stirred at this temperature for 16 hours. The 
reaction mixture was then cooled to room temperature and diluted into ethyl acetate. Organics 
were washed sequentially with sat. NH4Cl (2x) and water (2x) then dried over anhydrous Na2SO4. 
Organics were concentrated in vacuo and purified by flash chromatography 1:20 ethyl 
acetate:hexanes gradient to 2:5 ethyl acetate:hexanes to furnish benzo[c]coumarins 3a-3h. 
 
 
9-phenyl-6H-benzo[c]chromen-6-one (3a). Synthesized using general procedure 2. (223 mg, 82% 
yield). Characterization data was in accordance with previous reports.9 
 
2-bromo-9-phenyl-6H-benzo[c]chromen-6-one (3b). Synthesized using general procedure 2. (46 
mg, 88% yield). Characterization data was in accordance with previous reports. 6a 
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2,9-diphenyl-6H-benzo[c]chromen-6-one (3c). Synthesized using general procedure 2. Gray solid 
(35 mg, 67% yield, m.p. 184–185 ºC). TLC: Rf  0.54 (ethyl acetate/hexanes = 1:4). IR (neat) max: 
3057, 2925, 1723, 1611, 1484, 1270, 1076, 883, 761 cm-1. 1H NMR (600 MHz) δ 8.44 (dd, J = 8.1, 
1.5 Hz, 1H), 8.31 (s, 1H), 8.26 (s, 1H), 7.78 (s, 1H), 7.71 (d, J = 7.3 Hz, 2H), 7.68 (d, J = 8.6, 1H), 7.64 
(d, J = 7.4 Hz, 2H), 7.53 (t, J = 7.4 Hz, 2H), 7.51–7.45 (m, 3H), 7.44–7.37 (m, 2H). 13C NMR (151 
MHz) δ 161.0, 150.9, 147.8, 140.1, 139.6, 137.9, 135.0, 131.2, 129.5, 129.1, 129.0 (2C), 128.8 (2C), 
128.0 (2C), 127.7 (2C), 127.5 (2C), 127.2, 121.2, 120.1, 120.0, 118.2. HRMS (ESI) m/z calcd for 
C25H16O2Na ([M + Na]+) 371.1048; found 371.1047. 
 
9-(p-tolyl)-6H-benzo[c]chromen-6-one (3d). Synthesized using general procedure 2. (33 mg, 77% 
yield). Characterization data was in accordance with previous reports. 6a 
 
9-(4-methoxyphenyl)-6H-benzo[c]chromen-6-one (3e). Synthesized using general procedure 2. 
(37 mg, 82% yield). Characterization data was in accordance with previous reports. 9 




9-(4-chlorophenyl)-6H-benzo[c]chromen-6-one (3f). Synthesized using general procedure 2. (42 




9-(4-(trifluoromethyl)phenyl)-6H-benzo[c]chromen-6-one (3g). Synthesized using general 
procedure 2. Beige solid (24 mg, 46% yield, m.p. 172–174 ºC). TLC: Rf 0.27 (ethyl acetate/hexanes 
= 1:5). IR (neat) max: 3021, 2160, 1977, 1712, 1611, 1449, 1322, 1165, 1107, 1087, 826, 871 cm-
1. 1H NMR (400 MHz) δ 8.51 (d, J = 8.2 Hz, 1H), 8.30 (d, J = 1.8 Hz, 1H), 8.16 (dd, J = 7.9, 1.6 Hz, 
1H), 7.85–7.76 (m, 5H), 7.53 (m, J = 8.5 Hz, 1H), 7.44–7.35 (m, 2H). 13C NMR (101 MHz) δ 160.9, 
151.5, 146.2, 143.2, 135.3, 131.4, 130.8, 127.9, 126.1 (d, J = 3.8 Hz), 124.7, 122.7, 120.7, 120.4, 
119.1 (q, JC-F = 272.1 Hz, 1C), 117.8 [Note : While peaks corresponding to the CF3 were observed, 
some portion of the peaks were lost in signal noise]. HRMS (ESI) m/z calcd for C20H12F3O2 ([M + 
H]+) 341.0789; found 341.0794. 




9-(furan-2-yl)-6H-benzo[c]chromen-6-one (3h). Synthesized using general procedure 2. Yellow 
oil (24 mg, 62% yield). TLC: Rf 0.40 (ethyl acetate/hexanes = 1:4). IR (neat) max: 2922, 2852, 1716, 
1612, 1476, 1275, 1208, 1105, 916, 898, 734 cm-1.  1H NMR (400 MHz) δ 8.39 (dd, J = 5.0, 3.3 Hz, 
2H), 8.19–8.11 (m, 1H), 7.83 (dd, J = 8.4, 1.6 Hz, 1H), 7.60 (d, J = 1.8 Hz, 1H), 7.50 (ddd, J = 8.4, 
7.0, 1.6 Hz, 1H), 7.37 (t, J = 7.6 Hz, 2H), 6.95 (d, J = 3.4 Hz, 1H), 6.58 (dd, J = 3.5, 1.8 Hz, 1H). 13C 
NMR (101 MHz) δ 161.0, 152.3, 151.5, 143.9, 136.4, 135.4, 131.1, 130.6, 124.5, 124.1, 122.9, 
119.5, 118.0, 117.8, 116.0, 112.4, 108.7. HRMS (ESI) m/z calcd for C17H11O3 ([M + H]+) 263.0708; 
found 263.0710. 
 
7-methyl-9-phenyl-6H-benzo[c]chromen-6-one (3i). Synthesized using general procedure 2. (25 
mg, 59% yield). Characterization data was in accordance with previous reports. 6a 
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4.9.4  GENERAL PROCEDURE 3 FOR THE SYNTHESIS OF N-ALKYLAMINOCHALCONES 
To a solution of N-methylacetophenones (1.0 equiv.) in ethanol (2.5 M) was added solid NaOH 
(3.0 equiv.). After the solid was fully dissolved, the appropriate benzaldehyde (1.2 equiv.) was 
added, and the mixture was stirred at room temperature overnight. The reaction mixture was 
then cooled to 0 ºC in an ice/water bath and the mixture was carefully neutralized using 1N HCl. 
The crude mixture was extracted with dichloromethane (3x) then washed with water (2x) and 
brine (2x). Organics were dried over Na2SO4 and concentrated to furnish chalcones which were 
purified by flash chromatography 1:20 ethyl acetate:hexanes gradient to 2:5 ethyl 
acetate:hexanes to furnish N-alkylaminochalcones. 
 
(E)-1-(2-(methylamino)phenyl)-3-phenylprop-2-en-1-one. Synthesized using general procedure 




(E)-1-(2-(benzylamino)phenyl)-3-phenylprop-2-en-1-one. Synthesized using general procedure 
3. (55 mg, 35% yield). Characterization data was in accordance with previous reports. 11 




(E)-1-(5-bromo-2-(methylamino)phenyl)-3-phenylprop-2-en-1-one. Synthesized using general 
procedure 3. Orange solid (270 mg, 28% yield, mp 73 – 75 ºC). TLC: Rf 0.70 (ethyl acetate/hexanes 
= 1:4). IR (neat) max: 3309, 3924, 2907, 1642, 1585, 1447, 1187, 1165, 984, 813 cm-1. 1H NMR 
(400 MHz)  8.98 (bs, 1H), 7.96 (s, 1H), 7.72 (d, J = 15.5 Hz, 1H), 7.64 (m, J = 9.1 Hz, 2H), 7.55 (d, 
J = 15.5 Hz, 1H), 7.41 (s, 4H), 6.62 (d, J = 9.1 Hz, 1H), 2.92 (s, 3H). 13C NMR (101 MHz)  190.5, 
151.5, 143.4, 137.5, 135.0, 133.5, 130.3, 128.9 (2C), 128.4 (2C), 122.4, 119.5, 113.3, 105.2, 29.5. 
HRMS (ESI) m/z calcd for C16H15BrNO ([M+H]+) 316.0337; found 316.0338. 
 
(E)-3-(4-chlorophenyl)-1-(2-(methylamino)phenyl)prop-2-en-1-one. Synthesized using general 




(E)-3-(4-methoxyphenyl)-1-(2-(methylamino)phenyl)prop-2-en-1-one. Synthesized using 
general procedure 3. (315 mg, quant. yield). Characterization data was in accordance with 
previous reports. 13 





(E)-4-(3-(2-(methylamino)phenyl)-3-oxoprop-1-en-1-yl)benzonitrile. Synthesized using general 
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4.9.5  GENERAL PROCEDURE 4 FOR THE SYNTHESIS OF N-ALKYL-N-
CROTONYLAMINOCHALCONES (6)  
To a solution of N-alkylaminochalcone (1.0 equiv.) in dichloromethane (0.2M) at 0 oC was added 
solid NaHCO3 (1.5 equiv.). The mixture was stirred at this temperature for 10 minutes before 
crotonyl chloride (1.2 equiv.) was added slowly by syringe. The reaction mixture was allowed to 
warm naturally to room temperature and stirred at this temperature overnight. The reaction 
mixture was diluted with dichloromethane, then washed with water (2x). The organic layer was 
then dried over Na2SO4 and concentrated to give crude N-alkyl-N-crotonylaminochalcones (5) as 
a separable mixture of E/Z isomers, which were then purified via column chromatography 1:10 
ethyl acetate:hexanes gradient to 1:1 ethyl acetate:hexanes to furnish pure N-alkyl-N-
crotonylaminochalcones 6a-6i.  
 
(E)-N-(2-cinnamoylphenyl)-N-methylbut-2-enamide (6a). Synthesized using general procedure 
4. Orange oil (970 mg, 81% yield). TLC: Rf 0.23 (ethyl acetate/hexanes = 2:5). IR (neat) max: 3033, 
1664, 1631, 1595, 1478, 1367, 1288, 1206, 1095, 963, 771 cm-1. 1H NMR (500 MHz) δ 7.68 (dd, J 
= 7.6, 1.6 Hz, 1H), 7.59 (td, J = 7.7, 1.7 Hz, 1H), 7.56–7.47 (m, 6H), 7.40 (m, 4H), 7.28 (d, J = 6.1 Hz, 
1H), 7.01 (d, J = 16.0 Hz, 1H), 6.90 (dq, J = 15.0, 6.9 Hz, 1H), 5.74 (dd, J = 15.0, 1.7 Hz, 1H), 3.28 (s, 
3H). 13C NMR (75 MHz) δ 192.9, 165.8, 145.8, 141.8, 138.1, 134.2, 132.1, 130.8, 129.9, 129.6, 
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129.3, 128.9, 128.4 (2C), 128.1 (2C), 125.1, 122.5, 37.7, 18.0. HRMS (ESI) m/z calcd for C20H10NO2 
([M + H]+) 306.1494; found 306.1486. 
 
(E)-N-benzyl-N-(2-cinnamoylphenyl)but-2-enamide (6b). Synthesized using general procedure 
4. Yellow oil (44 mg, 47% yield). TLC: Rf 0.43 (ethyl acetate/hexanes = 3:7). IR (neat) max: 3028, 
2245, 1662, 1595, 1446, 1386, 1354, 1288, 1203, 907, 725 cm-1. 1H NMR (300 MHz) δ 7.66–7.61 
(m, 1H), 7.52–7.45 (m, 2H), 7.40 (m, J = 8.5 Hz, 5H), 7.21–7.14 (m, 4H), 7.03–6.92 (m, 2H), 6.90–
6.85 (m, 1H), 5.74 (dq, J = 15.0, 1.6 Hz, 1H), 5.48 (d, J = 14.3 Hz, 1H), 4.24 (d, J = 14.4 Hz, 1H), 1.70 
(dd, J = 6.9, 1.7 Hz, 3H). 13C NMR (75 MHz) δ 192.9, 165.9, 145.9, 142.4, 139.8, 138.4, 137.1, 
134.3, 131.6, 131.0, 130.9, 129.5, 129.3, 129.0 (2C), 128.5 (2C), 128.3 (2C), 128.1 (2C), 127.4, 
125.1, 122.9, 53.3, 18.1. HRMS (ESI) m/z calcd for C26H24NO2 ([M+H]+ 382.1807; found 382.1806. 
 
(E)-N-(4-bromo-2-cinnamoylphenyl)-N-methylbut-2-enamide (6d). Synthesized using general 
procedure 4. Yellow oil (347 mg, 90% yield). TLC: Rf 0.26 (ethyl acetate/hexanes = 3:7). IR (neat) 
max: 3055, 2631, 1597, 1447, 1393, 1293, 1198, 1102, 962, 823, 774 cm-1.  1H NMR (400 MHz)  
7.77 (d, J = 2.4 Hz, 1H), 7.68 (dd, J = 8.3, 2.5 Hz, 1H), 7.56–7.48 (m, 3H), 7.39 (d, J = 6.7 Hz, 3H), 
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7.14 (d, J = 8.4 Hz, 1H), 6.99–6.83 (m, 2H), 5.75–5.66 (m, 1H), 3.23 (s, 3H), 1.71 (dd, J = 7.0, 1.7 
Hz, 3H). 13C NMR (101 MHz)  191.3, 165.7, 146.6, 142.8, 140.7, 139.8, 135.1, 134.0, 132.5, 131.2, 
131.0, 129.1 (2C), 128.6 (2C), 124.4, 122.1, 121.8, 37.7, 18.1. HRMS (ESI) m/z calcd for 
C20H19BrNO2 ([M + H]+) 384.0599; found 384.0601. 
 
(E)-N-(2-((E)-3-(4-chlorophenyl)acryloyl)phenyl)-N-methylbut-2-enamide (6f). Synthesized 
using general procedure 4. Yellow oil (337 mg, 99% yield). IR (neat) max: 2911, 1663, 1590, 1488, 
1367, 1290, 1204, 1089, 962, 768 cm-1. TLC: Rf 0.30 (ethyl acetate/hexanes = 2:5). 1H NMR (300 
MHz) δ 7.65 (dd, J = 7.5, 1.7 Hz, 1H), 7.57 (td, J = 7.6, 1.7 Hz, 1H), 7.45 (m, J = 16.3, 4H), 7.33 (d, J 
= 8.5 Hz, 2H), 7.25 (dd, J = 7.9, 1.2 Hz, 1H), 6.94 (d, J = 15.9 Hz, 1H), 6.89–6.79 (m, 1H), 5.75–5.64 
(m, 1H), 3.24 (s, 3H), 1.67 (dd, J = 7.0, 1.7 Hz, 3H). 13C NMR (75 MHz) δ 192.5, 165.8, 144.1, 142.2, 
141.7, 138.0, 136.7, 132.8, 132.3, 129.7, 129.6, 129.3, 129.3 (2C), 128.1 (2C), 125.4, 122.4, 37.8, 
18.1. HRMS (ESI) m/z calcd for C20H18ClNO2Na ([M + Na]+) 362.0924 ; found 362.0920. 
 
(E)-N-(2-((E)-3-(4-methoxyphenyl)acryloyl)phenyl)-N-methylbut-2-enamide (6g). Synthesized 
using general procedure 4. Yellow oil (295 mg, 75% yield). IR (neat) max: 2933, 1663, 1592, 1444, 
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1329, 1303, 1171, 1020, 962, 826, 730 cm-1. TLC: Rf 0.18 (ethyl acetate/hexanes = 2:5). 1H NMR 
(300 MHz) δ 7.61 (dd, J = 7.5, 1.8 Hz, 1H), 7.52 (td, J = 7.6, 1.8 Hz, 1H), 7.48–7.39 (m, 4H), 7.21 
(dd, J = 7.8, 1.3 Hz, 1H), 6.92–6.78 (m, 4H), 5.70 (dd, J = 15.0, 1.7 Hz, 1H), 3.79 (s, 3H), 3.22 (s, 
3H), 1.65 (dd, J = 6.9, 1.7 Hz, 3H). 13C NMR (75 MHz) δ 193.1, 165.9, 161.9, 145.9, 141.8, 141.5, 
138.5, 131.9, 130.3, 129.5, 129.3 (2C), 128.4 (2C), 126.9, 122.9, 122.5, 114.5, 55.4, 37.7, 18.0. 
HRMS (ESI) m/z calcd for C21H21NO3Na ([M + Na]+) 358.1419 ; found 358.1418. 
 
(E)-N-methyl-N-(2-((E)-3-(p-tolyl)acryloyl)phenyl)but-2-enamide (6h). Synthesized using 
general procedure 4. Yellow oil (495 mg, 77% yield). IR (neat) max: 3050, 2915, 1664, 1628, 1596, 
1445, 1370, 1297, 1205, 1040, 963, 813, 731 cm-1. TLC: Rf 0.48 (ethyl acetate/hexanes = 1:1). 1H 
NMR (300 MHz) δ 7.61 (d, J = 9.1 Hz, 1H), 7.53 (t, J = 7.6 Hz, 1H), 7.48 – 7.40 (m, 2H), 7.36 (d, J = 
8.1 Hz, 2H), 7.22 (d, J = 8.8 Hz, 1H), 7.14 (d, J = 7.9 Hz, 2H), 6.92 (d, J = 15.9 Hz, 1H), 6.88 – 6.77 
(m, 1H), 5.70 (d, J = 16.7 Hz, 1H), 3.23 (s, 3H), 2.32 (s, 3H), 1.67 – 1.59 (m, 3H). HRMS (ESI) m/z 
calcd for C21H22NO2 ([M + H]+) 320.1651; found 320.1649. 
  




(E)-N-(2-((E)-3-(4-cyanophenyl)acryloyl)phenyl)-N-methylbut-2-enamide (6i). Synthesized using 
general procedure 4. Yellow oil (102 mg, 32% yield). IR (neat) max: 3462, 3054, 2226, 1661, 1445, 
1295, 1096, 963, 827, 770 cm-1. TLC: Rf 0.18 (ethyl acetate/hexanes = 2:5). 1H NMR (300 MHz) δ 
7.72–7.52 (m, 9H), 7.50–7.43 (m, 2H), 7.29–7.21 (m, 1H), 7.03 (d, J = 15.9 Hz, 1H), 6.95–6.79 (m, 
1H), 5.68 (dd, J = 15.0, 1.7 Hz, 1H), 3.24 (s, 3H), 1.67 (dd, J = 7.0, 1.6 Hz, 3H). 13C NMR (75 MHz) δ 
191.8, 165.8, 142.5, 142.4, 141.9, 138.7, 137.5, 132.9, 132.7, 129.9, 129.3, 128.7, 128.2, 127.8, 
122.2, 118.3, 113.6, 37.8, 18.1. HRMS (ESI) m/z calcd for C21H18N2O2Na ([M + Na]+)  352.1266; 
found 352.1266. 
 
4.9.6  GENERAL PROCEDURE 5 FOR THE SYNTHESIS OF PHENANTHRADIN-6(5H)-ONES (7) :  
To a 15 mL round bottom flask was measured N-aklyl-N-crotonylaminochalcone (6) (1.0 equiv.). 
DMSO (0.15M) was then added, followed by the addition of DBU (3.0 equiv.). The reaction vessel 
was equipped with a magnetic stir bar and stirred open to air at room temperature for 90 
minutes. The reaction mixture was then heated to 80 oC  and stirred at this temperature for 16 
hours. The reaction mixture was then cooled to room temperature and diluted with ethyl acetate. 
Organics were washed sequentially with sat. NH4Cl (2x) and water (2x) then dried over anhydrous 
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Na2SO4. Organics were concentrated in vacuo and purified by flash chromatography using a 1:10 
ethyl acetate:hexanes gradient to 1:1 ethyl acetate:hexanes to furnish phenanthradinones 7a-7i. 
 
5-methyl-9-phenylphenanthridin-6(5H)-one (7a). Synthesized using general procedure 5. Yellow 
oil (259 mg, 91% yield). TLC: Rf 0.43 (ethyl acetate/hexanes = 3:10). IR (neat) max: 3029, 2252, 
1625, 1584, 1466, 1417, 1277, 1158, 1075, 866, 744 cm-1. 1H NMR (500 MHz) δ 8.63 (d, J = 8.2 
Hz, 1H), 8.47 (d, J = 1.7 Hz, 1H), 7.82 (dd, J = 8.3, 1.6 Hz, 1H), 7.75 (dd, J = 8.2, 1.3 Hz, 2H), 7.59 
(ddd, J = 8.6, 7.1, 1.5 Hz, 1H), 7.54 (t, J = 7.6 Hz, 2H), 7.48–7.44 (m, 2H), 7.36 (ddd, J = 8.1, 7.2, 1.1 
Hz, 1H), 3.85 (s, 3H). 13C NMR (75 MHz) δ 161.5, 145.1, 140.4, 138.2, 133.8, 129.7, 129.5, 129.0 
(2C), 128.3 (2C), 127.5, 127.1, 124.4, 123.2, 122.5, 120.1, 119.3, 115.1, 30.0. HRMS (ESI) m/z calcd 
for C20H16NO ([M + H]+) 286.1232; found 286.1237. 
 
5-benzyl-9-phenylphenanthridin-6(5H)-one (7b). Synthesized using general procedure 5. (36 mg, 
86% yield). Characterization data was in accordance with previous reports.15 
 
 




2-bromo-5-methyl-9-phenylphenanthridin-6(5H)-one (7e). Synthesized using general procedure 
5. Yellow oil (29 mg, 70% yield). TLC: Rf 0.45 (ethyl acetate/hexanes = 3:10). IR (neat)max: 3085, 
2920, 2120, 1639, 1582, 1361, 1187, 1033, 853, 625 cm-1. 1H NMR (600 MHz)  8.59 (d, J = 8.3 
Hz, 1H), 8.44 (s, 1H), 8.35 (d, J = 1.7 Hz, 1H), 7.84 (dd, J = 8.3, 1.7 Hz, 1H), 7.76–7.70 (m, 2H), 7.65 
(dd, J = 8.8, 2.2 Hz, 1H), 7.54 (t, J = 7.5 Hz, 2H), 7.46 (t, J = 7.5 Hz, 1H), 7.31 (d, J = 8.9 Hz, 1H), 3.81 
(s, 3H). 13C NMR (151 MHz)  161.2, 145.6, 140.1, 137.3, 132.6, 132.3, 129.6, 129.0 (2C), 128.4 
(2C), 127.8, 127.5, 126.0, 124.6, 121.1, 120.2, 116.8, 115.7, 30.1. HRMS (ESI) m/z calcd for 
C20H15BrNO ([M + H]+) 364.0337; found 364.0342.  
 
9-(4-chlorophenyl)-5-methylphenanthridin-6(5H)-one (7f). Synthesized using general procedure 
5. Yellow Oil (38 mg, 80% yield). TLC: Rf  0.28 (ethyl acetate/hexanes = 1:4). IR (neat) max: 2923, 
1644, 1585, 1444, 1389, 1343, 1092, 1005, 814, 689 cm-1. 1H NMR (300 MHz) δ 8.61 (dd, J = 8.3, 
0.5 Hz, 1H), 8.42–8.39 (m, 1H), 8.36 (dd, J = 8.1, 1.5 Hz, 1H), 7.78–7.73 (m, 1H), 7.70–7.63 (m, 
2H), 7.58 (ddd, J = 8.5, 7.1, 1.5 Hz, 1H), 7.52–7.47 (m, 2H), 7.47–7.42 (m, 1H), 7.35 (ddd, J = 8.3, 
7.3, 1.2 Hz, 1H), 3.84 (s, 3H). 13C NMR (75 MHz) δ 161.4, 143.9, 138.8, 138.3, 134.5, 133.9, 129.8, 
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129.7, 129.2 (2C), 128.8 (2C), 126.9, 124.7, 123.2, 122.5, 120.0, 119.1, 115.2, 30.0. HRMS (ESI) 
m/z calcd for C20H15ClNO ([M + H]+) 320.0842; found 320.0851. 
 
9-(4-methoxyphenyl)-5-methylphenanthridin-6(5H)-one (7g). Synthesized using general 
procedure 5. Yellow oil (45 mg, 81% yield). TLC: Rf 0.21 (ethyl acetate/hexanes = 1:4). IR (neat) 
max: 2927, 1643, 1585, 1520, 1444, 1298, 1246, 1178, 1032, 826, 750 cm-1. 1H NMR (300 MHz) δ 
8.58 (d, J = 8.3 Hz, 1H), 8.41 (d, J = 1.7 Hz, 1H), 8.38 (dd, J = 8.2, 1.5 Hz, 1H), 7.78 (dd, J = 8.3, 1.7 
Hz, 1H), 7.72–7.65 (m, 2H), 7.57 (ddd, J = 8.5, 7.1, 1.5 Hz, 1H), 7.44 (dd, J = 8.5, 1.2 Hz, 1H), 7.35 
(ddd, J = 8.2, 7.1, 1.2 Hz, 1H), 7.05 (d, J = 8.7 Hz, 2H), 3.89 (s, 3H), 3.84 (s, 3H). 13C NMR (75 MHz) 
δ 159.9, 144.8, 138.3, 133.9, 129.6 (2C), 129.5, 128.6, 126.8, 124.0, 123.2 (2C), 122.4 (2C), 121.8, 
119.4 (2C), 115.1, 114.4, 55.4, 30.0. HRMS (ESI) m/z calcd for C21H18NO2 ([M + H]+) 316.1338; 
found 316.1345. 
 
5-methyl-9-(p-tolyl)phenanthridin-6(5H)-one (7h). Synthesized using general procedure 5. 
Yellow solid (269 mg, 89% yield, m.p. 136–138 ºC). TLC: Rf 0.33 (ethyl acetate/hexanes = 1:3). IR 
(neat) max: 2914, 1920, 1642, 1614, 1584, 1445, 1338, 1306, 1101, 1044, 814, 781, 684 cm-1. 1H 
NMR (300 MHz) δ 8.51 (d, J = 8.3 Hz, 1H), 8.30 (s, 1H), 8.23 (d, J = 7.8 Hz, 2H), 7.70 (d, J = 8.1 Hz, 
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1H), 7.58 (d, J = 7.8 Hz, 2H), 7.48 (t, J = 7.4 Hz, 1H), 7.29 (q, J = 7.2 Hz, 4H), 3.73 (s, 3H), 2.42 (s, 
3H). 13C NMR (75 MHz). δ 161.4, 144.9, 138.2, 137.3, 133.7, 129.7, 129.5, 129.4 (2C), 127.3, 126.8, 
124.1 (2C), 123.1, 122.3 (2C), 119.6, 119.2, 115.0, 29.9, 21.2. HRMS (ESI) m/z calcd for C21H18NO 
([M + H]+) 300.1388; found 300.1389. 
 
4-(5-methyl-6-oxo-5,6-dihydrophenanthridin-9-yl)benzonitrile (7i). Synthesized using general 
procedure 5. Yellow oil (31 mg, 68% yield, ). TLC: Rf 0.14 (ethyl acetate/hexanes = 1:4). IR (neat) 
max: 3090, 3035, 2219, 1645, 1604, 1478, 1347, 1035, 824 cm-1. 1H NMR (300 MHz) δ 8.64 (dd, J 
= 8.3, 0.5 Hz, 1H), 8.43 (d, J = 1.8 Hz, 1H), 8.35 (dd, J = 8.1, 1.5 Hz, 1H), 7.82 (d, J = 1.5 Hz, 4H), 
7.77 (dd, J = 8.3, 1.7 Hz, 1H), 7.60 (ddd, J = 8.5, 7.1, 1.5 Hz, 1H), 7.45 (dd, J = 8.5, 1.1 Hz, 1H), 7.36 
(ddd, J = 8.2, 7.1, 1.2 Hz, 1H), 3.83 (s, 3H). 13C NMR (75 MHz) δ 161.2, 144.8, 143.0, 138.3, 134.1, 
132.8, 130.1, 129.9, 128.2 (2C), 126.8, 125.4, 123.2 (2C), 122.6, 120.5, 118.9, 118.7, 115.3, 111.9, 
30.1. HRMS (ESI) m/z calcd for C21H15N2O ([M + H]+) 311.1184; found 311.1191. 
 4.9.7  GENERAL PROCEDURE 6 FOR THE SYNTHESIS OF ARYLACETYLCHALCONES (8)  
a.) To a round bottom flask was measured 2’-hydroxyacetophenones (1) (1.0 equiv.), which was 
then dissolved in dichloromethane (0.2 M). This solution was cooled in an ice/water bath then 
arylacetic acid (1.2 equiv.) and DMAP (0.1 equiv.) were added, followed by the addition of 1-
Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDCI, 1.5 equiv.). The reaction 
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vessel was allowed to warm naturally to room temperature and stirred for 4 hours. The reaction 
mixture was then diluted with excess dichloromethane and washed sequentially with 1N HCl (2x) 
and sat. NaHCO3 (2x). Organics were dried over anhydrous Na2SO4, concentrated in vacuo, then 
purified by flash chromatography eluting with 1:20 ethyl acetate:hexanes gradient to 2:5 ethyl 
acetate:hexanes to furnish arylacetichydroxychalcones 8a-8d.  
b.) To a stirred solution of corresponding arylacetic acid (1.2 equiv.) was added one drop of DMF. 
The reaction vessel was equipped with a reflux condenser and a 2M solution of (COCl)2 (1.5 
equiv.) was slowly added by syringe. The mixture was heated to reflux with stirring for 90 
minutes, then cooled to room temperature. Solvent was removed by rotary evaporation and the 
crude acyl chloride was carried forward without further purification. To a solution of N-
methylaminochalcone (1.0 equiv.) in dichloromethane (0.2M) at 0 oC was added solid NaHCO3 
(1.5 equiv.). The mixture was stirred at this temperature for 10 minutes before crude acyl chloride 
(1.2 equiv.) was added slowly by syringe. The reaction mixture was allowed to warm naturally to 
room temperature and stirred at this temperature overnight. The reaction mixture was diluted 
with dichloromethane, then washed with water (2x). The organic layer was then dried over 
Na2SO4 and concentrated to give crude N-alkyl-N-arylaceticaminochalcones (8), which were then 
purified via column chromatography 3:10 ethyl acetate:hexanes gradient to 1:1 ethyl 
acetate:hexanes to furnish pure N-alkyl-N-arylaminochalcones 8f-8h.  
 




2-cinnamoylphenyl 2-(furan-3-yl)acetate (8a). Synthesized using general procedure 6a. Yellow 
oil (467 mg, 80% yield). TLC: Rf  0.33 (ethyl acetate/hexanes = 1:4). IR (neat) max: 3058, 2915, 
1761, 1666, 1604, 1448, 1303, 1194, 1112, 1020, 998, 872, 731 cm-1. 1H NMR (300 MHz, 
Chloroform-d) δ 7.70 (dd, J = 7.7, 1.7 Hz, 1H), 7.60 – 7.50 (m, 4H), 7.44 – 7.31 (m, 6H), 7.21 – 7.10 
(m, 2H), 6.38 (s, 1H), 3.68 (s, 3H). 13C NMR (75 MHz, Chloroform-d) δ 191.7, 169.6, 148.6, 145.7, 
143.0, 140.7, 134.4, 132.5, 132.2, 130.9, 129.9, 129.0, 128.5 (2C), 126.2, 125.3, 123.4, 116.4, 
111.4, 30.7. HRMS (ESI) m/z calcd for C21H16O4Na ([M + Na]+) 355.0946; found 355.0948. 
 
(Z)-4-(2-phenyl-2-(thiophen-2-yl)vinyl)-2H-chromen-2-one (8b). Synthesized using general 
procedure 6a. Yellow oil (690 mg, 77% yield). TLC: Rf  0.32 (ethyl acetate/hexanes = 1:4). IR (neat) 
max: 3028, 2923, 2854, 1703, 1603, 1450, 1282, 1110, 1051, 970 cm-1. 1H NMR (400 MHz, 
Chloroform-d) δ 7.95 (d, J = 8.1 Hz, 1H), 7.55 (d, J = 7.0 Hz, 1H), 7.54 – 7.47 (m, 3H), 7.43 (t, J = 
7.0 Hz, 4H), 7.38 (d, J = 7.0 Hz, 1H), 7.32 (d, J = 9.2 Hz, 1H), 7.12 – 7.09 (m, 1H), 7.04 (d, J = 4.7 Hz, 
2H). 13C NMR (101 MHz, Chloroform-d) δ 160.3, 153.0, 146.5, 138.6, 135.8, 134.7, 131.5, 131.26, 
 Ch. 4 – Development of a Metal-Free Cascade Approach to Aromatic Heterocycles 
221 
 
129.2 (2C), 129.0 (2C), 128.2 (2C), 127.1, 126.6, 124.3, 122.5, 119.0, 118.7, 117.2. HRMS (ESI) m/z 
calcd for C21H15O2S ([M + H]+) 331.0793; found 331.0788. 
 
2-cinnamoylphenyl 2-(benzofuran-3-yl)acetate (8c). Synthesized using general procedure 6a. 
Yellow oil (260 mg, 76% yield). TLC: Rf  0.25 (ethyl acetate/hexanes = 1:4). IR (neat) max: 3060, 
2954, 1760, 1604, 1449, 1331, 1303, 1196, 1097, 731 cm-1. 1H NMR (300 MHz, Chloroform-d) δ 
7.69 (dd, J = 7.7, 1.7 Hz, 1H), 7.59 – 7.49 (m, 6H), 7.45 (d, J = 8.1 Hz, 1H), 7.43 – 7.33 (m, 4H), 7.32 
– 7.25 (m, 1H), 7.21 (d, J = 7.5 Hz, 1H), 7.16 (d, J = 8.0 Hz, 1H), 7.09 (d, J = 16.1 Hz, 1H), 3.92 (s, 
2H). 13C NMR (101 MHz, Chloroform-d) δ 191.7, 169.2, 155.1, 148.6, 145.8, 143.2, 134.3, 132.5, 
132.2, 130.9, 129.8, 129.0 (2C), 128.5 (2C), 127.5, 126.3, 125.2, 124.5, 123.5, 122.7, 119.8, 112.3, 








2-cinnamoylphenyl 2-(1-methyl-1H-indol-3-yl)acetate (8d). Synthesized using general 
procedure 6b. Yellow oil (140 mg, 19% yield). TLC: Rf  0.22 (ethyl acetate/hexanes = 1:4). IR (neat) 
max: 3057, 2929, 1756, 1603, 1474, 1447, 1330, 1193, 1104, 1013, 916, 775 cm-1. 1H NMR (300 
MHz, Chloroform-d) δ 7.66 (d, J = 7.6 Hz, 1H), 7.58 (d, J = 7.9 Hz, 1H), 7.54 – 7.45 (m, 4H), 7.41 – 
7.29 (m, 4H), 7.24 (t, J = 6.7 Hz, 2H), 7.20 – 7.10 (m, 2H), 7.07 (m, 1H), 6.99 (d, J = 19.7 Hz, 1H), 
3.96 (s, 2H), 3.66 (s, 3H). 13C NMR (151 MHz, Chloroform-d) δ 192.1, 170.3, 148.7, 145.5, 136.8, 
134.5, 132.5, 132.2, 130.6, 129.7 (2C), 128.9 (2C), 128.5, 128.0, 127.7, 126.0, 125.6, 123.4, 121.8, 
119.3, 118.9, 109.3, 105.6, 32.6, 31.2. HRMS (ESI) m/z calcd for C26H21NO3Na ([M + Na]+) 
418.1419; found 418.1411. 
 
2-(benzofuran-3-yl)-N-(2-cinnamoylphenyl)-N-methylacetamide (8e). Synthesized using 
general procedure 6b. Yellow oil (184 mg, 93% yield). TLC: Rf  0.53 (ethyl acetate/hexanes = 1:1). 
IR (neat) max: 3060, 2924, 2247, 1731, 1644, 1596, 1449, 1330, 1207, 1095, 906, 856, 725 cm-1. 
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1H NMR (300 MHz, Chloroform-d) δ 7.73 – 7.68 (m, 1H), 7.57 – 7.53 (m, 2H), 7.52 – 7.48 (m, 2H), 
7.47 – 7.43 (m, 2H), 7.42 – 7.32 (m, 5H), 7.28 – 7.22 (m, 1H), 7.22 – 7.19 (m, 1H), 7.19 – 7.12 (m, 
1H), 7.00 (d, J = 16.0 Hz, 1H), 3.25 (s, 3H). 13C NMR (75 MHz, Chloroform-d) δ 192.5, 170.2, 155.0, 
146.5, 142.9, 141.8, 137.6, 134.1, 132.4, 131.1, 129.7, 129.6, 129.0 (2C), 128.6 (2C), 128.6 (2C), 
127.9, 124.8, 124.2, 122.5, 119.9, 114.08, 111.3, 29.9. HRMS (ESI) m/z calcd for C26H21NO2 ([M + 
H]+) 396.1600; found 396.1604. 
 
N-(2-cinnamoylphenyl)-N-methyl-2-(1-methyl-1H-indol-3-yl)acetamide (8f). Synthesized using 
general procedure 6b. Yellow oil (117 mg, 65% yield). TLC: Rf  0.40 (ethyl acetate/hexanes = 1:1). 
IR (neat) max: 3055, 2928, 2240, 1644, 1596, 1484, 1447, 1371, 1329, 1206, 1109, 1012, 908, 728 
cm-1. 1H NMR (300 MHz, Chloroform-d) δ 7.65 (d, J = 8.9 Hz, 1H), 7.50 (dd, J = 15.8, 9.0 Hz, 3H), 
7.36 (s, 5H), 7.23 (d, J = 7.6 Hz, 2H), 7.12 (s, 2H), 7.01 (s, 1H), 6.84 (s, 1H), 6.72 (d, J = 15.9 Hz, 1H), 
3.61 (d, J = 5.2 Hz, 2H), 3.55 (s, 3H), 3.29 (s, 3H). 13C NMR (75 MHz, Chloroform-d) δ 192.3, 171.5, 
145.6, 142.3, 137.8, 136.6, 134.1, 132.4, 130.9, 129.7, 128.9 (2C), 128.6 (2C), 128.3 (2C), 127.9, 
127.7, 124.5, 121.4, 118.9, 118.7, 109.2, 107.3, 38.1, 32.6, 31.1. HRMS (ESI) m/z calcd for 
C27H25N2O2 ([M + H]+) 409.1916; found 409.1922. 
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4.9.8 GENERAL PROCEDURE 7 FOR THE SYNTHESIS OF HETEROBENZO[C]COUMARINS AND 
HETEROARYLPHENANTHRADIN-6(5H)-ONES (9)  
To a 15 mL round bottom flask was measured arylaceticchalcone (9) (1.0 equiv.). DMSO (0.15M) 
was then added, followed by the addition of DBU (3.0 equiv.). The reaction vessel was equipped 
with a magnetic stir bar, and stirred open to air at room temperature for 90 minutes. The reaction 
mixture was then heated to 120 oC  and stirred at this temperature for 16 hours. The reaction 
mixture was then cooled to room temperature and diluted into ethyl acetate. Organics were 
washed sequentially with sat. NH4Cl (2x) and water (2x) then dried over anhydrous Na2SO4. 
Organics were concentrated in vacuo and purified by flash chromatography 1:20 ethyl 
acetate:hexanes gradient to 2:5 ethyl acetate:hexanes to furnish heteroarylbenzo[c]coumarins 
9a-9d. 
 
11-phenyl-4H-benzofuro[4,5-c]chromen-4-one (9a). Synthesized using general procedure 7. 
Beige solid (61 mg, 90% yield, m.p. 204–206 ºC). TLC: Rf  0.50 (ethyl acetate/hexanes = 1:4). IR 
(neat) max: 3027, 2921, 1726, 1607, 1482, 1350, 1251, 1200, 1109, 1025, 873, 684 cm-1. 1H NMR 
(300 MHz, Chloroform-d) δ 8.15 (d, J = 9.1 Hz, 2H), 7.94 (dd, J = 8.2, 1.4 Hz, 2H), 7.86 (dd, J = 24.4, 
2.1 Hz, 2H), 7.63 – 7.50 (m, 3H), 7.50 – 7.38 (m, 2H), 7.36 (d, J = 7.8 Hz, 1H). 13C NMR (75 MHz, 
Chloroform-d) δ 160.3, 152.2, 151.3, 148.0, 135.0, 132.6, 132.1, 129.9, 129.2, 129.2, 129.1 (2C), 
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128.9 (2C), 124.5, 122.9, 118.4, 117.8, 117.1, 112.7, 108.8. HRMS (ESI) m/z calcd for C21H13O3 ([M 
+ H]+) 313.0865; found 313.0867. 
 
11-phenyl-4H-thieno[2',3':5,6]benzo[1,2-c]chromen-4-one (9b). Synthesized using general 
procedure 7. Beige solid (19 mg, 83% yield, m.p. 206–208 ºC). TLC: Rf  0.50 (ethyl acetate/hexanes 
= 1:4). IR (neat) max: 2923, 2359, 1702, 1583, 1498, 1332, 1280, 1199, 967, 746 cm-1. 1H NMR 
(400 MHz, Chloroform-d) δ 8.22 (d, J = 8.0 Hz, 1H), 8.12 (s, 1H), 7.74 (d, J = 5.6 Hz, 1H), 7.68 (d, J 
= 6.8 Hz, 2H), 7.62 – 7.47 (m, 6H), 7.40 (t, J = 7.4 Hz, 1H). 13C NMR (126 MHz, Chloroform-d) δ 
160.6, 151.2, 144.4, 139.8, 139.1, 132.8, 131.0, 130.4, 129.2 (2C), 128.9 (2C), 128.7 (2C), 124.7, 
123.3, 123.0, 118.3 (2C), 117.9 (2C). HRMS (ESI) m/z calcd for C21H14O2S ([M + H]+) 329.0636; 
found 329.0643. 
 
6-phenyl-12H-benzo[2,3]benzofuro[4,5-c]chromen-12-one (9c). Synthesized using general 
procedure 7. Beige solid (12 mg, 89% yield, m.p. 247–249 ºC). TLC: Rf  0.42 (ethyl acetate/hexanes 
= 1:4). IR (neat) max: 2919, 2849, 1723, 1599, 1451, 1364, 1252, 1195, 1142, 966, 874, 767 cm-1. 
1H NMR (300 MHz, Chloroform-d) δ 9.41 (d, J = 9.3 Hz, 1H), 8.30 (s, 1H), 8.15 (d, J = 8.0 Hz, 1H), 
7.97 (d, J = 6.8 Hz, 2H), 7.67 – 7.51 (m, 5H), 7.51 – 7.45 (m, 2H), 7.45 – 7.38 (m, 1H), 7.37 – 7.29 
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(m, 1H). 13C NMR (126 MHz, Chloroform-d) δ 160.2, 157.5, 153.6, 151.1, 135.2, 132.8, 132.1, 
130.0, 129.4, 129.2, 129.0 (2C), 128.3 (2C), 125.7, 124.5, 123.4, 123.1, 123.0 (2C), 120.4, 118.3, 
117.6, 115.2, 111.4. HRMS (ESI) m/z calcd for C25H15O3 ([M + H]+) 363.1021; found 363.1029. 
 
7-methyl-6-phenylchromeno[4,3-c]carbazol-12(7H)-one (9d). Synthesized using general 
procedure 7. Yellow solid (19 mg, 71% yield, m.p. 251–253 ºC). TLC: Rf  0.40 (ethyl 
acetate/hexanes = 1:4). IR (neat) max: 2919, 2850, 1712, 1594, 1400, 1321, 1143, 1005, 873, 738 
cm-1. 1H NMR (400 MHz, Chloroform-d) δ 9.66 (d, J = 8.7 Hz, 1H), 8.09 – 8.01 (m, 2H), 7.56 (s, 6H), 
7.41 – 7.32 (m, 4H), 7.27 (d, J = 4.6 Hz, 1H), 3.40 (s, 3H). 13C NMR (101 MHz, Chloroform-d) δ 
160.8, 150.8, 143.4, 139.5 (2C), 139.1, 133.2, 129.5, 129.0, 128.4 (2C), 128.4 (2C), 128.2 (2C), 
127.4, 124.1, 123.4, 122.7, 121.9, 120.1, 118.9, 117.2, 115.1, 108.7, 33.4. HRMS (ESI) m/z calcd 
for C26H18NO2 ([M + H]+) 376.1338; found 376.1340. 
 
13-methyl-6-phenylbenzofuro[3,2-i]phenanthridin-12(13H)-one (9e). Synthesized using general 
procedure 7. Beige solid (58 mg, 86% yield, m.p. 234–236 ºC). TLC: Rf  0.38 (ethyl acetate/hexanes 
= 1:1). IR (neat) max: 3032, 2921, 1915, 1642, 1604, 1486, 1328, 1219, 1047, 866, 743 cm-1. 1H 
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NMR (300 MHz, Chloroform-d) δ 9.60 (d, J = 8.1 Hz, 1H), 8.38 (s, 1H), 8.27 (d, J = 9.4 Hz, 1H), 7.94 
(d, J = 6.9 Hz, 2H), 7.60 (t, J = 7.2 Hz, 3H), 7.54 (d, J = 7.0 Hz, 1H), 7.46 (q, J = 8.3 Hz, 3H), 7.36 (d, 
J = 9.3 Hz, 1H), 7.26 (t, 1H), 3.85 (s, 3H). 13C NMR (75 MHz, Chloroform-d) δ 161.3, 157.2, 153.4, 
137.6, 135.8, 130.7, 130.5, 129.3, 129.2, 129.0, 128.8 (2C), 128.7, 128.0, 124.3, 124.1, 123.4, 
123.0, 122.3, 120.86, 120.7, 119.5, 114.8, 111.1, 30.0. HRMS (ESI) m/z calcd for C25H18NO2 ([M + 
H]+) 376.1338; found 376.1338. 
 
7,13-dimethyl-6-phenyl-7,13-dihydro-12H-indolo[3,2-i]phenanthridin-12-one (9f). Synthesized 
using general procedure 7. Yellow oil (48 mg, 63% yield). TLC: Rf  0.46 (ethyl acetate/hexanes = 
1:1). IR (neat) max: 3050, 2925, 2241, 1629, 1598, 1448, 1307, 1246, 1078, 907, 729 cm-1. 1H NMR 
(300 MHz, Chloroform-d) δ 8.13 (dd, J = 8.2, 1.5 Hz, 1H), 7.59 (ddd, J = 8.5, 7.1, 1.5 Hz, 1H), 7.45 
(dd, J = 8.1, 1.1 Hz, 2H), 7.37 – 7.30 (m, 1H), 7.30 – 7.25 (m, 4H), 7.24 (d, J = 8.7 Hz, 1H), 7.22 – 
7.17 (m, 1H), 7.10 – 7.03 (m, 2H), 6.86 (d, J = 16.8 Hz, 1H), 3.84 (s, 3H), 3.79 (s, 3H). 13C NMR (126 
MHz, Chloroform-d) δ 161.7, 142.7, 139.6, 136.9, 136.7, 136.2, 131.3, 129.7, 128.7 (2C), 128.1 
(2C), 127.6, 127.4, 126.6, 125.0, 124.6, 121.8, 121.5, 121.3, 120.4, 119.6, 114.4, 109.5, 109.3, 
33.0, 30.3. HRMS (ESI) m/z calcd for C27H21N2O ([M + H]+) 389.1654; found 389.1654. 
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4.9.9 SYNTHESIS OF ETHYL 2-PHENYLDIBENZO[B,D]FURAN-3-CARBOXYLATE (11) 
 
ethyl (E)-4-(2-cinnamoylphenoxy)but-2-enoate (10). To a suspension of anhydrous potassium 
carbonate (6.0 mmol, 829 mg, 3.0 equiv.) in DMSO (2 mL) was added hydroxychalcone (448 mg, 
2.0 mmol, 1.0 equiv.). Ethyl 4-bromocrotonate (0.736 mL, 4.0 mmol, 2.0 equiv.) was then added 
dropwise via syringe. The mixture was then stirred at room temperature for 6 hours. The 
inorganic solids were removed via filtration and organics were quenched via addition of cold 
water. The aqueous solution was extracted with dichloromethane (3x 20 mL) and the organics 
were washed with water (3x 15 mL). Organics were dried over dried over anhydrous Na2SO4, 
concentrated, and purified by flash chromatography to furnish Ethyl (E)-4-(2-
cinnamoylphenoxy)but-2-enoate 10. Yellow oil (362 mg, 54% yield). TLC: Rf = 0.21 (ethyl 
acetate/hexanes = 1:4). IR (neat) max: 2980, 1715, 1660, 1599, 1448, 1303, 1271, 1177, 1021, 
970, 753 cm-1. 1H NMR (300 MHz) δ 7.67–7.59 (m, 2H), 7.58–7.51 (m, 2H), 7.47–7.38 (m, 2H), 
7.38–7.30 (m, 3H), 7.09–6.97 (m, 2H), 6.92 (dd, J = 8.4, 0.9 Hz, 1H), 6.15 (dt, J = 15.8, 2.1 Hz, 1H), 
4.75 (dd, J = 3.9, 2.1 Hz, 2H), 4.05 (q, J = 7.1 Hz, 2H), 1.13 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz) δ 
192.6, 165.9, 156.4, 143.4, 141.4, 134.8, 132.9, 130.6, 130.3, 129.7, 128.8 (2C), 128.5 (2C), 126.9, 
122.2, 121.5, 112.7, 67.1, 60.4, 14.1. HRMS (ESI) m/z calcd for C21H21O4 ([M + H]+) 337.1440; 
found 337.1431.  




ethyl 2-phenyldibenzo[b,d]furan-3-carboxylate (12). To a 15 mL round bottom flask was 
measured ethyl (E)-4-(2-cinnamoylphenoxy)but-2-enoate (10) (1.0 equiv.). DMSO (0.15M) was 
then added, followed by the addition of DBU (3.0 equiv.). The reaction vessel was equipped with 
a magnetic stir bar, and stirred open to air at room temperature for 90 minutes. The reaction 
mixture was then heated to 120 oC and stirred at this temperature for 16 hours. The reaction 
mixture was then cooled to room temperature and diluted into ethyl acetate. Organics were 
washed sequentially with sat. NH4Cl (2x) and water (2x) then dried over anhydrous Na2SO4. 
Organics were concentrated in vacuo and purified by flash chromatography to furnish 
dibenzofuran 11. Yellow oil (26 mg, 55% yield). TLC: Rf 0.57 (ethyl acetate/hexanes = 1:4). IR 
(neat) max: 3057, 2979, 2358, 1707, 1458, 1217, 1106, 1017,786 cm-1. 1H NMR (600 MHz) δ 8.07 
(d, J = 2.2 Hz, 1H), 7.96 (d, J = 7.8 Hz, 1H), 7.92 (d, J = 2.2 Hz, 1H), 7.62 (d, J = 8.3 Hz, 1H), 7.53 (t, 
J = 7.9 Hz, 1H), 7.45–7.33 (m, 6H), 4.13 (q, J = 7.0 Hz, 2H), 1.02 (t, J = 7.1 Hz, 3H). 13C NMR (151 
MHz) δ 168.4, 157.5, 154.7, 141.9, 137.8, 130.0, 128.7 (2C), 128.4 (2C), 128.0, 127.0, 126.8, 123.4, 
123.1, 122.6, 121.2, 113.2, 112.0, 61.12 13.6. HRMS (ESI) m/z calcd for C21H16O3Na ([M + Na]+) 
339.0997; found 339.0986. 
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4.9.10. SYNTHESIS OF ETHYL- 9-METHYL-3-PHENYL-9H-CARBAZOLE-2-CARBOXYLATE (13) 
 
ethyl (E)-4-((2-cinnamoylphenyl)(methyl)amino)but-2-enoate (11). To a solution of N-
methylaminochalcone (356 mg, 1.50 mmol, 1.0 equiv.) and ethyl 4-bromocrotonate (0.310 mL, 
1.80 mmol, 1.2 equiv.) in MeCN (3 mL) was added anhydrous potassium carbonate (207 mg, 1.50 
mmol, 1.0 equiv.). The reaction vessel was sealed and heated to reflux with stirring for 16 hours. 
The reaction mixture was cooled to room temperature and inorganic salts were removed via 
filtration. Organics were then concentrated and purified by flash chromatography to furnish Ethyl 
(E)-4-((2-cinnamoylphenyl)(methyl)amino)but-2-enoate 9. Yellow oil (468 mg, 89% yield). TLC: Rf 
0.32 (ethyl acetate/hexanes = 1:4). IR (neat) max: 2980, 1715, 1658, 1597, 1485, 1448, 1367, 
1265, 1173, 1030, 974, 704 cm-1. 1H NMR (400 MHz) δ 7.65 (d, J = 16.0 Hz, 1H), 7.59–7.54 (m, 
2H), 7.50 (dd, J = 7.6, 1.7 Hz, 1H), 7.44–7.34 (m, 3H), 7.30 (d, J = 16.0 Hz, 1H), 7.03 (qd, J = 7.8, 
7.4, 1.0 Hz, 2H), 6.87 (dt, J = 15.7, 5.7 Hz, 1H), 5.93 (dt, J = 15.7, 1.7 Hz, 1H), 4.09 (q, J = 7.1 Hz, 
2H), 3.80 (dd, J = 5.7, 1.6 Hz, 2H), 2.79 (s, 3H), 1.18 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz) δ 195.2, 
165.9, 150.8, 143.8, 143.2, 134.9, 132.8, 131.8, 130.3 (2C), 128.9 (2C), 128.4 (2C), 126.3, 123.5, 
121.4, 118.5, 60.4, 57.9, 41.3, 14.1. HRMS (ESI) m/z calcd for C22H24NO3 ([M + H]+) 350.1756; 
found 350.1758. 




ethyl 9-methyl-3-phenyl-9H-carbazole-2-carboxylate (13). To a 15 mL round bottom flask was 
measured ethyl (E)-4-((2-cinnamoylphenyl)(methyl)amino)but-2-enoate (12) (1.0 equiv.). DMSO 
(0.15M) was then added, followed by the addition of DBU (3.0 equiv.). The reaction vessel was 
equipped with a magnetic stir bar, and stirred open to air at room temperature for 90 minutes. 
The reaction mixture was then heated to 120 oC and stirred at this temperature for 16 hours. The 
reaction mixture was then cooled to room temperature and diluted into ethyl acetate. Organics 
were washed sequentially with sat. NH4Cl (2x) and water (2x) then dried over anhydrous Na2SO4. 
Organics were concentrated in vacuo and purified by flash chromatography to furnish carbazole 
9. Orange oil (64 mg, 69% yield). TLC: Rf 0.36 (ethyl acetate/hexanes = 1:4). IR (neat) max: 2978, 
1701, 1493, 1460, 1368, 1234, 1095, 1018, 908, 785, 699 cm-1. 1H NMR (500 MHz) δ 8.11 (d, J = 
7.8 Hz, 1H), 8.07 (d, J = 1.5 Hz, 1H), 7.95 (d, J = 1.5 Hz, 1H), 7.56 (t, J = 7.9 Hz, 1H), 7.46 (d, J = 8.3 
Hz, 1H), 7.45–7.34 (m, 4H), 7.30–7.26 (m, 2H), 4.14 (qd, J = 7.1, 1.4 Hz, 2H), 3.94 (d, J = 1.6 Hz, 
3H), 1.01 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz) δ 169.6, 142.8, 142.4, 139.5, 133.6, 128.9 (2C), 
128.5 (2C), 127.9, 126.9, 126.5, 125.0, 122.2 (2C), 121.0, 119.4, 110.4, 108.8, 61.0, 29.3, 13.6. 
LRMS* (ESI) m/z calcd for C22H22NO3 ([M + H + H2O]+) 348.2; found 348.5. 
*We were unable to obtain an accurate HRMS in ESI for this compound.  
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 As drug development has shifted its focus towards straightforward, planar molecules in 
the 21st century which can be quickly and conveniently synthesized, there exists a need to expand 
the chemical space of the drug development process to encompass molecules with a higher 
degree of structural complexity. The current trend in combinatorial chemistry has shifted 
development of pharmaceuticals to flat, aromatic compounds; because biological targets like 
proteins and receptors are complex three-dimensional structures, carefully designed, structurally 
complex small molecules are capable of binding with a high degree of selectivity, mitigating 
undesired side effects of off-target binding. Since the cost of a drug is directly related to the 
number of synthetic steps used to prepare the compound, we have formed a central research 
hypothesis utilizing reactive intermediates to form such compounds in a cascade fashion, directly 
reducing the number of steps in their synthesis. Ultimately, culmination of this research effort 
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has produced new methods of generating spiroethers, carbocycles, spirothiophenes, and an 
array of aromatic heterocycles.  
 First, we have employed a catalytic cocktail comprised of Rh2(esp)2 and Au+, which had 
been previously used for the formation of -butyrolactones from -diazocarbonyl compounds 
through an acid O–H insertion/Conia-ene cascade, towards the formation of tetrahydrofurans 
(Chapter 2). This approach has proven general for a range of ketoester, diketone, and malonate 
diazo substrates with primary and secondary alkynols. We have also shown that this approach 
could be applied to cyclic diazo substrates, for the formation of spiroethers. Targeting the core 
of the natural product Berkeleyamide D, we were able to synthesize -spiro--lactams with a high 
degree of stereocontrol. These efforts were not met without challenges however, as we observed 
reduced yields and diastereoselectivity when chiral secondary alkynols were used with these 
lactam diazos.  
 Next, we pursued the applications of using underexplored S–H and sp3 C–H nucleophiles 
in a cascade fashion (Chapter 3). When secondary mercaptynes were exposed to Rh2(esp)2 in the 
presence of a linear diazo substrate, we were able to isolate the corresponding insertion product 
then induce a Conia-ene cyclization in a stepwise fashion by exposing this compound to Au+. 
However, when the mercaptyne and diazo were exposed to all catalysts in a one-pot fashion, we 
instead isolated a thiofuranofuran product, which we expect formed via undesired 5-endo-dig 
cyclization of the mercaptyne before S–H insertion could occur. By altering our cascade approach 
to an intramolecular insertion/Conia-ene strategy, we were able to develop a diazo substrate 
capable of producing 3-spiroinden-2-ones through benzylic sp3 C-H insertion. These conditions 
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however did not prove general for the 5-membered and 7-membered Conia-ene cyclization 
however, as we had previously observed in a sp2 C–H insertion/Conia-ene cascade.  
 Lastly, in an orthogonal research effort, we have discovered a metal-free cascade 
approach to four classes of heterocycles (Chapter 4). The reaction cascade is commenced by an 
intramolecular aldol condensation generating a 1,3,5-triene intermediate; the triene undergoes 
a 6 electrocyclization and oxidative aromatization to generate a new aromatic ring. The cascade 
precursors are conveniently accessed through coupling of readily accessible 2’-
hydroxy/aminochalcones with vinylic carboxylic acids/acyl chlorides. The reaction conditions 
were suitable scale-up to gram scale without significant decrease in yields, and could also utilize 
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